# ::snt Identification and targeted disruption of the mouse gene encoding ESG1 ( PH34/ECAT2/DPPA5 ) .
# ::tok Identification and targeted disruption of the mouse gene encoding ESG1 ( PH34/ECAT2/DPPA5 ) .
# ::alignments 9-10|0.0.1.0+0.0.1+0.0 8-9|0.0.0 7-8|0.0.0.0 6-7|0.0.0.0.0 3-4|0.1.1 2-3|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:12.266
(t / target-01 
      :ARG1 (p / person 
            :ARG1-of (e / encode-01 
                  :ARG0 (g / gene 
                        :mod (m / mouse))) 
            :name (n / name 
                  :op1 "ESG1")) 
      :op2-of (a / and 
            :op1 (i / identification) 
            :op3 (d / disruption)))

# ::snt Embryonic stem cell-specific gene ( ESG ) 1 , which encodes a KH-domain containing protein , is specifically expressed in early embryos , germ cells , and embryonic stem ( ES ) cells .
# ::tok Embryonic stem cell-specific gene ( ESG ) 1 , which encodes a KH-domain containing protein , is specifically expressed in early embryos , germ cells , and embryonic stem ( ES ) cells .
# ::alignments 32-33|0.1.0.3 30-31|0.1.0.0.2.0 28-29|0.1.0.3.0 27-28|0.0.0 26-27|0.1.0 24-25|0.1.0.2 23-24|0.1.0.2.0 21-22|0.1.0.0.1 20-21|0.1.0.0.3 18-19|0.1.0.0 17-18|0.1.0.0.2 14-15|0 13-14|0.1 10-11|0.0 7-8|0.1.0.3.0.0 5-6|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 3-4|0.1.0.0.0.0.0 1-2|0.1.0.0.0.0 0-1|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:13.433
(p / protein 
      :ARG1-of (e6 / encode-01 
            :ARG0 (e2 / embryonic)) 
      :ARG1-of (c3 / contain-01 
            :ARG0 (a / and 
                  :ARG1-of (e5 / express-01 
                        :ARG0 (e7 / embryonic 
                              :ARG0-of (s3 / stem-01 
                                    :ARG1 (g2 / gene))) 
                        :ARG2 (e3 / embryo) 
                        :manner (s2 / specific-02 
                              :ARG1 (e / e)) 
                        :time (e4 / early)) 
                  :op1 (o / organization 
                        :name (n / name 
                              :op1 "ESG")) 
                  :op2 (c2 / cell 
                        :mod (g / germ)) 
                  :op3 (c / cell 
                        :mod (s / stem 
                              :mod 1)))))

# ::snt Previous studies identified genomic clones containing the mouse ESG1 gene and five pseudogenes .
# ::tok Previous studies identified genomic clones containing the mouse ESG1 gene and five pseudogenes .
# ::alignments 12-13|0.1.0.1.0 11-12|0.1.1 10-11|0.1.0.1 9-10|0.1.0.0 7-8|0.0.1 5-6|0.1.0 4-5|0.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:14.035
(i / identify-01 
      :ARG0 (s / study-01 
            :mod (p2 / previou) 
            :op1-of (m / mouse)) 
      :ARG1 (c2 / clone-01 
            :ARG0-of (c / contain-01 
                  :ARG1 (g / gene) 
                  :op1-of (a / and 
                        :op2 (p / pseudogen))) 
            :ARG1 5))

# ::snt However , their chromosomal localizations or physiological functions have not been determined .
# ::tok However , their chromosomal localizations or physiological functions have not been determined .
# ::alignments 11-12|0 9-10|0.1 7-8|0.0 6-7|0.0.1.1 5-6|0.0.1 4-5|0.0.1.0 3-4|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:14.107
(d / determined-02 
      :ARG0 (f / function-01 
            :ARG1 (c / chromosomal) 
            :op3-of (o / or 
                  :op1 (l / localization) 
                  :op2 (p / physiological))) 
      :polarity -)

# ::snt A Blast search of mouse genomic databases failed to locate the ESG1 gene .
# ::tok A Blast search of mouse genomic databases failed to locate the ESG1 gene .
# ::alignments 12-13|0.1.0 11-12|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 9-10|0.1 7-8|0 6-7|0.0.0 4-5|0.0.0.0 2-3|0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:14.653
(f / fail-01 
      :ARG1 (s / search-01 
            :ARG1 (d / database 
                  :mod (m / mouse)) 
            :ARG1-of (b / blast-01)) 
      :ARG2 (l / locate-02 
            :ARG1 (g / gene 
                  :mod (p / person 
                        :name (n / name 
                              :op1 "ESG1")))))

# ::snt We identified several bacterial artificial clones containing the mouse ESG1 gene and an additional ESG1-like sequence with a similar gene structure from chromosome 9 .
# ::tok We identified several bacterial artificial clones containing the mouse ESG1 gene and an additional ESG1-like sequence with a similar gene structure from chromosome 9 .
# ::alignments 23-24|0.0.1.1.0.0.0.1 22-23|0.0.2 20-21|0.0 19-20|0.0.0 18-19|0 15-16|0.0.1 13-14|0.0.1.0 11-12|0.0.1.1 10-11|0.0.1.1.0.1 9-10|0.0.1.1.1.1.0+0.0.1.1.1.1+0.0.1.1.1 8-9|0.0.1.1.1.0 6-7|0.0.1.1.0 5-6|0.0.1.1.0.0 4-5|0.0.1.1.0.0.1 3-4|0.0.1.1.0.0.2 2-3|0.0.1.1.0.0.3 1-2|0.0.1.1.0.0.0 0-1|0.0.1.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:16.000
(r / resemble-01 
      :ARG1 (s / structure 
            :mod (g / gene) 
            :prep-with-of (s2 / sequence 
                  :mod (a / additional) 
                  :op2-of (a2 / and 
                        :ARG1-of (c2 / contain-01 
                              :ARG0 (c3 / clone-01 
                                    :ARG1-of (i / identify-01 
                                          :ARG0 (w / we) 
                                          :ARG2 9) 
                                    :mod (a3 / artificial) 
                                    :mod (b / bacterial) 
                                    :quant (s3 / several)) 
                              :ARG2 (g2 / gene)) 
                        :op1 (p / person 
                              :mod (m / mouse) 
                              :name (n / name 
                                    :op1 "ESG1")))) 
            :source (c / chromosome)))

# ::snt The ESG1-like sequence contained a multiple critical mutations , indicating that it was a duplicated pseudogene .
# ::tok The ESG1-like sequence contained a multiple critical mutations , indicating that it was a duplicated pseudogene .
# ::alignments 15-16|0.0.0.0 14-15|0.0.0.0.0 9-10|0.0.0 7-8|0.1 6-7|0.1.0 5-6|0.1.1 3-4|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:16.069
(c2 / contain-01 
      :ARG0 (s / sequence 
            :ARG0-of (i / indicate-01 
                  :ARG1 (p / pseudogene 
                        :ARG1-of (d / duplicate-01)))) 
      :ARG1 (m / mutate-01 
            :ARG1-of (c / critical-02) 
            :quant (m2 / multiple)))

# ::snt The 5 ' flanking region of the ESG1 gene , but not that of the pseudogene , exhibited strong enhancer and promoter activity in undifferentiated ES cells by luciferase reporter assay .
# ::tok The 5 ' flanking region of the ESG1 gene , but not that of the pseudogene , exhibited strong enhancer and promoter activity in undifferentiated ES cells by luciferase reporter assay .
# ::alignments 30-31|0.0.1.0 29-30|0.0.0.1.0.0 26-27|0.0.0.1.0 25-26|0.0.0.1.0.1 24-25|0.0.0.1.0.2 22-23|0.0.1 21-22|0.0.1.1 20-21|0.0 19-20|0.0.0.1 18-19|0.0.0.1.1 17-18|0.0.0 15-16|0.0.1.1.1 12-13|0.0.1.1.1.0 11-12|0.0.1.1.0 10-11|0 8-9|0.1 7-8|0.1.0.0.0+0.1.0.0+0.1.0 4-5|0.0.0.0 3-4|0.0.0.0.0 1-2|0.0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:18.765
(c2 / contrast-01 
      :ARG1 (a3 / and 
            :ARG1-of (e3 / exhibit-01 
                  :ARG0 (r2 / region 
                        :ARG1-of (f / flank-01)) 
                  :ARG2 (e2 / enhance-01 
                        :ARG1 (c / cell 
                              :ARG1-of (r / report-01 
                                    :ARG0 5) 
                              :mod (e / e) 
                              :mod (u / undifferentiat)) 
                        :ARG1-of (s / strong-02))) 
            :op1 (a2 / activity-06 
                  :ARG0 (a / assay) 
                  :ARG1 (p / promote-01 
                        :ARG0 - 
                        :ARG1 (p2 / pseudogene 
                              :mod (t / that))))) 
      :ARG2 (g / gene 
            :mod (p3 / person 
                  :name (n / name 
                        :op1 "ESG1"))))

# ::snt To study the physiological functions of the ESG1 gene , we replaced this sequence in ES cells with a -geo cassette by homologous recombination .
# ::tok To study the physiological functions of the ESG1 gene , we replaced this sequence in ES cells with a -geo cassette by homologous recombination .
# ::alignments 23-24|0.0.0.1.2 22-23|0 20-21|0.0.0.1.0 16-17|0.0.0.1.3 15-16|0.0.0.1.3.0 13-14|0.0.0.1.1 12-13|0.0.0.1.1.0 11-12|0.0.0.1 10-11|0.0.0 8-9|0.0.0.0.0 7-8|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 4-5|0.0.0.0 3-4|0.0.0.0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:19.164
(h / homologou 
      :ARG0-of (s2 / study-01 
            :ARG1 (w / we 
                  :ARG0-of (f / function-01 
                        :ARG1 (g / gene 
                              :mod (p / person 
                                    :name (n / name 
                                          :op1 "ESG1"))) 
                        :mod (p2 / physiological)) 
                  :ARG0-of (r2 / replace-01 
                        :ARG1 (c / cassette) 
                        :ARG2 (s / sequence 
                              :mod (t / this)) 
                        :destination (r / recombination) 
                        :location (c2 / cell 
                              :mod (e / e))))))

# ::snt Despite specific expression in early embryos and germ cells , ESG1 - / - mice developed normally and were fertile .
# ::tok Despite specific expression in early embryos and germ cells , ESG1 - / - mice developed normally and were fertile .
# ::alignments 19-20|0.2 17-18|0 16-17|0.1.2 15-16|0.1 14-15|0.1.0 12-13|0.0 8-9|0.1.1.0.1 7-8|0.1.1.0.1.0 6-7|0.1.1.0 5-6|0.1.1.0.0 4-5|0.1.1.0.0.0 2-3|0.1.1 1-2|0.1.1.1 0-1|0.1.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:19.314
(a / and 
      :op1 (s / slash) 
      :op2 (d / develop-02 
            :ARG0 (m / mouse) 
            :ARG1 (e3 / express-01 
                  :ARG1 (a2 / and 
                        :op1 (e / embryo 
                              :mod (e2 / early)) 
                        :op2 (c / cell 
                              :mod (g / germ))) 
                  :ARG1-of (s2 / specific-02) 
                  :op1-of (d2 / despite)) 
            :ARG1-of (n / normal-02)) 
      :op3 (f / fertile))

# ::snt We also generated ESG1 - / - ES cells both by a second independent homologous recombination and directly from blastocysts derived from heterozygous intercrosses .
# ::tok We also generated ESG1 - / - ES cells both by a second independent homologous recombination and directly from blastocysts derived from heterozygous intercrosses .
# ::alignments 23-24|0.0 22-23|0 20-21|0.0.0 19-20|0.0.0.1 17-18|0.0.0.1.0 16-17|0.0.0.2.0.1 15-16|0.0.0.2.0 14-15|0.0.0.2.0.0 13-14|0.0.0.2.1+0.0.0.2 9-10|0.0.0.0 8-9|0.0.0.2.0.1.0.1 7-8|0.0.0.2.0.1.0.1.0 5-6|0.0.0.1.0.0 2-3|0.0.0.2.0.1.0 1-2|0.0.0.2.0.1.0.2 0-1|0.0.0.2.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:20.414
(h / heterozygou 
      :mod-of (i / intercross 
            :ARG2-of (d / derive-01 
                  :ARG0 (b2 / both) 
                  :ARG1 (b / blastocyst 
                        :ARG2-of (d2 / direct-02 
                              :ARG1 (s / slash))) 
                  :ARG1-of (d3 / depend-01 
                        :ARG0 (r / recombination 
                              :mod (h2 / homologou) 
                              :op1-of (a / and 
                                    :ARG2-of (g / generate-01 
                                          :ARG0 (w / we) 
                                          :ARG1 (c / cell 
                                                :mod (e / e)) 
                                          :mod (a2 / also)))) 
                        :polarity -))))

# ::snt Northern blot and western blot analyses confirmed the absence of ESG1 in these cells .
# ::tok Northern blot and western blot analyses confirmed the absence of ESG1 in these cells .
# ::alignments 13-14|0.1.1 12-13|0.1.1.0 10-11|0.1.0.0.0+0.1.0.0+0.1.0 8-9|0.1 6-7|0 5-6|0.0.2 4-5|0.0.2.0 3-4|0.0.1.1+0.0.1.0.0+0.0.1.0+0.0.1 2-3|0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:20.520
(c2 / confirm-01 
      :ARG0 (a3 / and 
            :op1 (b2 / blot-01 
                  :mod "Northern_Ireland") 
            :op2 (w / world-region 
                  :name (n2 / name 
                        :op1 "West") 
                  :wiki "Western_world") 
            :op3 (a2 / analysis 
                  :ARG1-of (b / blot-01))) 
      :ARG1 (a / absent-01 
            :ARG1 (p / person 
                  :name (n / name 
                        :op1 "ESG1")) 
            :location (c / cell 
                  :mod (t / this))))

# ::snt These ES cells demonstrated normal morphology , proliferation , and differentiation .
# ::tok These ES cells demonstrated normal morphology , proliferation , and differentiation .
# ::alignments 10-11|0.2.1 9-10|0.2 7-8|0.2.0 5-6|0.1 4-5|0.1.0 3-4|0 2-3|0.0 1-2|0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:20.958
(d2 / demonstrate-01 
      :ARG0 (c / cell 
            :mod (t / this) 
            :mod (e / e)) 
      :ARG1 (m / morphology 
            :ARG1-of (n / normal-02)) 
      :op1-of (a / and 
            :op2 (p / proliferate-01) 
            :op3 (d / differentiation)))

# ::snt The mouse ESG1 gene , together with a duplicated pseudogene , is located on chromosome 9 .
# ::tok The mouse ESG1 gene , together with a duplicated pseudogene , is located on chromosome 9 .
# ::alignments 15-16|0.0 14-15|0.2.2 12-13|0.2 9-10|0.1 8-9|0 5-6|0.2.0 3-4|0.2.1 2-3|0.2.1.0.1.0+0.2.1.0.1+0.2.1.0 1-2|0.2.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:21.447
(d / duplicate-01 
      :ARG0 9 
      :ARG1 (p / pseudogene) 
      :ARG2 (l / locate-01 
            :ARG0 (t / together) 
            :ARG1 (g / gene 
                  :mod (p2 / person 
                        :mod (m / mouse) 
                        :name (n / name 
                              :op1 "ESG1"))) 
            :location (c / chromosome)))

# ::snt Despite its specific expression in pluripotent cells and germ cells , ESG1 is dispensable for self-renewal of ES cells and establishment of germcells .
# ::tok Despite its specific expression in pluripotent cells and germ cells , ESG1 is dispensable for self-renewal of ES cells and establishment of germcells .
# ::alignments 22-23|0.0.0.0.0 20-21|0.0.0.0 19-20|0.0.0.3 18-19|0.0.0.3.0 17-18|0.0.0.3.0.1 15-16|0.0.0.3.0.0 13-14|0.0.0.1 11-12|0.0.0.2.0+0.0.0.2+0.0.0 9-10|0.0.3.0 8-9|0.0.3.0.0 7-8|0.0.3 6-7|0.0.1 5-6|0.0.1.0 3-4|0.0 2-3|0.0.2 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:21.638
(d2 / despite 
      :op1 (e3 / express-01 
            :ARG0 (p / person 
                  :ARG0-of (e / establish-01 
                        :location (g / germcell)) 
                  :domain-of (d / dispensable) 
                  :name (n / name 
                        :op1 "ESG1") 
                  :op1-of (a / and 
                        :op2 (c / cell 
                              :domain-of (s / self-renewal) 
                              :mod (e2 / e)))) 
            :ARG1 (c3 / cell 
                  :mod (p2 / pluripotent)) 
            :ARG1-of (s2 / specific-02) 
            :location (a2 / and 
                  :op1 (c2 / cell 
                        :mod (g2 / germ)))))

# ::snt Embryonic stem ( ES ) cells were first derived from the blastocysts of mice in 1981 [ 1,2 ] and humans in 1998 [ 3 ] .
# ::tok Embryonic stem ( ES ) cells were first derived from the blastocysts of mice in 1981 [ 1,2 ] and humans in 1998 [ 3 ] .
# ::alignments 24-25|0.0 22-23|0.0.0.3.0+0.0.0.3 20-21|0.0.0.2.0 19-20|0.0.0.2 15-16|0.0.0.1.1.0+0.0.0.1.1 13-14|0.0.0.1.0 11-12|0.0.0.1 8-9|0.0.0 5-6|0.0.0.0 3-4|0 1-2|0.0.0.0.0 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:22.031
(e / e 
      :mod (3 / 3 
            :op1 (d3 / derive-01 
                  :ARG1 (c / cell 
                        :mod (s / stem 
                              :mod (e2 / embryonic))) 
                  :ARG2 (b / blastocyst 
                        :mod (m / mouse) 
                        :time (d2 / date-entity 
                              :year 1981)) 
                  :duration (a / and 
                        :op1 (h / human)) 
                  :op1-of (d / date-entity 
                        :year 1998))))

# ::snt ES cells have two important properties : theability to maintain pluripotency , which is the ability to differentiate into a wide variety of cells , and rapid proliferation .
# ::tok ES cells have two important properties : theability to maintain pluripotency , which is the ability to differentiate into a wide variety of cells , and rapid proliferation .
# ::alignments 27-28|0.0.0.0 26-27|0.0.0.0.0 25-26|0.0.0 23-24|0.2 21-22|0 20-21|0.1 17-18|0.0 15-16|0.0.1 10-11|0.0.0.1.1 9-10|0.0.0.1 5-6|0.0.0.2 4-5|0.0.0.2.0 3-4|0.0.0.2.1 1-2|0.0.0.1.0 0-1|0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:23.047
(v / variety 
      :ARG1-of (d / differentiate-01 
            :ARG0 (a / and 
                  :ARG0-of (p / proliferate-01 
                        :manner (r / rapid)) 
                  :ARG1-of (m / maintain-01 
                        :ARG0 (c2 / cell 
                              :mod (e / e)) 
                        :ARG2 (p2 / pluripotency)) 
                  :op1 (p3 / property 
                        :mod (i / important) 
                        :quant 2)) 
            :purpose-of (a2 / ability)) 
      :ARG1-of (w / wide-02) 
      :domain (c / cell))

# ::snt These characteristics make mouse ES cells an essential component of gene targeting technology .
# ::tok These characteristics make mouse ES cells an essential component of gene targeting technology .
# ::alignments 12-13|0.0.0.0.1 11-12|0.0.0.0 10-11|0.0.0.0.0 8-9|0.0.0 7-8|0.0.0.1 5-6|0.0 4-5|0.0.1 3-4|0.0.1.0 1-2|0+0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:23.442
(c3 / characteristic-02 
      :ARG1 (c2 / cell 
            :domain-of (c / component 
                  :ARG2-of (t2 / target-01 
                        :ARG0 (g / gene) 
                        :ARG1 (t / technology)) 
                  :mod (e / essential)) 
            :mod (e2 / e 
                  :mod (m / mouse))) 
      :ARG2 (t3 / thing 
            :mod (t4 / this)))

# ::snt These qualitiesalso make human ES cells attractive sources for cell transplantation therapy to treat various diseases , including spinal cord injuries and juvenile diabetes .
# ::tok These qualitiesalso make human ES cells attractive sources for cell transplantation therapy to treat various diseases , including spinal cord injuries and juvenile diabetes .
# ::alignments 23-24|0.2 22-23|0.2.0 21-22|0 20-21|0.1 19-20|0.1.1 18-19|0.1.2 15-16|0.0.0.0.1 14-15|0.0.0.0.1.0 13-14|0.0.0.0 11-12|0.0.0.0.2 10-11|0.0.0.0.2.0 9-10|0.0.0.0.2.0.0 7-8|0.0.0 6-7|0.0 5-6|0.0.1 3-4|0.1.0 1-2|0.0.0.0.0 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:24.599
(a / and 
      :op1 (a2 / attract-01 
            :ARG0 (s2 / source 
                  :location-of (t / treat-01 
                        :ARG0 (q / qualitiesalso 
                              :mod (t4 / this)) 
                        :ARG1 (d2 / disease 
                              :mod (v / various)) 
                        :ARG2 (t2 / therapy 
                              :mod (t3 / transplantation 
                                    :mod (c2 / cell))))) 
            :ARG1 (c3 / cell)) 
      :op2 (i / injure-01 
            :ARG0 (h / human) 
            :ARG1 (c / cord) 
            :mod (s / spinal)) 
      :op3 (d / diabetes 
            :mod (j / juvenile)))

# ::snt The molecular mechanisms underlying the pluripotency and rapid proliferation of ES cells are currently a major focus of the field of stem cell biology [ 4-6 ] .
# ::tok The molecular mechanisms underlying the pluripotency and rapid proliferation of ES cells are currently a major focus of the field of stem cell biology [ 4-6 ] .
# ::alignments 23-24|0.0.1.0.0.1.1 22-23|0.0.1.0.0.1 21-22|0.0.1.0.0.1.0 19-20|0.0.1.0.0.0 16-17|0.0.1.0.0 15-16|0.0.1.0.0.2 13-14|0.0.1.0.0.3 11-12|0.0.0 10-11|0.0.0.0 8-9|0.0 7-8|0.0.2 6-7|0 3-4|0.0.1 2-3|0.0.1.0 1-2|0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:25.102
(a / and 
      :op1 (p / proliferate-01 
            :ARG0 (c3 / cell 
                  :mod (e / e)) 
            :ARG1-of (u / underlie-01 
                  :ARG0 (m2 / mechanism 
                        :ARG2-of (f2 / focus-01 
                              :ARG0 (f / field) 
                              :ARG1 (c / cell 
                                    :mod (s / stem) 
                                    :mod-of (b / biology)) 
                              :ARG1-of (m / major-02) 
                              :time (c2 / current)) 
                        :mod (m3 / molecule))) 
            :manner (r / rapid)))

# ::snt To identify molecules essential in ES cells for these properties , several groups have utilized transcriptome analyses to identify genes specifically expressed in ES cells and early embryos .
# ::tok To identify molecules essential in ES cells for these properties , several groups have utilized transcriptome analyses to identify genes specifically expressed in ES cells and early embryos .
# ::alignments 27-28|0.3 26-27|0.2 25-26|0 24-25|0.1 21-22|0.0 20-21|0.0.1 19-20|0.0.0 18-19|0.0.0.0 16-17|0.0.0.0.0.0.0 14-15|0.0.0.0.0.0 12-13|0.0.0.0.0 11-12|0.0.0.0.0.2 9-10|0.0.1.0.0 8-9|0.0.1.0 6-7|0.0.0.0.0.1.0.0.0 5-6|0.0.0.0.0.1.0.0.0.0 3-4|0.0.0.0.0.1.0.0 2-3|0.0.0.0.0.1.0 1-2|0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:25.539
(a / and 
      :ARG2-of (e3 / express-01 
            :ARG1 (g / gene 
                  :ARG1-of (i / identify-01 
                        :ARG0 (g2 / group 
                              :ARG0-of (u / utilize-01 
                                    :ARG1 (a2 / analysis)) 
                              :ARG0-of (i2 / identify-01 
                                    :ARG1 (m / molecule 
                                          :mod (e5 / essential 
                                                :location (c2 / cell 
                                                      :mod (e4 / e))))) 
                              :quant (s2 / several)))) 
            :manner (s / specific-02 
                  :ARG1 (t / this 
                        :mod-of (p / property)))) 
      :op1 (c / cell) 
      :op2 (e2 / early) 
      :op3 (e / embryo))

# ::snt These analyses , including DNA microarray analyses [ 7 ] and expressed sequence tag analyses [ 8-12 ] , identified several common transcripts , including ESG1 that was also designated dppa5 or ECAT2 .
# ::tok These analyses , including DNA microarray analyses [ 7 ] and expressed sequence tag analyses [ 8-12 ] , identified several common transcripts , including ESG1 that was also designated dppa5 or ECAT2 .
# ::alignments 31-32|0.1 29-30|0.4.0 28-29|0.4.0.1 25-26|0.4.1.0+0.4.1+0.4 22-23|0.3.1 21-22|0.3.1.0 20-21|0.3.1.1 19-20|0.3 14-15|0.2.1 13-14|0.2.1.0 12-13|0.2.1.0.0 11-12|0.2 10-11|0 8-9|0.4.0.0 6-7|0.2.0 5-6|0.2.0.0 4-5|0.3.0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:26.377
(a3 / and 
      :op1 (a5 / analysis 
            :mod (t3 / this)) 
      :op1-of (o / or) 
      :op2 (e / express-01 
            :ARG0 (a4 / analysis 
                  :mod (m / microarray)) 
            :ARG1 (a2 / analysis 
                  :ARG0-of (t2 / tag-01 
                        :ARG1 (s2 / sequence)))) 
      :op3 (i / identify-01 
            :ARG0 (d2 / DNA) 
            :ARG1 (t / transcript 
                  :mod (c / common) 
                  :quant (s / several))) 
      :op4 (p / person 
            :ARG1-of (d / designate-01 
                  :ARG2 7 
                  :mod (a / also)) 
            :name (n / name 
                  :op1 "ESG1")))

# ::snt ESG1 was originally identified as a transcript Ph34 that was down-regulated by retinoic acid in embryonic carcinoma cells [ 13 ] .
# ::tok ESG1 was originally identified as a transcript Ph34 that was down-regulated by retinoic acid in embryonic carcinoma cells [ 13 ] .
# ::alignments 19-20|0.0 17-18|0.2.0.0.0 16-17|0.2.0.0 15-16|0.2.0.0.0.0 13-14|0.2.0 7-8|0.2 6-7|0.2.1.0+0.2.1 3-4|0 2-3|0.3 0-1|0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:26.502
(i / identify-01 
      :ARG0 13 
      :ARG1 (p2 / person 
            :name (n / name 
                  :op1 "ESG1")) 
      :ARG2 (p / Ph34 
            :location (a / acid 
                  :source (c2 / carcinoma 
                        :mod-of (c / cell 
                              :mod (e / embryonic)))) 
            :mod (t / thing 
                  :ARG1-of (t2 / transcribe-01))) 
      :time (o / original))

# ::snt The expression of this gene was confined in mice to early embryos and germ cells [ 14 ] .
# ::tok The expression of this gene was confined in mice to early embryos and germ cells [ 14 ] .
# ::alignments 16-17|0.0 14-15|0.1.0.0 13-14|0.1.0 12-13|0.2.1 11-12|0.2 10-11|0.2.0 8-9|0.3 6-7|0 4-5|0.1.1 3-4|0.1.1.0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:26.655
(c2 / confine-01 
      :ARG0 14 
      :ARG1 (e3 / express-01 
            :ARG0 (g / germ 
                  :mod-of (c / cell)) 
            :ARG1 (g2 / gene 
                  :mod (t / this))) 
      :ARG2 (e / embryo 
            :mod (e2 / early) 
            :op1-of (a / and)) 
      :location (m / mouse))

# ::snt It is also expressed in pluripotent cells , including ES cells , embryonic germ cells , and multipotent germline stem cells [ 15 ] .
# ::tok It is also expressed in pluripotent cells , including ES cells , embryonic germ cells , and multipotent germline stem cells [ 15 ] .
# ::alignments 22-23|0.0 20-21|0.4.0.1 19-20|0.4.0 18-19|0.4.0.0 17-18|0.4.0.0.0 16-17|0.4 14-15|0.4.0.2.0 13-14|0.4.0.2.0.0 12-13|0.4.0.2 10-11|0.4.0.1.0.0 9-10|0.4.0.1.0 6-7|0.2 3-4|0 2-3|0.3 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:26.900
(e3 / express-01 
      :ARG0 15 
      :ARG1 (i / it) 
      :manner (c4 / cell) 
      :mod (a2 / also) 
      :op1-of (a / and 
            :op2 (s / stem-01 
                  :ARG0 (g / germline 
                        :mod (m / multipotent)) 
                  :ARG1 (c / cell 
                        :topic (e2 / e 
                              :mod-of (c3 / cell))) 
                  :ARG2 (e / embryonic 
                        :mod-of (c2 / cell 
                              :mod (g2 / germ))))))

# ::snt ESG1 encodes a polypeptide of 118 amino acids that contains a single KH domain , which is an RNA-binding domain [ 16 ] .
# ::tok ESG1 encodes a polypeptide of 118 amino acids that contains a single KH domain , which is an RNA-binding domain [ 16 ] .
# ::alignments 21-22|0.0.3 19-20|0.0.2 18-19|0 13-14|0.0.0.0.0 12-13|0.0.0.0.0.1.0.0+0.0.0.0.0.1.0+0.0.0.0.0.1 11-12|0.0.0.0.0.0 9-10|0.0.0.0 7-8|0.0.0.0.0.2 6-7|0.0.0.0.0.2.0 3-4|0.0.1 1-2|0.0 0-1|0.0.0.1.0+0.0.0.1+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:27.114
(r / rna-bind 
      :op1 (e / encode-01 
            :ARG0 (p2 / person 
                  :ARG0-of (c / contain-01 
                        :ARG1 (d2 / domain 
                              :ARG1-of (s / single-02) 
                              :mod (t / thing 
                                    :name (n / name 
                                          :op1 "KH")) 
                              :mod-of (a / acid 
                                    :mod (a2 / amino)))) 
                  :name (n2 / name 
                        :op1 "ESG1")) 
            :ARG1 (p / polypeptide) 
            :ARG2 (d / domain) 
            :op1-of 16))

# ::snt It remains unclear , however , if ESG1 functions as an RNA-binding protein or the roles it plays in ES cells and mice .
# ::tok It remains unclear , however , if ESG1 functions as an RNA-binding protein or the roles it plays in ES cells and mice .
# ::alignments 22-23|0.3 21-22|0 20-21|0.2 19-20|0.2.0 17-18|0.1 15-16|0.1.0 13-14|0.1.0.0 12-13|0.1.0.0.1 11-12|0.1.0.0.1.0 8-9|0.1.0.0.0 2-3|0.0.1+0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:27.255
(a / and 
      :ARG1-of (c2 / clear-06 
            :ARG3-of (r3 / remain-01 
                  :ARG1 (i / it)) 
            :polarity -) 
      :ARG2-of (p / play-02 
            :ARG1 (r / role 
                  :op2-of (o / or 
                        :ARG1-of (f / function-01) 
                        :op1 (p2 / protein 
                              :mod (r2 / rna-bind))))) 
      :op1 (c / cell 
            :mod (e / e)) 
      :op2 (m / mouse))

# ::snt Previous genomic library screening by identified genomic clones containing the mouse ESG1 gene and seven pseudogenes [ 17 ] .
# ::tok Previous genomic library screening by identified genomic clones containing the mouse ESG1 gene and seven pseudogenes [ 17 ] .
# ::alignments 17-18|0.0.0.0.1 15-16|0.0.0.0.0.0.0 14-15|0.0.0.0.0.0.0.0 13-14|0.0.0.1 12-13|0.0.0.0.0.0 11-12|0.0.0.0.0.0.1.0.0+0.0.0.0.0.0.1.0+0.0.0.0.0.0.1 10-11|0.1 8-9|0.0.0.0.0 7-8|0.0.0.0 5-6|0.0.0 3-4|0 2-3|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:27.919
(s / screen-01 
      :ARG0 (l / library 
            :ARG0-of (i / identify-01 
                  :ARG1 (c2 / clone-01 
                        :ARG0-of (c / contain-01 
                              :ARG1 (g / gene 
                                    :location-of (p / pseudogen 
                                          :quant 7) 
                                    :mod (p2 / person 
                                          :name (n / name 
                                                :op1 "ESG1")))) 
                        :ARG1 17) 
                  :op1-of (a / and)) 
            :mod (p3 / previou)) 
      :ARG1 (m / mouse))

# ::snt Two of these pseudogenes exhibit a similar exon-intron structure as the ESG1 gene , indicating their generation by gene duplication .
# ::tok Two of these pseudogenes exhibit a similar exon-intron structure as the ESG1 gene , indicating their generation by gene duplication .
# ::alignments 19-20|0.3.0 18-19|0.3.0.0 16-17|0.3.1 14-15|0.3 12-13|0.2 11-12|0.2.0.0.0+0.2.0.0+0.2.0 8-9|0.1 6-7|0.1.0 4-5|0 3-4|0.0 2-3|0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:28.143
(e / exhibit-01 
      :ARG0 (p2 / pseudogen 
            :mod (t / this) 
            :quant 2) 
      :ARG1 (s / structure 
            :ARG1-of (r / resemble-01)) 
      :ARG3 (g3 / gene 
            :mod (p / person 
                  :name (n / name 
                        :op1 "ESG1"))) 
      :purpose (i / indicate-01 
            :ARG0 (d / duplication 
                  :mod (g / gene)) 
            :ARG1 (g2 / generation)))

# ::snt The five remaining pseudogenes did not contain any introns , indicating that these were generated by retrotransposition of ESG1 transcripts .
# ::tok The five remaining pseudogenes did not contain any introns , indicating that these were generated by retrotransposition of ESG1 transcripts .
# ::alignments 19-20|0.0.0.0.0.0 16-17|0.0.0.0.0 14-15|0.0.0.0 12-13|0.0.0.0.1 10-11|0.0.0 8-9|0.1 7-8|0.1.0 6-7|0 5-6|0.2 3-4|0.0 2-3|0.0.1 1-2|0.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:28.395
(c / contain-01 
      :ARG0 (p / pseudogen 
            :ARG0-of (i / indicate-01 
                  :ARG1 (g / generate-01 
                        :ARG0 (r / retrotransposition 
                              :mod (t / transcript)) 
                        :ARG1 (t2 / this) 
                        :ARG2 5)) 
            :ARG1-of (r2 / remain-01)) 
      :ARG1 (i2 / intron 
            :mod (a / any)) 
      :polarity -)

# ::snt The chromosomal localizations of the mouse ESG1 gene and pseudogenes , however , have not been reported .
# ::tok The chromosomal localizations of the mouse ESG1 gene and pseudogenes , however , have not been reported .
# ::alignments 16-17|0 14-15|0.1 9-10|0.0.3 8-9|0.0 7-8|0.0.2 6-7|0.0.1.0.0+0.0.1.0+0.0.1 5-6|0.0.2.0 2-3|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:28.586
(r / report-01 
      :ARG1 (a / and 
            :op1 (l / localization 
                  :mod (c / chromosomal)) 
            :op2 (p2 / person 
                  :name (n / name 
                        :op1 "ESG1")) 
            :op3 (g / gene 
                  :mod (m / mouse)) 
            :op4 (p / pseudogen)) 
      :polarity -)

# ::snt In this study , we determined the structure of the mouse gene encoding this protein and related pseudogenes .
# ::tok In this study , we determined the structure of the mouse gene encoding this protein and related pseudogenes .
# ::alignments 17-18|0.0.0.0.0.1.0 16-17|0.0.0.0.0.1.0.0 15-16|0.0.0.0.0.1 14-15|0.0.0.0 13-14|0.0.0.0.1 12-13|0.0.0.0.0 11-12|0.0.0.0.0.0 10-11|0.0.0.0.0.0.0 7-8|0.1 5-6|0 4-5|0.0 2-3|0.0.0 1-2|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:29.745
(d / determine-01 
      :ARG0 (w / we 
            :ARG0-of (s2 / study-01 
                  :ARG1 (p2 / protein 
                        :ARG1-of (e / encode-01 
                              :ARG0 (g / gene 
                                    :mod (m / mouse)) 
                              :op1-of (a / and 
                                    :op2 (p / pseudogen 
                                          :ARG1-of (r / relate-01)))) 
                        :mod (t / this)) 
                  :mod (t2 / this))) 
      :ARG1 (s / structure))

# ::snt We also performed gene targeting to determine the physiological function of ESG1 .
# ::tok We also performed gene targeting to determine the physiological function of ESG1 .
# ::alignments 11-12|0.0.0.0.0+0.0.0.0+0.0.0 9-10|0.0 8-9|0.0.1 6-7|0 4-5|0.1 3-4|0.1.0 2-3|0.1.0.0 1-2|0.1.0.0.1 0-1|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:29.861
(d / determine-01 
      :ARG1 (f / function-01 
            :ARG0 (p / person 
                  :name (n / name 
                        :op1 "ESG1")) 
            :ARG1 (p2 / physiological)) 
      :ARG1-of (t / target-01 
            :ARG0 (g / gene 
                  :ARG1-of (p3 / perform-02 
                        :ARG0 (w / we) 
                        :mod (a / also)))))

# ::snt Chromosomal localization and structures of mouse ESG1 gene and psedogenes .
# ::tok Chromosomal localization and structures of mouse ESG1 gene and psedogenes .
# ::alignments 9-10|0.0.1.1 8-9|0.0.1 7-8|0.0.1.0 5-6|0.0.1.0.0 3-4|0.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:29.908
(a2 / and 
      :op1 (l / localization 
            :mod (c / chromosomal) 
            :op1-of (a / and 
                  :op2 (g / gene 
                        :mod (m / mouse)) 
                  :op3 (p / psedogen))) 
      :op2 (s / structure))

# ::snt To determine the chromosomal localizations of the mouse ESG1 gene and pseudogenes , we performed a Blast analysis of the mouse genomic database with the ESG1 cDNA sequence as a query .
# ::tok To determine the chromosomal localizations of the mouse ESG1 gene and pseudogenes , we performed a Blast analysis of the mouse genomic database with the ESG1 cDNA sequence as a query .
# ::alignments 30-31|0.0.0.0.0 27-28|0.0.0.0.1.0.0.1 26-27|0.0.0.0.1.0.0.1.0 22-23|0.0.0.0.1.0.0 20-21|0.0.0.0.1.0.0.0 17-18|0.0.0.0.1.0 16-17|0.0.0.0.1.0.1 14-15|0.0.0.0.1 13-14|0.0.0.0 11-12|0 10-11|0.0 9-10|0.0.2 8-9|0.0.1.0.0+0.0.1.0+0.0.1 7-8|0.0.0.0.0.0 4-5|0.0.0.1 3-4|0.0.0.1.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:31.339
(p2 / pseudogen 
      :op4-of (a2 / and 
            :op1 (d2 / determine-01 
                  :ARG0 (w / we 
                        :ARG0-of (q / query-01 
                              :ARG1 (m2 / mouse)) 
                        :ARG0-of (p / perform-02 
                              :ARG1 (a / analyze-01 
                                    :ARG1 (d / database 
                                          :mod (m / mouse) 
                                          :poss (s / sequence 
                                                :mod (c / cdna))) 
                                    :ARG2 (b / blast-01)))) 
                  :ARG1 (l / localization 
                        :mod (c2 / chromosomal))) 
            :op2 (p3 / person 
                  :name (n / name 
                        :op1 "ESG1")) 
            :op3 (g / gene)))

# ::snt We identified several putative pseudogenes without introns on chromosomes 1 , 5 , 11 , 12 , 14 , 16 , 17 , and X ( Figure 1 ) .
# ::tok We identified several putative pseudogenes without introns on chromosomes 1 , 5 , 11 , 12 , 14 , 16 , 17 , and X ( Figure 1 ) .
# ::alignments 27-28|0.0.1.1 26-27|0.0.1.2.0 24-25|0.0.1.0.0 23-24|0 21-22|0.0.5 19-20|0.0.8 17-18|0.0.4 15-16|0.0.6 13-14|0.0.7 11-12|0.0.3 9-10|0.0.1.1.0 8-9|0.1 6-7|0.0.2 4-5|0.0.1 3-4|0.0.1.0 2-3|0.0.1.2 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:31.979
(a / and 
      :op1 (i2 / identify-01 
            :ARG0 (w / we) 
            :ARG1 (p / pseudogen 
                  :mod (p2 / putative 
                        :mod (x / x)) 
                  :mod (1 / 1 
                        :mod-of 1) 
                  :quant (s / several 
                        :quant-of (f / figure))) 
            :manner (i / intron) 
            :op1-of 5 
            :op1-of 14 
            :op1-of 17 
            :op1-of 12 
            :op1-of 11 
            :op1-of 16) 
      :op2 (c / chromosom))

# ::snt In addition , two intron-less pseudogenes were identified in DNA fragments for which the chromosomal localization remained unmapped .
# ::tok In addition , two intron-less pseudogenes were identified in DNA fragments for which the chromosomal localization remained unmapped .
# ::alignments 17-18|0 16-17|0.0 15-16|0.0.1 14-15|0.0.1.0 10-11|0.0.0 9-10|0.0.0.0 7-8|0.0.0.1 5-6|0.0.0.1.0 4-5|0.0.0.1.0.0 3-4|0.0.0.1.0.1 1-2|0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:32.305
(u / unmapp 
      :ARG2-of (r / remain-01 
            :ARG0-of (f / fragment-01 
                  :ARG1 (d / DNA) 
                  :ARG2-of (i / identify-01 
                        :ARG1 (p / pseudogen 
                              :mod (i2 / intron-les) 
                              :quant 2) 
                        :time (a / addition))) 
            :ARG1 (l / localization 
                  :mod (c / chromosomal))))

# ::snt While these pseudodgenes have significant homology to ESG1 cDNA , they could not produce functional proteins , because of critical mutations .
# ::tok While these pseudodgenes have significant homology to ESG1 cDNA , they could not produce functional proteins , because of critical mutations .
# ::alignments 20-21|0.0.2.0 19-20|0.0.2.0.1 17-18|0.0.2 15-16|0.0.1 14-15|0.0.1.0 13-14|0.0 12-13|0.2 11-12|0 10-11|0.0.0 8-9|0.0.2.0.0.0 7-8|0.0.2.0.0 5-6|0.0.0.0 4-5|0.0.0.0.0 2-3|0.1.0 1-2|0.1.0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:33.010
(p3 / possible-01 
      :ARG1 (p2 / produce-01 
            :ARG0 (t / they 
                  :poss-of (h / homology 
                        :ARG1-of (s / significant-02))) 
            :ARG1 (p / protein 
                  :mod (f / functional)) 
            :ARG1-of (c2 / cause-01 
                  :ARG0 (m / mutate-01 
                        :ARG1 (e / ESG1 
                              :mod-of (c3 / cdna)) 
                        :ARG1-of (c / critical-02)))) 
      :ARG1-of (w / while-01 
            :ARG0 (p4 / pseudodgen 
                  :mod (t2 / this))) 
      :polarity -)

# ::snt This result suggests that there are a larger number of intron-less pseudogenes than previously anticipated .
# ::tok This result suggests that there are a larger number of intron-less pseudogenes than previously anticipated .
# ::alignments 14-15|0.1.0 13-14|0.1.0.0 11-12|0.1.2 10-11|0.1.2.0 8-9|0.1 7-8|0.1.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:33.056
(s / suggest-01 
      :ARG0 (r / result-01 
            :mod (t / this)) 
      :ARG1 (n / number 
            :ARG1-of (a / anticipate-01 
                  :time (p / previous)) 
            :mod (l / large) 
            :quant-of (p2 / pseudogen 
                  :mod (i / intron-les))))

# ::snt Existence of multiple retropseudogenes is a hallmark of pluripotent cell-specific genes [ 18 ] .
# ::tok Existence of multiple retropseudogenes is a hallmark of pluripotent cell-specific genes [ 18 ] .
# ::alignments 12-13|0.0.1 10-11|0.1 6-7|0 3-4|0.0.0 2-3|0.0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:33.088
(h / hallmark 
      :domain (e / existence 
            :mod (r / retropseudogen 
                  :quant (m / multiple)) 
            :poss-of 18) 
      :poss (g / gene))

# ::snt ESG1pseudogenes identified by a Blast search of mouse genomic databases .
# ::tok ESG1pseudogenes identified by a Blast search of mouse genomic databases .
# ::alignments 9-10|0.0 7-8|0 5-6|0.0.0 4-5|0.0.0.1 1-2|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:33.118
(m / mouse 
      :mod-of (d / database 
            :ARG1-of (s / search-01 
                  :manner-of (i / identify-01 
                        :ARG1 (e / esg1pseudogen)) 
                  :medium (b / blast-01))))

# ::snt Substitution mutations are indicated by black lines .
# ::tok Substitution mutations are indicated by black lines .
# ::alignments 6-7|0.0 5-6|0.0.0 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:33.137
(i / indicate-01 
      :ARG0 (l / line 
            :ARG1-of (b / black-04)) 
      :ARG1 (m / mutate-01 
            :mod (s / substitution)))

# ::snt Intron-like gap sequences are indicated with triangles .
# ::tok Intron-like gap sequences are indicated with triangles .
# ::alignments 6-7|0.1 4-5|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:33.189
(i / indicate-01 
      :ARG1 (s / sequence 
            :mod (g / gap)) 
      :ARG2 (t / triangl))

# ::snt Chromosomal localizations are shown on the right .
# ::tok Chromosomal localizations are shown on the right .
# ::alignments 6-7|0.1 3-4|0 0-2|0.0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:33.287
(s / show-01 
      :ARG1 (t / thing 
            :name (n / name 
                  :op1 (c / Chromosomal) 
                  :op2 (l / localizations))) 
      :ARG2 (r / right-05))

# ::snt On chromosome 9 , we identified a DNA fragment similar to the ESG1 gene that included two putative introns .
# ::tok On chromosome 9 , we identified a DNA fragment similar to the ESG1 gene that included two putative introns .
# ::alignments 18-19|0.1 17-18|0.1.0 16-17|0.1.1 15-16|0 13-14|0.0 9-10|0.0.0 8-9|0.0.0.1 7-8|0.0.0.1.0 5-6|0.0.0.1.1 4-5|0.0.0.1.1.0 2-3|0.0.0.0 1-2|0.0.0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:33.496
(i2 / include-01 
      :ARG0 (g / gene 
            :ARG2-of (r / resemble-01 
                  :ARG0 9 
                  :ARG1 (f / fragment-01 
                        :ARG1 (d / DNA) 
                        :ARG1-of (i3 / identify-01 
                              :ARG0 (w / we) 
                              :ARG2 (c / chromosome))))) 
      :ARG1 (i / intron 
            :mod (p / putative) 
            :quant 2))

# ::snt These putative first and second exons , however , contained ( 4 ) multiple mutations of the ESG1 cDNA sequence .
# ::tok These putative first and second exons , however , contained ( 4 ) multiple mutations of the ESG1 cDNA sequence .
# ::alignments 19-20|0.2.0 18-19|0.2.0.0 17-18|0.2.0.0.0 14-15|0.2 13-14|0.2.2 11-12|0.2.1 9-10|0 5-6|0.0 3-4|0.1 1-2|0.0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:34.133
(c2 / contain-01 
      :ARG0 (e2 / exon 
            :mod (p / putative)) 
      :ARG1 (a / and 
            :mod (t / this)) 
      :ARG2 (m / mutate-01 
            :ARG0 (s / sequence 
                  :mod (c / cdna 
                        :mod (e / ESG1))) 
            :ARG1 4 
            :quant (m2 / multiple)))

# ::snt The putative third exon was identical to that of the previously reported ESG1 gene .
# ::tok The putative third exon was identical to that of the previously reported ESG1 gene .
# ::alignments 13-14|0.0 11-12|0 10-11|0.2 7-8|0.1.1 5-6|0.1 3-4|0.1.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:34.217
(r / report-01 
      :ARG1 (g / gene) 
      :purpose-of (i / identical-01 
            :ARG1 (e / exon 
                  :mod (p2 / putative)) 
            :ARG2 (t / that)) 
      :time (p / previous))

# ::snt Also on chromosome 9 , we identified another DNA fragment that was similar , but not identical , to the third exon of the ESG1 gene .
# ::tok Also on chromosome 9 , we identified another DNA fragment that was similar , but not identical , to the third exon of the ESG1 gene .
# ::alignments 25-26|0.1.1.0 21-22|0.1.1 16-17|0.2 15-16|0.2.1 14-15|0 12-13|0.1 9-10|0.1.0 8-9|0.1.0.0 7-8|0.1.0.2 6-7|0.1.0.1 5-6|0.1.0.1.0 3-4|0.2.0 2-3|0.1.0.1.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:34.439
(c / contrast-01 
      :ARG0 (a2 / also) 
      :ARG1 (r / resemble-01 
            :ARG1 (f / fragment-01 
                  :ARG1 (d / DNA) 
                  :ARG1-of (i2 / identify-01 
                        :ARG0 (w / we) 
                        :ARG2 (c2 / chromosome)) 
                  :mod (a / another)) 
            :ARG2 (e / exon 
                  :poss (g / gene))) 
      :ARG2 (i / identical-01 
            :ARG1 9 
            :polarity -))

# ::snt These findings suggest that these ESG1-like sequences on chromosome 9 have not been correctly assembled .
# ::tok These findings suggest that these ESG1-like sequences on chromosome 9 have not been correctly assembled .
# ::alignments 14-15|0.1 13-14|0.1.2 11-12|0.1.3 9-10|0.1.2.0 8-9|0.1.1.0 6-7|0.1.1 4-5|0.1.0 2-3|0 1-2|0.0.0+0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:34.549
(s2 / suggest-01 
      :ARG0 (t2 / thing 
            :ARG1-of (f / find-01) 
            :mod (t3 / this)) 
      :ARG1 (a / assemble-01 
            :ARG0 (t / this) 
            :ARG1 (s / sequence 
                  :location (c2 / chromosome)) 
            :ARG1-of (c / correct-02 
                  :ARG0 9) 
            :polarity -))

# ::snt To obtain DNA fragments containing the ESG1 gene , we screened the bacterial artificial chromosome ( BAC ) DNA pool by PCR using primer pairs that would only amplify the real gene , not the pseudogenes .
# ::tok To obtain DNA fragments containing the ESG1 gene , we screened the bacterial artificial chromosome ( BAC ) DNA pool by PCR using primer pairs that would only amplify the real gene , not the pseudogenes .
# ::alignments 35-36|0.0.0.0.0.0 33-34|0.0.0.0.0 31-32|0.0.1.0.1.0 30-31|0.0.1.0.1.0.0 28-29|0.0.1.0.1 27-28|0.0.1.0.1.1 24-25|0.0.1.0 23-24|0.0.1.0.2 22-23|0.0.1 19-20|0.0.1.0.3.0 18-19|0.0.1.0.3 16-17|0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 14-15|0.1 13-14|0.1.0 12-13|0.1.1 10-11|0 9-10|0.0 7-8|0.0.0.0.1.0 4-5|0.0.0.0.1 3-4|0.0.0.0 2-3|0.0.0.0.2 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:35.339
(s / screen-01 
      :ARG0 (w / we 
            :ARG0-of (o3 / obtain-01 
                  :ARG1 (f / fragment-01 
                        :ARG0 (- / - 
                              :polarity-of (p / pseudogen)) 
                        :ARG0-of (c2 / contain-01 
                              :ARG1 (g2 / gene)) 
                        :ARG1 (d2 / DNA))) 
            :ARG0-of (u / use-01 
                  :ARG1 (p2 / pair-01 
                        :ARG0 (o2 / organization 
                              :name (n / name 
                                    :op1 "BAC")) 
                        :ARG0-of (a / amplify-01 
                              :ARG1 (g / gene 
                                    :mod (r / real)) 
                              :mod (o / only)) 
                        :ARG1 (p3 / primer) 
                        :ARG2 (d / DNA 
                              :mod-of (p4 / pool))))) 
      :ARG1 (c / chromosome 
            :mod (a2 / artificial) 
            :mod (b / bacterial)))

# ::snt We obtained two independent , but overlapping BAC clones .
# ::tok We obtained two independent , but overlapping BAC clones .
# ::alignments 8-9|0.1 7-8|0.1.0.0.0+0.1.0.0+0.1.0 6-7|0.1.2 5-6|0 3-4|0.0.1+0.0 2-3|0.0.0 1-2|0.1.1 0-1|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:35.426
(c2 / contrast-01 
      :ARG1 (d / depend-01 
            :ARG1 2 
            :polarity -) 
      :ARG2 (c / clone-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "BAC")) 
            :ARG1 (o3 / obtain-01 
                  :ARG0 (w / we)) 
            :ARG1-of (o2 / overlap-01)))

# ::snt Southern blot analyses and sequencing demonstrated that these clones contained a sequence exhibiting complete identity with ESG1 cDNA that was interrupted by two putative introns ( Figure 2A ) .
# ::tok Southern blot analyses and sequencing demonstrated that these clones contained a sequence exhibiting complete identity with ESG1 cDNA that was interrupted by two putative introns ( Figure 2A ) .
# ::alignments 26-27|0.1.0.0 24-25|0.0.2.0.0.0 23-24|0.0.2.0.0.0.0 22-23|0.0.2.0.0.0.1 20-21|0.0.2.0.0 17-18|0.0.2.0 16-17|0.0.2.1.0+0.0.2.1+0.0.2 14-15|0.1.1.0.0 13-14|0.1.1.0.0.0 12-13|0.1.1.0 11-12|0.1.1 9-10|0.1 8-9|0.1.0 7-8|0.1.0.1 5-6|0 4-5|0.0.1 3-4|0.0 2-3|0.0.0 1-2|0.0.0.0 0-1|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:36.782
(d / demonstrate-01 
      :ARG0 (a / and 
            :op1 (a2 / analysis 
                  :ARG1-of (b / blot-01 
                        :ARG0 (t2 / thing 
                              :name (n2 / name 
                                    :op1 "Southern")))) 
            :op2 (s2 / sequence) 
            :op3 (p2 / person 
                  :mod-of (c / cdna 
                        :ARG1-of (i2 / interrupt-01 
                              :ARG0 (i / intron 
                                    :mod (p / putative) 
                                    :quant 2))) 
                  :name (n / name 
                        :op1 "ESG1"))) 
      :ARG1 (c3 / contain-01 
            :ARG0 (c4 / clone-01 
                  :ARG1 (f / figure) 
                  :mod (t / this)) 
            :ARG1 (s / sequence 
                  :ARG0-of (e / exhibit-01 
                        :ARG1 (i3 / identity 
                              :ARG1-of (c2 / complete-02))))))

# ::snt The two intron sequences begin with GT and terminate with AG , fulfilling the GT-AG rule of exon-intron junctions [ 19 ] .
# ::tok The two intron sequences begin with GT and terminate with AG , fulfilling the GT-AG rule of exon-intron junctions [ 19 ] .
# ::alignments 20-21|0.1.0 18-19|0.1.1.0.0.0 15-16|0.1.1.0.0 14-15|0.1.1.0.0.1.0.0+0.1.1.0.0.1.0+0.1.1.0.0.1 12-13|0.1.1.0 10-11|0.2 8-9|0.1 7-8|0 6-7|0.0.0.0.0+0.0.0.0+0.0.0 4-5|0.0 3-4|0.1.1 2-3|0.1.1.1 1-2|0.1.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:36.951
(a2 / and 
      :op1 (b / begin-01 
            :ARG1 (o / organization 
                  :name (n2 / name 
                        :op1 "GT"))) 
      :op2 (t2 / terminate-01 
            :ARG0 19 
            :ARG1 (s / sequence 
                  :ARG0-of (f / fulfill-01 
                        :ARG1 (r / rule-03 
                              :ARG0 (j / junction) 
                              :ARG1 (t / thing 
                                    :name (n / name 
                                          :op1 "GT-AG")))) 
                  :mod (i / intron) 
                  :quant 2)) 
      :op3 (a / ag))

# ::snt The 5 ' flanking region of this DNA fragment exhibited strong promoter/enhancer activity by luciferase reporter assays in undifferentiated ES cells , but not in somatic cells ( Figure 3 ) .
# ::tok The 5 ' flanking region of this DNA fragment exhibited strong promoter/enhancer activity by luciferase reporter assays in undifferentiated ES cells , but not in somatic cells ( Figure 3 ) .
# ::alignments 29-30|0.0 28-29|0.1.2.0.1 26-27|0.1.0.0.0.0 25-26|0.1.0.0.0 23-24|0.1.3.1 22-23|0 20-21|0.1.3.0.0 19-20|0.1.3.0.0.0 18-19|0.1.3.0.0.1 16-17|0.1.3.0 15-16|0.1.2.0 12-13|0.1 11-12|0.1.1 10-11|0.1.2 9-10|0.1.3 8-9|0.1.2.0.2 7-8|0.1.2.0.2.0 6-7|0.1.2.0.2.1 4-5|0.1.0 3-4|0.1.0.0 1-2|0.1.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:37.637
(c2 / contrast-01 
      :ARG1 3 
      :ARG2-of (a2 / activity-06 
            :ARG0 (r2 / region 
                  :ARG1-of (f3 / flank-01 
                        :ARG0 (s / somatic 
                              :mod-of (c / cell)))) 
            :ARG1 (p / promoter/enhanc) 
            :ARG1-of (s2 / strong-02 
                  :ARG2 (r / report-01 
                        :ARG0 5 
                        :ARG1 (f / figure) 
                        :ARG2 (f2 / fragment-01 
                              :ARG1 (d / DNA) 
                              :mod (t / this)))) 
            :ARG1-of (e2 / exhibit-01 
                  :ARG0 (a / assay 
                        :location (c3 / cell 
                              :mod (e / e) 
                              :mod (u / undifferentiat))) 
                  :ARG2 -)))

# ::snt The same fragment showed much weaker activity after induction of differentiation by retinoic acid .
# ::tok The same fragment showed much weaker activity after induction of differentiation by retinoic acid .
# ::alignments 13-14|0.1.1 10-11|0.2.0.1 8-9|0.2.0 7-8|0.2 6-7|0.1 5-6|0.1.0 4-5|0.2.0.0 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:37.744
(s / show-01 
      :ARG0 (f / fragment-01 
            :ARG1-of (s2 / same-01)) 
      :ARG1 (a3 / activity-06 
            :ARG1 (w / weak) 
            :ARG2 (a / acid)) 
      :time (a2 / after 
            :op1 (i / induct-02 
                  :ARG0 (m / much) 
                  :ARG1 (d / differentiation))))

# ::snt We concluded that this sequence is the ESG1 gene .
# ::tok We concluded that this sequence is the ESG1 gene .
# ::alignments 8-9|0.1 4-5|0.1.0 3-4|0.1.0.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:37.776
(c / conclude-01 
      :ARG0 (w / we) 
      :ARG1 (g / gene 
            :domain (s / sequence 
                  :mod (t / this))))

# ::snt BAC clones containing the ESG1 gene and a duplication pseudogene ( PS ) .
# ::tok BAC clones containing the ESG1 gene and a duplication pseudogene ( PS ) .
# ::alignments 11-12|0.1.0.0.0.0 9-10|0.1.0.0 8-9|0.1.0.0.0 6-7|0.1.0 5-6|0.1.1 2-3|0.1 1-2|0 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:38.080
(c2 / clone-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "BAC")) 
      :ARG0-of (c / contain-01 
            :ARG1 (a / and 
                  :op1 (p2 / pseudogene 
                        :mod (d / duplication 
                              :op1 (p / p)))) 
            :ARG2 (g / gene)))

# ::snt A ) Localization of the gene and PS on chromosome 9 .
# ::tok A ) Localization of the gene and PS on chromosome 9 .
# ::alignments 10-11|0.0 9-10|0.1.0.0 7-8|0.1.0.1 6-7|0.1.0 5-6|0.1 2-3|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:38.115
(l / localization 
      :mod-of 9 
      :op1 (g / gene 
            :op1-of (a / and 
                  :location (c / chromosome) 
                  :op2 (p / p))))

# ::snt B ) Sequence comparison of the gene and PS revealed that these are homologous from eight base pairs upstream of the first exon to 675 bp downstream of the third exon .
# ::tok B ) Sequence comparison of the gene and PS revealed that these are homologous from eight base pairs upstream of the first exon to 675 bp downstream of the third exon .
# ::alignments 30-31|0.3 26-27|0.3.1 22-23|0.3.0.1 17-18|0.3.0 16-17|0.0.0.2 15-16|0.3.0.0.0 11-12|0.0.0.1 9-10|0.0 8-9|0.2 7-8|0 6-7|0.0.0.0 3-4|0.0.0 2-3|0.3.0.0 0-1|0.1.1+0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:38.746
(a / and 
      :ARG1-of (r / reveal-01 
            :ARG0 (c / compare-01 
                  :ARG0 (g / gene) 
                  :ARG1 (t / this) 
                  :ARG2 (b / base))) 
      :op1 (l / location 
            :name (n / name 
                  :op1 "B") 
            :wiki -) 
      :op2 (p2 / p) 
      :op3 (e / exon 
            :op1 (p / pair-01 
                  :ARG1 (s / sequence 
                        :poss-of 8) 
                  :domain-of (e2 / exon)) 
            :topic-of (d / downstream)))

# ::snt Substitution mutations are indicated by black lines .
# ::tok Substitution mutations are indicated by black lines .
# ::alignments 6-7|0.0 5-6|0.0.0 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:38.773
(i / indicate-01 
      :ARG0 (l / line 
            :ARG1-of (b / black-04)) 
      :ARG1 (m / mutate-01 
            :mod (s / substitution)))

# ::snt The insertion is indicated by an open triangle .
# ::tok The insertion is indicated by an open triangle .
# ::alignments 7-8|0.0 6-7|0.0.0 3-4|0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:38.794
(i / indicate-01 
      :ARG0 (t / triangle 
            :ARG1-of (o / open-04)) 
      :ARG1 (i2 / insert-01))

# ::snt Promoter/enhancer activity of the ESG1 gene and pseudogene .
# ::tok Promoter/enhancer activity of the ESG1 gene and pseudogene .
# ::alignments 7-8|0.0.0 6-7|0.0 5-6|0.1 4-5|0.1.0 1-2|0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:38.830
(a2 / activity-06 
      :ARG0 (a / and 
            :op1 (p / pseudogene)) 
      :ARG1 (g / gene 
            :mod (e / ESG1)) 
      :mod (p2 / promoter/enhanc))

# ::snt DNA fragments of ~ 6 kbp isolated from the 5 ' flanking regions of the gene and PS were transferred into luciferase reporter plasmids .
# ::tok DNA fragments of ~ 6 kbp isolated from the 5 ' flanking regions of the gene and PS were transferred into luciferase reporter plasmids .
# ::alignments 23-24|0.2.1 22-23|0.0.1.1 19-20|0.2 17-18|0.2.0 16-17|0 15-16|0.1 12-13|0.0.2 11-12|0.0.2.0 9-10|0.0.2.0.0 6-7|0.0 5-6|0.0.0 4-5|0.0.1.1.0 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:39.132
(a / and 
      :op1 (i / isolate-01 
            :ARG0 (k / kbp) 
            :ARG1 (f2 / fragment-01 
                  :ARG1 (d / DNA) 
                  :ARG2-of (r / report-01 
                        :ARG0 6)) 
            :ARG2 (r2 / region 
                  :ARG1-of (f / flank-01 
                        :ARG0 5))) 
      :op2 (g / gene) 
      :op3 (t / transfer-01 
            :ARG1 (p2 / p) 
            :ARG2 (p / plasmid)))

# ::snt We introduced the reporter genes into undifferentiated ES cells ( open columns ) , retinoic acid-treated ES cells ( grey columns ) , and NIH3T3 cells ( closed columns ) .
# ::tok We introduced the reporter genes into undifferentiated ES cells ( open columns ) , retinoic acid-treated ES cells ( grey columns ) , and NIH3T3 cells ( closed columns ) .
# ::alignments 28-29|0.3.0 27-28|0.3.0.0 25-26|0.3.2 24-25|0.3.2.0 23-24|0.3 20-21|0.2.0.0.0 19-20|0.2.0.0.0.0 17-18|0.3.1 15-16|0.3.1.0 11-12|0.2.0.0.1.0 10-11|0.2.0.0.1 8-9|0.2 7-8|0.2.0 6-7|0.2.1 4-5|0.1 3-4|0.2.0.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:39.665
(i / introduce-02 
      :ARG0 (w / we) 
      :ARG1 (g2 / gene) 
      :ARG2 (c7 / cell 
            :mod (e / e 
                  :ARG3-of (r / report-01 
                        :ARG0 (c4 / column 
                              :mod (g / grey)) 
                        :ARG1 (o / open-04 
                              :ARG1 (c6 / column)))) 
            :mod (u / undifferentiat)) 
      :destination (a / and 
            :domain (c / column 
                  :ARG1-of (c2 / close-01)) 
            :op1 (c5 / cell 
                  :mod (a2 / acid-treat)) 
            :op2 (c3 / cell 
                  :mod (n / NIH3T3))))

# ::snt Data represent the averages and standard deviations of three independent experiments .
# ::tok Data represent the averages and standard deviations of three independent experiments .
# ::alignments 10-11|0.1.0.0 9-10|0.1.0.0.0.0+0.1.0.0.0 8-9|0.1.0.0.1 6-7|0.1.1 5-6|0.1.1.0 4-5|0.1 3-4|0.1.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:39.950
(r / represent-01 
      :ARG0 (d3 / data) 
      :ARG1 (a / and 
            :op1 (a2 / average-01 
                  :ARG1 (e / experiment-01 
                        :ARG0-of (d / depend-01 
                              :polarity -) 
                        :quant 3)) 
            :op2 (d2 / deviation 
                  :ARG1-of (s / standard-02))))

# ::snt We also found that the two BAC clones contained another ESG1-like sequence ( Figure 2A ) .
# ::tok We also found that the two BAC clones contained another ESG1-like sequence ( Figure 2A ) .
# ::alignments 13-14|0.1.1.0.0 11-12|0.1.1 9-10|0.1.1.0 8-9|0.1 7-8|0.1.0 6-7|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 5-6|0.1.0.1 2-3|0 1-2|0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:40.009
(f2 / find-01 
      :ARG0 (w / we) 
      :ARG1 (c / contain-01 
            :ARG0 (c2 / clone-01 
                  :ARG0 (o / organization 
                        :name (n / name 
                              :op1 "BAC")) 
                  :quant 2) 
            :ARG1 (s / sequence 
                  :mod (a / another 
                        :mod-of (f / figure)))) 
      :mod (a2 / also))

# ::snt The two sequences , separated by a 68 kbp intergenic sequence , were oriented in opposite directions .
# ::tok The two sequences , separated by a 68 kbp intergenic sequence , were oriented in opposite directions .
# ::alignments 16-17|0.0.0.1 15-16|0.0.0.1.0 13-14|0.0.0 10-11|0 7-8|0.0.0.1.0.0 4-5|0.0 2-3|0.0.0.0 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:40.079
(s / sequence 
      :ARG0-of (s2 / separate-01 
            :ARG1 (o2 / orient-01 
                  :ARG1 (s3 / sequence 
                        :quant 2) 
                  :ARG3 (d / direction 
                        :ARG1-of (o / opposite-01 
                              :ARG0 68)))))

# ::snt The ESG1-like sequence exhibited greater than 95 % identity to the exons and introns of the ESG1 gene .
# ::tok The ESG1-like sequence exhibited greater than 95 % identity to the exons and introns of the ESG1 gene .
# ::alignments 17-18|0.2.0.0 13-14|0.2.1 12-13|0.2 11-12|0.2.0 8-9|0.1 7-8|0.1.0 6-7|0.3.0 4-5|0.3 3-4|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:40.236
(e2 / exhibit-01 
      :ARG0 (s / sequence) 
      :ARG1 (i2 / identity 
            :mod (p / percentage-entity)) 
      :ARG2 (a / and 
            :op1 (e / exon 
                  :poss (g / gene)) 
            :op2 (i / intron)) 
      :degree (g2 / great 
            :op1 95))

# ::snt This sequence , however , contained critical nucleotide substitutions in all of the exons and one nucleotide insertion in exon 2 ( Figure 2B ) .
# ::tok This sequence , however , contained critical nucleotide substitutions in all of the exons and one nucleotide insertion in exon 2 ( Figure 2B ) .
# ::alignments 22-23|0.2 20-21|0.1.0.0 19-20|0.3.1.1 17-18|0.3.1 16-17|0.3.1.0 14-15|0.3 13-14|0.3.0 10-11|0.3.0.0 8-9|0.1 7-8|0.1.1 6-7|0.1.0 5-6|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:40.484
(c2 / contain-01 
      :ARG0 (s2 / sequence 
            :mod (t / this)) 
      :ARG1 (s / substitution 
            :ARG1-of (c / critical-02 
                  :ARG0 2) 
            :mod (n2 / nucleotide)) 
      :ARG2 (f / figure) 
      :manner (a / and 
            :op1 (e2 / exon 
                  :quant (a2 / all)) 
            :op2 (i / insert-01 
                  :ARG1 (n / nucleotide) 
                  :location (e / exon))))

# ::snt Although 675 base pairs of the 3 ' flanking regions were conserved between the ESG1 gene and the pseudogene , only five base pairs of the 5 ' flanking region were identical .
# ::tok Although 675 base pairs of the 3 ' flanking regions were conserved between the ESG1 gene and the pseudogene , only five base pairs of the 5 ' flanking region were identical .
# ::alignments 31-32|0.0.0.1.0.2 29-30|0.0.0.1.0.1 28-29|0.0.0.1.0.1.0 26-27|0.0.0.2 23-24|0.0.0.1.0 22-23|0.0.0.1.0.4 21-22|0.0.0.0.0.0 20-21|0.0.0.1.0.3 18-19|0 16-17|0.0 15-16|0.0.1 11-12|0.0.0.1 9-10|0.0.0.0 8-9|0.0.0.0.0 6-7|0.0.0.0.1 3-4|0.0.0 2-3|0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:40.969
(p2 / pseudogene 
      :op2-of (a / and 
            :ARG0-of (p3 / pair-01 
                  :ARG1 (r2 / region 
                        :ARG1-of (f2 / flank-01 
                              :ARG0 5) 
                        :poss 3) 
                  :ARG1-of (c / conserve-01 
                        :ARG0 (p / pair-01 
                              :ARG0 (b2 / base) 
                              :ARG1 (r / region 
                                    :ARG1-of (f / flank-01)) 
                              :ARG1-of (i / identical-01) 
                              :ARG2 (o / only) 
                              :mod (b / base))) 
                  :ARG2 5) 
            :op1 (g / gene)))

# ::snt This 5 ' flanking region ( ~ 6 kbp ) did not possess any promoter/enhancer activity in luciferase reporter assays ( Figure 3 ) .
# ::tok This 5 ' flanking region ( ~ 6 kbp ) did not possess any promoter/enhancer activity in luciferase reporter assays ( Figure 3 ) .
# ::alignments 22-23|0.0.0.0 21-22|0.0.0.1.1.1 19-20|0.1.1 18-19|0.0.0.1 17-18|0.0.0.1.0 15-16|0.1 14-15|0.1.0 13-14|0.1.2 12-13|0 11-12|0.3 8-9|0.2 7-8|0.0.0.1.2 4-5|0.0 3-4|0.0.0 1-2|0.0.0.1.1.0 0-1|0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:41.323
(p2 / possess-01 
      :ARG0 (r2 / region 
            :ARG1-of (f2 / flank-01 
                  :ARG2 3 
                  :purpose-of (r / report-01 
                        :ARG0 (l / luciferase) 
                        :ARG1 (t / this 
                              :mod-of 5 
                              :mod-of (f / figure)) 
                        :ARG2 6))) 
      :ARG1 (a2 / activity-06 
            :ARG0 (p / promoter/enhanc) 
            :ARG1 (a / assay) 
            :mod (a3 / any)) 
      :ARG2 (k / kbp) 
      :polarity -)

# ::snt It is thus unlikely that this sequence is transcribed or translated into a functional protein .
# ::tok It is thus unlikely that this sequence is transcribed or translated into a functional protein .
# ::alignments 14-15|0.1.1 13-14|0.1.1.0 10-11|0.1 9-10|0 8-9|0.1.0.0 6-7|0.1.0 5-6|0.1.0.1 3-4|0.0.2+0.0 2-3|0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:41.450
(o / or 
      :ARG1-of (l / likely-01 
            :ARG0 (i / it) 
            :degree (t4 / thus-far) 
            :polarity -) 
      :op1 (t / translate-01 
            :ARG1 (s / sequence 
                  :ARG1-of (t2 / transcribe-01) 
                  :mod (t3 / this)) 
            :ARG2 (p / protein 
                  :mod (f / functional))))

# ::snt This sequence likely represents a duplication pseudogene .
# ::tok This sequence likely represents a duplication pseudogene .
# ::alignments 6-7|0.1 5-6|0.1.0 3-4|0 2-3|0.2 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:41.472
(r / represent-01 
      :ARG0 (s / sequence 
            :mod (t / this)) 
      :ARG1 (p / pseudogene 
            :mod (d / duplication)) 
      :ARG1-of (l / likely-01))

# ::snt Bierbaum previously reported the existence of two pseudogenes with similar exon-intron organization as the ESG1 gene [ 17 ] .
# ::tok Bierbaum previously reported the existence of two pseudogenes with similar exon-intron organization as the ESG1 gene [ 17 ] .
# ::alignments 17-18|0.0 15-16|0.1.0 11-12|0.1.1 9-10|0.1.1.0 7-8|0.1.1.1 6-7|0.1.1.1.0 4-5|0.1 2-3|0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:41.539
(r2 / report-01 
      :ARG0 17 
      :ARG1 (e / exist-01 
            :ARG0 (g / gene) 
            :ARG1 (o / organization 
                  :ARG1-of (r / resemble-01) 
                  :poss-of (p / pseudogen 
                        :quant 2))) 
      :time (p2 / previous))

# ::snt We could not determine which of these two pseudogenes corresponds to the one we identified or the location of the remaining pseudogene .
# ::tok We could not determine which of these two pseudogenes corresponds to the one we identified or the location of the remaining pseudogene .
# ::alignments 21-22|0.1.1.2.0 20-21|0.1.1.2.0.0 17-18|0.1.1.2 15-16|0.1.1 14-15|0.1.1.1 13-14|0.1.1.1.0 12-13|0.1.1.0 9-10|0.1 8-9|0.1.0 7-8|0.1.0.0 6-7|0.1.1.1.1 3-4|0 2-3|0.2.0 1-2|0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:41.653
(d / determine-01 
      :ARG0 (w2 / we) 
      :ARG1 (c / correspond-01 
            :ARG1 (p2 / pseudogen 
                  :quant 2) 
            :ARG2 (o / or 
                  :op1 (o2 / one) 
                  :op2 (i / identify-01 
                        :ARG0 (w / we) 
                        :ARG1 (t / this)) 
                  :op3 (l / location 
                        :location-of (p / pseudogene 
                              :ARG1-of (r / remain-01))))) 
      :ARG1-of (p3 / possible-01 
            :polarity -))

# ::snt Targeted disruption of the mouse ESG1 gene .
# ::tok Targeted disruption of the mouse ESG1 gene .
# ::alignments 6-7|0.0.0 4-5|0.0.0.0 1-2|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:41.666
(t / target-01 
      :ARG1 (d / disruption 
            :mod (g / gene 
                  :mod (m / mouse))))

# ::snt To study the function of ESG1 , we deleted the gene by homologous recombination in mouse ES cells .
# ::tok To study the function of ESG1 , we deleted the gene by homologous recombination in mouse ES cells .
# ::alignments 17-18|0.1.0 16-17|0.1.0.0 15-16|0.0.0.0.0 13-14|0.2 12-13|0.2.0 10-11|0.1 8-9|0 7-8|0.0 3-4|0.0.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:41.810
(d / delete-01 
      :ARG0 (w / we 
            :ARG0-of (s / study-01 
                  :ARG1 (f / function-01 
                        :op1-of (m / mouse)))) 
      :ARG1 (g / gene 
            :location (c / cell 
                  :mod (e / e))) 
      :topic-of (r / recombination 
            :mod (h / homologou)))

# ::snt We replaced the three exons with either a fusion of the neomycin-resistance and -galactosidase genes ( -geo ) or the hygromycin resistant gene ( HygR ) using two targeting vectors ( Figure 4A ) introduced into RF8 ES cells by electroporation .
# ::tok We replaced the three exons with either a fusion of the neomycin-resistance and -galactosidase genes ( -geo ) or the hygromycin resistant gene ( HygR ) using two targeting vectors ( Figure 4A ) introduced into RF8 ES cells by electroporation .
# ::alignments 40-41|0.2.0 38-39|0.1 36-38|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 34-35|0 31-32|0.0 29-30|0.2.1 28-29|0.2.1.0 27-28|0.2.1.1 26-27|0.2 24-25|0.2.3.1.0.0+0.2.3.1.0+0.2.3.1 22-23|0.2.2 21-22|0.2.2.0 20-21|0.2.3.0.0.1 18-19|0.2.3.0.0 14-15|0.2.3.0 12-13|0.2.3 8-9|0.2.3.2 6-7|0.2.3.0.0.0 4-5|0.2.3.2.0.1 3-4|0.2.3.2.0.1.0 1-2|0.2.3.2.0 0-1|0.2.3.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:43.159
(i / introduce-02 
      :ARG1 (f / figure) 
      :ARG2 (c / cell 
            :mod (t / thing 
                  :name (n / name 
                        :op1 (r / RF8) 
                        :op2 (e2 / ES)))) 
      :ARG2-of (u / use-01 
            :ARG0 (e / electroporation) 
            :ARG1 (v / vector 
                  :ARG1-of (t2 / target-01) 
                  :quant 2) 
            :instrument (g / gene 
                  :ARG1-of (r2 / resist-01)) 
            :op3-of (a / and 
                  :op1 (g2 / gene 
                        :op1-of (o2 / or 
                              :mod (e3 / either) 
                              :op2 (h / hygromycin))) 
                  :op2 (o / organization 
                        :name (n2 / name 
                              :op1 "HygR")) 
                  :quant (f2 / fusion 
                        :prep-with-of (r3 / replace-01 
                              :ARG0 (w / we) 
                              :ARG1 (e4 / exon 
                                    :quant 3))))))

# ::snt We obtained eight ES cell clones with correct homologous recombination of the -geo targeting vector , which was confirmed by Southern blot analysis ( Figure 4B ) .
# ::tok We obtained eight ES cell clones with correct homologous recombination of the -geo targeting vector , which was confirmed by Southern blot analysis ( Figure 4B ) .
# ::alignments 24-25|0.1.0.0.1.0.0 22-23|0.1 21-22|0 20-21|0.1.1.0.0+0.1.1.0+0.1.1 18-19|0.1.0 14-15|0.1.0.0 13-14|0.1.0.0.0 9-10|0.1.0.0.1 8-9|0.1.0.0.1.2 7-8|0.1.0.0.1.0 5-6|0.1.0.0.1.1.1 4-5|0.1.0.0.1.1.1.0 3-4|0.1.0.0.1.1.1.0.0 2-3|0.0 1-2|0.1.0.0.1.1 0-1|0.1.0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:43.456
(b / blot-01 
      :ARG1 8 
      :ARG1-of (a / analyze-01 
            :ARG0-of (c / confirm-01 
                  :ARG1 (v / vector 
                        :ARG1-of (t2 / target-01) 
                        :poss-of (r / recombination 
                              :ARG1-of (c2 / correct-02 
                                    :ARG0 (f / figure)) 
                              :ARG2-of (o / obtain-01 
                                    :ARG0 (w / we) 
                                    :ARG1 (c3 / clone-01 
                                          :ARG1 (c4 / cell 
                                                :mod (e / e)))) 
                              :mod (h / homologou)))) 
            :manner (t / thing 
                  :name (n / name 
                        :op1 "Southern"))))

# ::snt We obtained only one clone with correct homologous recombination of the HygR targeting vector .
# ::tok We obtained only one clone with correct homologous recombination of the HygR targeting vector .
# ::alignments 13-14|0.1.1 12-13|0.1 11-12|0.1.0.0.0+0.1.0.0+0.1.0 8-9|0.2 7-8|0.2.1 6-7|0.2.0 4-5|0.0.0 2-3|0.0.0.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:43.561
(o3 / obtain-01 
      :ARG0 (w / we 
            :poss-of (c2 / clone 
                  :mod (o2 / only))) 
      :ARG1 (t / target-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "HygR")) 
            :ARG1 (v / vector)) 
      :manner (r / recombination 
            :ARG1-of (c / correct-02) 
            :mod (h / homologou)))

# ::snt Targeted disruption of the mouse ESG1 gene .
# ::tok Targeted disruption of the mouse ESG1 gene .
# ::alignments 6-7|0.0.0 4-5|0.0.0.0 1-2|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:43.576
(t / target-01 
      :ARG1 (d / disruption 
            :mod (g / gene 
                  :mod (m / mouse))))

# ::snt A ) Targeting strategy .
# ::tok A ) Targeting strategy .
# ::alignments 3-4|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:43.587
(s / strategy 
      :ARG1-of (t / target-01))

# ::snt Homologous regions are indicated by thick lines .
# ::tok Homologous regions are indicated by thick lines .
# ::alignments 6-7|0.0 5-6|0.0.0 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:43.606
(i / indicate-01 
      :ARG0 (l / line 
            :mod (t / thick-03)) 
      :ARG1 (r / region 
            :mod (h / homologou)))

# ::snt Recognition sites of PstI ( P ) and SpeI ( S ) , which were used for Southern blot analyses , are shown .
# ::tok Recognition sites of PstI ( P ) and SpeI ( S ) , which were used for Southern blot analyses , are shown .
# ::alignments 22-23|0 19-20|0.1.0.0.1 18-19|0.1.0.0.1.0 17-18|0.1.0.0.1.0.0.0.0+0.1.0.0.1.0.0.0+0.1.0.0.1.0.0 15-16|0.1.0.0 10-11|0.1.0.0.0.1.0+0.1.0.0.0.1 7-8|0.1 5-6|0.0 3-4|0.1.0.1.0+0.1.0.1+0.1.0 1-2|0.1.0.0.0 0-1|0.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:43.807
(s / show-01 
      :ARG0 (p / P60) 
      :ARG1 (a2 / and 
            :op1 (t2 / thing 
                  :ARG0-of (u / use-01 
                        :ARG1 (s2 / site 
                              :location-of (r / recognition) 
                              :name (n2 / name 
                                    :op1 "S-400")) 
                        :ARG2 (a / analysis 
                              :ARG1-of (b / blot-01 
                                    :ARG0 (t / thing 
                                          :name (n / name 
                                                :op1 "Southern"))))) 
                  :name (n3 / name 
                        :op1 "PstI"))))

# ::snt The gene encoding diphtheria toxin A ( DTA ) was inserted at the 3 ' end of the targeting vectors to facilitate negative selection .
# ::tok The gene encoding diphtheria toxin A ( DTA ) was inserted at the 3 ' end of the targeting vectors to facilitate negative selection .
# ::alignments 23-24|0.0.0.0 22-23|0.0.0.0.1 21-22|0.0.0 19-20|0.1.1 18-19|0.1.1.0 15-16|0.1 13-14|0.1.0 10-11|0 7-8|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 4-5|0.0 3-4|0.0.1 2-3|0.0.2.0 1-2|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:44.098
(i / insert-01 
      :ARG1 (t2 / toxin 
            :ARG0-of (f / facilitate-01 
                  :ARG1 (s / select-01 
                        :ARG1 (o / organization 
                              :name (n2 / name 
                                    :op1 "DTA")) 
                        :mod (n / negative))) 
            :mod (d / diphtheria) 
            :mod (g / gene 
                  :ARG1-of (e2 / encode-01))) 
      :time (e / end-01 
            :ARG0 3 
            :ARG1 (v / vector 
                  :ARG1-of (t / target-01))))

# ::snt B ) Southern blot analyses confirming homologous recombination .
# ::tok B ) Southern blot analyses confirming homologous recombination .
# ::alignments 7-8|0.0 6-7|0 5-6|0.0.0 4-5|0.0.0.1 3-4|0.0.0.0 2-3|0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 0-1|0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:44.163
(h / homologou 
      :mod-of (r / recombination 
            :ARG1-of (c / confirm-01 
                  :ARG0 (b / blot-01 
                        :ARG0 (l / location 
                              :name (n2 / name 
                                    :op1 "B") 
                              :wiki -) 
                        :ARG1 (t / thing 
                              :name (n / name 
                                    :op1 "Southern"))) 
                  :manner-of (a / analysis))))

# ::snt WT , wild-type ES cells ;  , -geo + / - ES cells ; H , HygR + / - ES cells ; - / - , ESG1-null ES cells .
# ::tok WT , wild-type ES cells ;  , -geo + / - ES cells ; H , HygR + / - ES cells ; - / - , ESG1-null ES cells .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:44.166
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Numbers indicate clone numbers .
# ::tok Numbers indicate clone numbers .
# ::alignments 3-4|0.0 2-3|0.0.0 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:44.219
(i / indicate-01 
      :ARG0 (n / number 
            :mod (c / clone)) 
      :ARG1 (n2 / number-01))

# ::snt C ) Northern blot ( upper ) and western blot ( lower ) analyses of wild-type ES cells ( WT ) , ESG1-null ES cells ( - / - , three clones ) and heterozygous ES cells ( + / - ) .
# ::tok C ) Northern blot ( upper ) and western blot ( lower ) analyses of wild-type ES cells ( WT ) , ESG1-null ES cells ( - / - , three clones ) and heterozygous ES cells ( + / - ) .
# ::alignments 39-40|0.0.0.2.3.0 36-37|0.2 33-34|0 31-32|0.0.0.2.2 30-31|0.0.0.2.0 27-28|0.0.0.1.0 24-25|0.1 17-18|0.0.1 16-17|0.0.1.0 13-14|0.0 11-12|0.0.0.2.3 9-10|0.0.0.2 8-9|0.0.0.2.1.1+0.0.0.2.1.0.0+0.0.0.2.1.0+0.0.0.2.1 7-8|0.0.0 5-6|0.0.0.2.2.0 3-4|0.0.0.1 2-3|0.0.0.1.1 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:44.497
(a / and 
      :op1 (a2 / analysis 
            :domain (a3 / and 
                  :domain-of (c5 / C) 
                  :op1 (b2 / blot-01 
                        :ARG1 (s2 / slash) 
                        :mod "Northern_Ireland") 
                  :op2 (b / blot-01 
                        :ARG0 3 
                        :ARG1 (w / world-region 
                              :name (n / name 
                                    :op1 "West") 
                              :wiki "Western_world") 
                        :ARG1-of (c2 / clone-01 
                              :ARG0 (u / upper)) 
                        :ARG1-of (l / low-04 
                              :ARG0 (s / slash)))) 
            :mod (c4 / cell 
                  :mod (e / e))) 
      :op2 (c3 / cell) 
      :op3 (c / cell))

# ::snt Northern blot was performed as previously described [ 20 ] .
# ::tok Northern blot was performed as previously described [ 20 ] .
# ::alignments 8-9|0.0.0.0 6-7|0 5-6|0.1 3-4|0.0 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:44.625
(d / describe-01 
      :ARG1 (p2 / perform-02 
            :ARG1 (b / blot-01 
                  :ARG1 20 
                  :mod "Northern_Ireland")) 
      :time (p / previous))

# ::snt To confirm the loading of equal amounts of RNA , ethidium bromide staining of ribosomal RNA is also shown ( middle ) .
# ::tok To confirm the loading of equal amounts of RNA , ethidium bromide staining of ribosomal RNA is also shown ( middle ) .
# ::alignments 20-21|0.0.2 18-19|0 17-18|0.2 15-16|0.0.1 12-13|0.0 11-12|0.0.0 10-11|0.0.0.0 8-9|0.1.0.0.1 6-7|0.1.0.0 5-6|0.1.0.0.0 3-4|0.1.0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:44.796
(s / show-01 
      :ARG1 (s2 / stain-01 
            :ARG0 (b / bromide 
                  :mod (e / ethidium)) 
            :ARG1 (r / rna) 
            :time (m / middle)) 
      :condition (c / confirm-01 
            :ARG1 (l / load-01 
                  :ARG1 (a2 / amount 
                        :ARG1-of (e2 / equal-01) 
                        :quant-of (r2 / rna)))) 
      :mod (a / also))

# ::snt To obtain homozygous mutant ES cells , we introduced the -geo vector into HygR heterozygous ES cells .
# ::tok To obtain homozygous mutant ES cells , we introduced the -geo vector into HygR heterozygous ES cells .
# ::alignments 16-17|0.2 14-16|0.2.1.0.1+0.2.1.0.0+0.2.1.0+0.2.1 13-14|0.2.0.0.0+0.2.0.0+0.2.0 11-12|0.1 8-9|0 7-8|0.0 5-6|0.3.0 4-5|0.3.0.0 3-4|0.3.0.2 2-3|0.3.0.1 1-2|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:44.890
(i / introduce-02 
      :ARG0 (w / we) 
      :ARG1 (v / vector) 
      :ARG2 (c / cell 
            :location (o / organization 
                  :name (n2 / name 
                        :op1 "HygR")) 
            :mod (t / thing 
                  :name (n / name 
                        :op1 (h / heterozygous) 
                        :op2 (e / ES)))) 
      :time (o2 / obtain-01 
            :ARG1 (c2 / cell 
                  :mod (e2 / e) 
                  :mod (h2 / homozygou) 
                  :mod (m / mutant))))

# ::snt Of 105 G418-resistant colonies tested , 49 were homozygous for ESG1 deletion .
# ::tok Of 105 G418-resistant colonies tested , 49 were homozygous for ESG1 deletion .
# ::alignments 11-12|0.0 10-11|0.0.1 8-9|0 6-7|0.0.0.1 4-5|0.0.0 3-4|0.0.0.0 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:44.934
(h / homozygou 
      :beneficiary (d / deletion 
            :ARG0-of (t / test-01 
                  :ARG1 (c / colony 
                        :quant 105) 
                  :op1-of 49) 
            :mod (e / ESG1)))

# ::snt Northern blot and western blot analyses confirmed the absence of ESG1 in these cells ( Figure 4C ) .
# ::tok Northern blot and western blot analyses confirmed the absence of ESG1 in these cells ( Figure 4C ) .
# ::alignments 15-16|0.1.0 13-14|0.1.1.0 12-13|0.1.1.0.0 10-11|0.1.1 8-9|0.1 6-7|0 5-6|0.0.2 4-5|0.0.2.0 3-4|0.0.1.1+0.0.1.0.0+0.0.1.0+0.0.1 2-3|0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:45.015
(c2 / confirm-01 
      :ARG0 (a3 / and 
            :op1 (b2 / blot-01 
                  :mod "Northern_Ireland") 
            :op2 (w / world-region 
                  :name (n / name 
                        :op1 "West") 
                  :wiki "Western_world") 
            :op3 (a2 / analysis 
                  :ARG1-of (b / blot-01))) 
      :ARG1 (a / absent-01 
            :ARG0 (f / figure) 
            :ARG1 (e / ESG1 
                  :location (c / cell 
                        :mod (t / this)))))

# ::snt In 29 clones , the -geo vector had replaced the HygR vector , such that the cells remained heterozygous .
# ::tok In 29 clones , the -geo vector had replaced the HygR vector , such that the cells remained heterozygous .
# ::alignments 18-19|0 17-18|0.1 16-17|0.1.0 13-14|0.1.1 11-12|0.0.0.1 10-11|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 8-9|0.0.0 6-7|0.0.0.0 2-3|0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:45.170
(h / heterozygou 
      :ARG1-of (c2 / clone-01 
            :ARG1-of (r2 / replace-01 
                  :ARG0 (v2 / vector) 
                  :ARG2 (v / vector 
                        :mod (o / organization 
                              :name (n / name 
                                    :op1 "HygR")))) 
            :quant 29) 
      :ARG2-of (r / remain-01 
            :ARG1 (c / cell) 
            :mod (s / such)))

# ::snt In the remaining 27 clones , the -geo vector was integrated at non-homologous sites .
# ::tok In the remaining 27 clones , the -geo vector was integrated at non-homologous sites .
# ::alignments 13-14|0.1 12-13|0.1.0 10-11|0 8-9|0.0 4-5|0.0.0 3-4|0.0.0.1 2-3|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:45.290
(i / integrate-01 
      :ARG1 (v / vector 
            :ARG1-of (c / clone-01 
                  :ARG1-of (r / remain-01) 
                  :quant 27)) 
      :ARG2 (s / site 
            :mod (n / non-homologou)))

# ::snt ESG1 - / - ES cells exhibited normal morphology ( Figure 5A ) .
# ::tok ESG1 - / - ES cells exhibited normal morphology ( Figure 5A ) .
# ::alignments 10-11|0.1.0.0 8-9|0.1 7-8|0.1.0 6-7|0 5-6|0.0 4-5|0.0.0 2-3|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:45.407
(e / exhibit-01 
      :ARG0 (c / cell 
            :mod (e2 / e)) 
      :ARG1 (m / morphology 
            :ARG1-of (n / normal-02 
                  :ARG0 (f / figure) 
                  :ARG2 (s / slash))))

# ::snt These cells also proliferated at a speed comparable to that of the control ( heterozygous and wild-type ) cells ( Figure 5B ) .
# ::tok These cells also proliferated at a speed comparable to that of the control ( heterozygous and wild-type ) cells ( Figure 5B ) .
# ::alignments 20-21|0.0.2 18-19|0.0.1.1 15-16|0 14-15|0.1 12-13|0.0.1.1.0 9-10|0.0.1.0.0 7-8|0.0.1.0 6-7|0.0.1 3-4|0.0 2-3|0.0.3 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:45.597
(a / and 
      :op1 (p / proliferate-01 
            :ARG0 (c4 / cell 
                  :mod (t2 / this)) 
            :ARG1 (s / speed 
                  :mod (c3 / comparable-03 
                        :ARG1 (t / that)) 
                  :poss (c / cell 
                        :ARG1-of (c2 / control-01))) 
            :ARG2 (f / figure) 
            :mod (a2 / also)) 
      :op2 (h / heterozygou))

# ::snt ESG1 - / - cells differentiated normally after the removal of leukemia inhibitory factor ( Figure 5B ) or retinoic acid treatment ( not shown ) .
# ::tok ESG1 - / - cells differentiated normally after the removal of leukemia inhibitory factor ( Figure 5B ) or retinoic acid treatment ( not shown ) .
# ::alignments 24-25|0 23-24|0.2 21-22|0.1 20-21|0.1.0 18-19|0.1.1 15-16|0.1.1.2 13-14|0.1.1.1 12-13|0.1.1.1.0.0 11-12|0.1.1.1.0.2+0.1.1.1.0.1.0+0.1.1.1.0.1+0.1.1.1.0 9-10|0.1.1.0 7-8|0.1.1.0.0 6-7|0.1.1.0.0.0.1 5-6|0.1.1.0.0.0 4-5|0.1.1.0.0.0.0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:45.896
(s / show-01 
      :ARG1 (s2 / slash) 
      :ARG1-of (t / treat-03 
            :ARG2 (a / acid) 
            :op3-of (o / or 
                  :ARG1-of (r / remove-01 
                        :op1-of (a2 / after 
                              :time-of (d2 / differentiate-01 
                                    :ARG1 (c / cell) 
                                    :ARG1-of (n2 / normal-02)))) 
                  :op1 (f2 / factor 
                        :mod (d / disease 
                              :mod-of (i / inhibitory) 
                              :name (n / name 
                                    :op1 "Leukemia") 
                              :wiki "Leukemia")) 
                  :op2 (f / figure))) 
      :polarity -)

# ::snt When transplanted into hind flanks of nude mice , these cells produced teratomas , tumors containing components of all three germ layers ( Figure 5C ) .
# ::tok When transplanted into hind flanks of nude mice , these cells produced teratomas , tumors containing components of all three germ layers ( Figure 5C ) .
# ::alignments 23-24|0.0.1.0.1.0 21-22|0.0 20-21|0 19-20|0.0.1 18-19|0.0.0 16-17|0.0.1.0.0.0.1.1 15-16|0.0.1.0.0.0.1 14-15|0.0.1.0.0.0.1.0 12-13|0.0.1.0.0.0.0 11-12|0.0.1.0.0.0 10-11|0.0.1.0.0 9-10|0.0.1.0.0.1 7-8|0.0.1.0.1.1 6-7|0.0.1.0.1.1.0 4-5|0.0.1.0.1 3-4|0.0.1.0.1.2 1-2|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:46.097
(g / germ 
      :mod-of (l / layer 
            :mod (a / all) 
            :quant (3 / 3 
                  :ARG1-of (t4 / transplant-01 
                        :ARG0 (c3 / cell 
                              :ARG0-of (p / produce-01 
                                    :ARG1 (t2 / teratoma) 
                                    :condition (c2 / contain-01 
                                          :ARG0 (t / tumor) 
                                          :ARG1 (c / component))) 
                              :mod (t3 / this)) 
                        :ARG2 (f2 / flank-01 
                              :ARG0 (f / figure) 
                              :ARG1 (m / mouse 
                                    :mod (n / nude)) 
                              :mod (h / hind))))))

# ::snt These results indicate that ESG1 is dispensable for the self-renewal properties and pluripotency of ES cells .
# ::tok These results indicate that ESG1 is dispensable for the self-renewal properties and pluripotency of ES cells .
# ::alignments 15-16|0.1.0.0.0 14-15|0.1.0.0.0.0 12-13|0.1.0.1 11-12|0.1.0 10-11|0.1.0.0 9-10|0.1.0.0.1 6-7|0.1 2-3|0 1-2|0.0.0+0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:46.156
(i / indicate-01 
      :ARG0 (t / thing 
            :ARG2-of (r / result-01) 
            :mod (t2 / this)) 
      :ARG1 (d / dispensable 
            :poss (a / and 
                  :op1 (p2 / property 
                        :domain (c / cell 
                              :mod (e / e)) 
                        :mod (s / self-renewal)) 
                  :op2 (p / pluripotency))))

# ::snt Analyses of ESG1-null ES cells .
# ::tok Analyses of ESG1-null ES cells .
# ::alignments 4-5|0.0.0 3-4|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:46.166
(a / analyse 
      :topic (e / e 
            :mod-of (c / cell)))

# ::snt A ) The morphology of ESG1-null ES cell colonies grown on STO feeder cells .
# ::tok A ) The morphology of ESG1-null ES cell colonies grown on STO feeder cells .
# ::alignments 13-14|0.0.0.0.1.0 12-13|0.0.0.0.1 9-10|0.0.0.0 8-9|0.0.0 7-8|0.0 6-7|0 3-4|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:46.218
(e / e 
      :mod-of (c3 / cell 
            :mod-of (c2 / colony 
                  :ARG1-of (g / grow-03 
                        :ARG0 (m / morphology) 
                        :ARG0-of (f / feed-01 
                              :ARG1 (c / cell))))))

# ::snt B ) Growth curve of wild-type ( WT ) , ESG1-null ( - / - ) and heterozygous ( + / - ) ES cells .
# ::tok B ) Growth curve of wild-type ( WT ) , ESG1-null ( - / - ) and heterozygous ( + / - ) ES cells .
# ::alignments 24-25|0.0.1.0.1 20-21|0.0.2 17-18|0.0.1 16-17|0.0.1.0 13-14|0.0.1.0.0 3-4|0.0 2-3|0.0.0 0-1|0.2+0.1.0+0.1+0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:46.402
(l / location 
      :ARG1-of (c2 / curve-01 
            :ARG0 (g / growth) 
            :ARG2 (h / heterozygou 
                  :op2-of (a / and 
                        :op1 (s2 / slash) 
                        :poss-of (c / cell))) 
            :op1-of (s / slash)) 
      :name (n / name 
            :op1 "B") 
      :wiki -)

# ::snt Each clone ( 1  104 cells/well ) was plated in 24-well plates .
# ::tok Each clone ( 1  104 cells/well ) was plated in 24-well plates .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:46.403
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Cell numbers were determined with a Coulter counter at 2 , 4 , and 6 days .
# ::tok Cell numbers were determined with a Coulter counter at 2 , 4 , and 6 days .
# ::alignments 15-16|0.0.0.0.0.0+0.0.0.0.0 14-15|0.0.0.0 13-14|0.1.1 11-12|0.2.1 9-10|0.2.0 7-8|0.2 6-7|0.1.0.0+0.1.0+0.1 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:46.721
(d2 / determined-02 
      :ARG0 (n2 / number 
            :mod (c2 / cell 
                  :mod-of (6 / 6 
                        :quant-of (t / temporal-quantity 
                              :unit (d / day))))) 
      :ARG1 (p / person 
            :name (n / name 
                  :op1 "Coulter") 
            :op1-of (a / and)) 
      :ARG2-of (c / counter-01 
            :ARG0 2 
            :ARG1 4))

# ::snt Data of + / - and - / - cells are shown as averages and standard deviations of three independent clones .
# ::tok Data of + / - and - / - cells are shown as averages and standard deviations of three independent clones .
# ::alignments 20-21|0.2.0.0.0.0.0 19-20|0.2.0.0.0.0.1+0.2.0.0.0.0 18-19|0.2.0.0.0.0.0.0 16-17|0.0.0 15-16|0.0.0.0 14-15|0.0 13-14|0.2 11-12|0 9-10|0.2.0 7-8|0.2.0.0.0.1 5-6|0.2.0.0.0 3-4|0.2.0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:46.912
(s2 / show-01 
      :ARG0 (a / and 
            :op1 (d2 / deviation 
                  :ARG1-of (s / standard-02))) 
      :ARG1 (d3 / data) 
      :ARG2 (a2 / average-01 
            :ARG1 (c2 / cell 
                  :mod (s4 / slash 
                        :op1-of (a3 / and 
                              :ARG1-of (d / depend-01 
                                    :ARG0 (c / clone-01 
                                          :quant 3) 
                                    :polarity -) 
                              :op2 (s3 / slash))))))

# ::snt C ) A section of teratoma derived from ESG1-null ES cells ( hematoxylin & eosin staining ) .
# ::tok C ) A section of teratoma derived from ESG1-null ES cells ( hematoxylin & eosin staining ) .
# ::alignments 15-16|0.0 14-15|0 12-13|0.0.1 10-11|0.0.0.0.1 9-10|0.0.0.0.1.0 6-7|0.0.0.0 5-6|0.0.0.1 3-4|0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:47.002
(e / eosin 
      :ARG1-of (s / stain-01 
            :ARG0 (s2 / section 
                  :ARG0-of (d / derive-01 
                        :ARG1 (c2 / C) 
                        :ARG2 (c / cell 
                              :mod (e2 / e))) 
                  :part-of (t / teratoma)) 
            :mod (h / hematoxylin)))

# ::snt We examined the gene expression profiles of ESG1 - / - ES cells using oligonucleotide-based DNA microarrays representing ~ 20,000 genes .
# ::tok We examined the gene expression profiles of ESG1 - / - ES cells using oligonucleotide-based DNA microarrays representing ~ 20,000 genes .
# ::alignments 20-21|0.0.0.1.1.1.0 17-18|0 16-17|0.0 15-16|0.0.1 14-15|0.0.2 13-14|0.0.0 12-13|0.0.0.0 11-12|0.0.0.0.0 9-10|0.0.0.1.1.3 7-8|0.0.0.1.1.0 5-6|0.0.0.1.1 4-5|0.0.0.1.1.1 3-4|0.0.0.1.1.2 1-2|0.0.0.1 0-1|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:47.597
(r / represent-01 
      :ARG1 (m / microarray 
            :ARG1-of (u / use-01 
                  :ARG0 (c / cell 
                        :mod (e / e)) 
                  :ARG2 (e4 / examine-01 
                        :ARG0 (w / we) 
                        :ARG1 (p / profile-01 
                              :ARG1 (e2 / ESG1) 
                              :ARG2 (e3 / express-01 
                                    :ARG1 (g / gene)) 
                              :mod (g2 / gene) 
                              :purpose (s / slash)))) 
            :mod (d / DNA) 
            :mod (o / oligonucleotide-bas)))

# ::snt In comparison to control ES cells , ESG1 was identified as the gene reduced to the greatest extent in ESG1 - / - ES cells ( Figure 6A ) .
# ::tok In comparison to control ES cells , ESG1 was identified as the gene reduced to the greatest extent in ESG1 - / - ES cells ( Figure 6A ) .
# ::alignments 26-27|0.2.1 24-25|0.2.0 21-22|0.0 17-18|0.1.0.0 16-17|0.1.0.0.0.0+0.1.0.0.0 13-14|0.1.0 12-13|0.1 9-10|0 5-6|0.2.2.0 4-5|0.2.2.0.0 3-4|0.2.2 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:47.894
(i / identify-01 
      :ARG1 (s / slash) 
      :ARG2 (g2 / gene 
            :ARG1-of (r / reduce-01 
                  :ARG4 (e / extent 
                        :mod (g / great 
                              :degree (m / most))))) 
      :manner (c4 / compare-01 
            :ARG0 (c / cell) 
            :ARG1 (f / figure) 
            :ARG2 (c3 / control-01 
                  :ARG1 (c2 / cell 
                        :mod (e2 / e)))))

# ::snt The expression of ES cell marker genes , such as Nanog and Oct3/4 , was normal in ESG1 - / - ES cells .
# ::tok The expression of ES cell marker genes , such as Nanog and Oct3/4 , was normal in ESG1 - / - ES cells .
# ::alignments 22-23|0.0.0.0.0 19-20|0.0.1.0 15-16|0.0.1 11-12|0 8-9|0.1 6-7|0.0.0 5-6|0.0.0.0 4-5|0.0.0.0.1 3-4|0.0.0.0.1.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:48.001
(a / and 
      :example-of (e2 / express-01 
            :ARG1 (g / gene 
                  :ARG1-of (m / mark-01 
                        :ARG0 (c / cell) 
                        :mod (c2 / cell 
                              :mod (e / e)))) 
            :ARG1-of (n / normal-02 
                  :ARG0 (s / slash))) 
      :op1 (s2 / such))

# ::snt We confirmed normal Oct3/4 expression at protein levels by Western blot ( Figure 6B ) .
# ::tok We confirmed normal Oct3/4 expression at protein levels by Western blot ( Figure 6B ) .
# ::alignments 12-13|0.1.0 10-11|0.1.3 9-10|0.1.3.0.1+0.1.3.0.0.0+0.1.3.0.0+0.1.3.0 7-8|0.1.1 6-7|0.1.1.0 4-5|0.1 2-3|0.1.2 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:48.161
(c / confirm-01 
      :ARG0 (w2 / we) 
      :ARG1 (e / express-01 
            :ARG0 (f / figure) 
            :ARG1 (l / level 
                  :mod (p / protein)) 
            :ARG1-of (n2 / normal-02) 
            :ARG2 (b / blot-01 
                  :mod (w / world-region 
                        :name (n / name 
                              :op1 "West") 
                        :wiki "Western_world"))))

# ::snt The overall gene expression profiles were similar between control ES cells and ESG1 - / - ES cells .
# ::tok The overall gene expression profiles were similar between control ES cells and ESG1 - / - ES cells .
# ::alignments 17-18|0.0.0.0 14-15|0.0.0.1 12-13|0.0.1.0.0.0.0 11-12|0.0.1.0.0.0 10-11|0.0.1.0.0 9-10|0.0.1.0 8-9|0.0.1 6-7|0 4-5|0.0 3-4|0.0.0 2-3|0.0.3 1-2|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:48.284
(r / resemble-01 
      :ARG1 (p / profile-01 
            :ARG1 (e3 / express-01 
                  :ARG0 (c / cell) 
                  :ARG1 (s / slash)) 
            :ARG1-of (c3 / control-01 
                  :mod-of (e2 / e 
                        :mod-of (c2 / cell 
                              :op1-of (a / and 
                                    :op2 (e / ESG1))))) 
            :mod (o / overall) 
            :mod (g / gene)))

# ::snt Several genes exhibited a greater than two-fold reduction in ESG1 - / - cells , including Krt1-8 , Pem , Ctgf , Ptgs2 , Igf2 and Inhba .
# ::tok Several genes exhibited a greater than two-fold reduction in ESG1 - / - cells , including Krt1-8 , Pem , Ctgf , Ptgs2 , Igf2 and Inhba .
# ::alignments 26-27|0.6.1.0+0.6.1+0.6 25-26|0 24-25|0.5.0.0+0.5.0+0.5 22-23|0.4.0.0+0.4.0+0.4 20-21|0.3.0.0+0.3.0+0.3 18-19|0.2.0.0+0.2.0+0.2 16-17|0.1.0.0+0.1.0+0.1 13-14|0.0.0.1 11-12|0.6.2 7-8|0.0.0 6-7|0.0.0.2 4-5|0.6.0 2-3|0.0 1-2|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:48.847
(a / and 
      :op1 (e / exhibit-01 
            :ARG1 (r / reduce-01 
                  :ARG0 (g2 / gene 
                        :part-of (s2 / several)) 
                  :ARG1 (c / cell) 
                  :mod (t2 / two-fold))) 
      :op2 (t / thing 
            :name (n6 / name 
                  :op1 "Krt1-8")) 
      :op3 (p5 / person 
            :name (n5 / name 
                  :op1 "Pem")) 
      :op4 (p4 / person 
            :name (n4 / name 
                  :op1 "Ctgf")) 
      :op5 (p3 / person 
            :name (n3 / name 
                  :op1 "Ptgs2")) 
      :op6 (p2 / person 
            :name (n2 / name 
                  :op1 "Igf2")) 
      :op7 (p / person 
            :mod (g / great) 
            :name (n / name 
                  :op1 "Inhba") 
            :op1-of (s / slash)))

# ::snt These genes might be regulated directly or indirectly by ESG1 .
# ::tok These genes might be regulated directly or indirectly by ESG1 .
# ::alignments 7-8|0.0.2.0 6-7|0.0.2 5-6|0.0.1 4-5|0.0 2-3|0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:48.879
(p / possible-01 
      :ARG1 (r / regulate-01 
            :ARG1 (g / gene 
                  :mod (t / this)) 
            :ARG1-of (d2 / direct-02) 
            :op1-of (o / or 
                  :op2 (d / direct-02))))

# ::snt Since ESG1 contains a KH-type RNA-binding domain , it may stabilize mRNA of these genes .
# ::tok Since ESG1 contains a KH-type RNA-binding domain , it may stabilize mRNA of these genes .
# ::alignments 14-15|0.0.0.0 13-14|0.0.0.0.0 11-12|0.0.0 10-11|0.0 9-10|0 6-7|0.0.1.0.1 5-6|0.0.1.0.1.0 2-3|0.0.1.0 1-2|0.0.1.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:48.942
(p / possible-01 
      :ARG1 (s / stabilize-01 
            :ARG1 (m / mrna 
                  :poss (g / gene 
                        :mod (t / this))) 
            :time (s2 / since 
                  :op1 (c / contain-01 
                        :ARG0 (e / ESG1) 
                        :ARG1 (d / domain 
                              :mod (r / rna-bind))))))

# ::snt Further studied are required to clarify this possibility .
# ::tok Further studied are required to clarify this possibility .
# ::alignments 7-8|0.2.0 6-7|0.2.0.0 5-6|0.2 3-4|0 1-2|0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:49.027
(r / require-01 
      :ARG0 (f / further) 
      :ARG1-of (s / study-01) 
      :ARG2 (c / clarify-10 
            :ARG1 (p / possible-01 
                  :mod (t / this))))

# ::snt Gene expression analyses of ESG1-null ES cells .
# ::tok Gene expression analyses of ESG1-null ES cells .
# ::alignments 6-7|0.1 5-6|0.1.0 2-3|0 1-2|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:49.051
(a / analysis 
      :ARG1-of (e2 / express-01 
            :ARG0 (p / person 
                  :name (n / name 
                        :op1 "Gene"))) 
      :poss (c / cell 
            :mod (e / e)))

# ::snt A ) DNA microarray analyses .
# ::tok A ) DNA microarray analyses .
# ::alignments 4-5|0.0 2-3|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:49.063
(d / DNA 
      :domain-of (a / analysis))

# ::snt Total RNA from wild-type ES cells and ESG1-null ES cells were labeled with Cy3 and Cy5 , respectively .
# ::tok Total RNA from wild-type ES cells and ESG1-null ES cells were labeled with Cy3 and Cy5 , respectively .
# ::alignments 17-18|0.0.0.0.0.2 15-16|0.0.0.0.0.1.1 14-15|0.0.0.0.0.1 13-14|0.0.0.0.0.1.0.0.0+0.0.0.0.0.1.0.0+0.0.0.0.0.1.0 11-12|0.0.0.0.0 9-10|0.0.0.0.0.0 6-7|0.0.0.0 5-6|0.0 4-5|0 1-2|0.0.0 0-1|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:49.224
(e / e 
      :mod-of (c3 / cell 
            :source-of (r2 / rna 
                  :op1-of (a2 / and 
                        :ARG0-of (l / label-01 
                              :ARG1 (c2 / cell 
                                    :ARG1-of (t / total-01)) 
                              :ARG2 (a / and 
                                    :op1 (p / person 
                                          :name (n / name 
                                                :op1 "Cy3")) 
                                    :op2 (c / Cy5)) 
                              :mod (r / respective))))))

# ::snt Samples were hybridized to Agilent Mouse Developmental Microarrays .
# ::tok Samples were hybridized to Agilent Mouse Developmental Microarrays .
# ::alignments 4-8|0.1.0.3+0.1.0.2+0.1.0.1+0.1.0.0+0.1.0+0.1 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:49.315
(h / hybridize-01 
      :ARG1 (s / sample-01) 
      :ARG2 (t / thing 
            :name (n / name 
                  :op1 "Agilent" 
                  :op2 "Mouse" 
                  :op3 "Developmental" 
                  :op4 "Microarrays")))

# ::snt The averages of two independent clones are shown .
# ::tok The averages of two independent clones are shown .
# ::alignments 7-8|0 5-6|0.0.0 4-5|0.0.0.0.0+0.0.0.0 3-4|0.0.0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:49.335
(s / show-01 
      :ARG1 (a / average-01 
            :ARG1 (c / clone-01 
                  :ARG0-of (d / depend-01 
                        :polarity -) 
                  :quant 2)))

# ::snt B ) Western blot analyses .
# ::tok B ) Western blot analyses .
# ::alignments 4-5|0.0 3-4|0.0.0 2-3|0.0.1.1+0.0.1.0.0+0.0.1.0+0.0.1 0-1|0.2+0.1.0+0.1+0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:49.355
(l / location 
      :mod (a / analysis 
            :ARG1-of (b / blot-01) 
            :mod (w / world-region 
                  :name (n / name 
                        :op1 "West") 
                  :wiki "Western_world")) 
      :name (n2 / name 
            :op1 "B") 
      :wiki -)

# ::snt Cell lysates from ESG1 + / - and ESG1 - / - cells were examined for expression of ESG1 , Oct3/4 and CDK4 with immunoblotting .
# ::tok Cell lysates from ESG1 + / - and ESG1 - / - cells were examined for expression of ESG1 , Oct3/4 and CDK4 with immunoblotting .
# ::alignments 24-25|0.0.1 21-22|0 16-17|0.0 14-15|0.0.2 12-13|0.0.2.0 10-11|0.0.2.0.0 7-8|0.1 5-6|0.0.0 1-2|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:49.600
(a / and 
      :ARG1-of (e / express-01 
            :ARG0 (s2 / slash 
                  :source-of (l / lysat 
                        :mod (c2 / cell))) 
            :ARG2 (i / immunoblott) 
            :purpose-of (e2 / examine-01 
                  :ARG1 (c / cell 
                        :op1-of (s / slash)))) 
      :op1 (a2 / and))

# ::snt To generate ESG1-knockout mice , we injected -geo-ESG1 + / - ES cell clones into the blastocysts of C57BL6 mice .
# ::tok To generate ESG1-knockout mice , we injected -geo-ESG1 + / - ES cell clones into the blastocysts of C57BL6 mice .
# ::alignments 19-20|0.0 18-19|0 16-17|0.0.1 13-14|0.0.0 12-13|0.0.0.1 9-10|0.0.0.0.0.0.0.0 6-7|0.0.0.0.0 5-6|0.0.0.0 3-4|0.0.0.0.0.0 1-2|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:49.680
(c / C57BL6 
      :mod-of (m / mouse 
            :ARG1-of (c2 / clone-01 
                  :ARG0 (w / we 
                        :ARG0-of (i / inject-01 
                              :ARG1 (m2 / mouse 
                                    :ARG1-of (g / generate-01 
                                          :ARG0 (s / slash))))) 
                  :mod (c3 / cell)) 
            :mod-of (b / blastocyst)))

# ::snt We obtained germline transmission from three clones .
# ::tok We obtained germline transmission from three clones .
# ::alignments 6-7|0.0.0 5-6|0.0.0.0 3-4|0.1 2-3|0.1.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:49.701
(o / obtain-01 
      :ARG0 (w / we 
            :ARG0-of (c / clone-01 
                  :quant 3)) 
      :ARG1 (t / transmission 
            :mod (g / germline)))

# ::snt We obtained ESG1 - / - mice at the Mendelian ratios ( 36 wild-type , 69 ESG1 + / - , and 45 ESG1 - / - ) from intercrosses of ESG1 + / - mice .
# ::tok We obtained ESG1 - / - mice at the Mendelian ratios ( 36 wild-type , 69 ESG1 + / - , and 45 ESG1 - / - ) from intercrosses of ESG1 + / - mice .
# ::alignments 35-36|0 33-34|0.0.0.0.0 29-30|0.0.0.0 25-26|0.0.3 22-23|0.0.5 21-22|0.0.0.0.0.2 18-19|0.0.4 15-16|0.0.6 12-13|0.0.0.0.0.0 10-11|0.0.2 9-10|0.0.0.0.0.1.0.0+0.0.0.0.0.1.0+0.0.0.0.0.1 6-7|0.0.1 4-5|0.0.0.0.0.2.0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:50.453
(m / mouse 
      :op1 (o / obtain-01 
            :ARG0 (w / we 
                  :poss-of (i / intercross 
                        :beneficiary (s / slash 
                              :mod 36 
                              :op1 (t / thing 
                                    :name (n / name 
                                          :op1 "Mendelian")) 
                              :op2-of (a / and 
                                    :op1 (s4 / slash))))) 
            :ARG1 (m2 / mouse) 
            :manner (r / ratio) 
            :op1-of (s2 / slash) 
            :op1-of (s3 / slash) 
            :op1-of 45 
            :op1-of 69))

# ::snt These animals exhibited normal development , gross appearance , and fertility ( not shown ) .
# ::tok These animals exhibited normal development , gross appearance , and fertility ( not shown ) .
# ::alignments 13-14|0.0.2.0 12-13|0.0.2.0.0 10-11|0.0.2.1.0 9-10|0.0.2 7-8|0.0.2.1 6-7|0.0.2.1.1 4-5|0.0 3-4|0.0.1 2-3|0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:50.935
(e / exhibit-01 
      :ARG1 (d / develop-02 
            :ARG0 (a3 / animal 
                  :mod (t / this)) 
            :ARG1-of (n / normal-02) 
            :op1-of (a / and 
                  :ARG1-of (s / show-01 
                        :polarity -) 
                  :op2 (a2 / appear-01 
                        :ARG1 (f / fertility) 
                        :ARG1-of (g / gross-03)))))

# ::snt Histological examination of testis and ovary could not identify any abnormalities ( not shown ) .
# ::tok Histological examination of testis and ovary could not identify any abnormalities ( not shown ) .
# ::alignments 13-14|0.0.1.0 12-13|0.0.1.0.0 10-11|0.0.1 9-10|0.0.1.1 8-9|0.0 7-8|0.1 6-7|0 5-6|0.0.0.2.0 4-5|0.0.0.2 3-4|0.0.0.1 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:51.303
(p / possible-01 
      :ARG1 (i / identify-01 
            :ARG0 (e / examine-01 
                  :ARG0 (h / histological) 
                  :ARG1 (t / testi) 
                  :op1-of (a3 / and 
                        :op2 (o / ovary))) 
            :ARG1 (a / abnormaliti 
                  :ARG1-of (s / show-01 
                        :polarity -) 
                  :mod (a2 / any))) 
      :polarity -)

# ::snt These data demonstrated that ESG1 is dispensable for both mouse development and germ cell formation .
# ::tok These data demonstrated that ESG1 is dispensable for both mouse development and germ cell formation .
# ::alignments 14-15|0 13-14|0.1 12-13|0.1.0 11-12|0.0 10-11|0.0.1 9-10|0.0.1.0 8-9|0.0.0 6-7|0.0.1.1 2-3|0.0.1.1.0 1-2|0.0.1.1.0.0 0-1|0.0.1.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:51.408
(f / form-01 
      :ARG1 (a / and 
            :mod (b / both) 
            :op1 (d / develop-02 
                  :ARG1 (m / mouse) 
                  :prep-for-of (d2 / dispensable 
                        :ARG1-of (d3 / demonstrate-01 
                              :ARG0 (d4 / data 
                                    :mod (t / this)))))) 
      :mod (c / cell 
            :mod (g / germ)))

# ::snt We also generated ES cells from blastocysts obtained by intercrosses of ESG1 + / - males and ESG1 - / - females .
# ::tok We also generated ES cells from blastocysts obtained by intercrosses of ESG1 + / - males and ESG1 - / - females .
# ::alignments 21-22|0.0.1 19-20|0.2 16-17|0 15-16|0.1 13-14|0.0 9-10|0.0.0 7-8|0.0.0.0 6-7|0.0.0.0.0 4-5|0.0.0.0.0.0.1 3-4|0.0.0.0.0.0.1.0 2-3|0.0.0.0.0.0 1-2|0.0.0.0.0.0.1.1 0-1|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:51.684
(a / and 
      :example-of (s2 / slash 
            :beneficiary-of (i / intercross 
                  :ARG0-of (o / obtain-01 
                        :ARG1 (b / blastocyst 
                              :ARG2-of (g / generate-01 
                                    :ARG0 (w / we) 
                                    :ARG1 (c / cell 
                                          :mod (e / e) 
                                          :mod (a2 / also)))))) 
            :mod-of (f / female)) 
      :op1 (m / male) 
      :op2 (s / slash))

# ::snt Of the eight ES cell lines established , two clones were ESG1 - / - .
# ::tok Of the eight ES cell lines established , two clones were ESG1 - / - .
# ::alignments 13-14|0.0.0.0.0 11-12|0 9-10|0.0 8-9|0.0.1 6-7|0.0.0.0 5-6|0.0.0 4-5|0.0.0.1 3-4|0.0.0.1.0 2-3|0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:51.752
(e / ESG1 
      :ARG1-of (c / clone-01 
            :ARG0 (l / line 
                  :ARG1-of (e2 / establish-01 
                        :ARG0 (s / slash)) 
                  :mod (c2 / cell 
                        :mod (e3 / e)) 
                  :quant 8) 
            :quant 2))

# ::snt These ESG1-null ES cells demonstrated normal morphology , proliferation , and differentiation ( not shown ) , confirming that ESG1 is dispensable in ES cells .
# ::tok These ESG1-null ES cells demonstrated normal morphology , proliferation , and differentiation ( not shown ) , confirming that ESG1 is dispensable in ES cells .
# ::alignments 24-25|0.0.0.0.0 21-22|0.0.0.0 17-18|0.0.0 14-15|0.2.1.0 13-14|0.2.1.0.0 11-12|0.2.1 10-11|0.2 8-9|0.2.0 6-7|0.1 5-6|0.1.0 4-5|0 3-4|0.0 2-3|0.0.2 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:52.521
(d3 / demonstrate-01 
      :ARG0 (c3 / cell 
            :ARG0-of (c2 / confirm-01 
                  :ARG1 (d / dispensable 
                        :location (c / cell))) 
            :mod (t / this) 
            :mod (e / e)) 
      :ARG1 (m / morphology 
            :ARG1-of (n / normal-02)) 
      :op1-of (a / and 
            :op2 (p / proliferate-01) 
            :op3 (d2 / differentiation 
                  :ARG1-of (s / show-01 
                        :polarity -))))

# ::snt To analyze the physiological roles of ESG1 , we identified the mouse gene on chromosome 9 and deleted it by homologous recombination in ES cells .
# ::tok To analyze the physiological roles of ESG1 , we identified the mouse gene on chromosome 9 and deleted it by homologous recombination in ES cells .
# ::alignments 24-25|0.0.1.0 23-24|0.0.1.0.0 21-22|0.0.1 20-21|0.0.2 17-18|0.0 16-17|0 15-16|0.0.0.0.2.0 14-15|0.0.0.0.1 12-13|0.0.0.0.0 11-12|0.0.0.0.0.0 9-10|0.0.0.0 8-9|0.0.0 4-5|0.0.0.0.2.1 3-4|0.0.0.0.2.1.0 1-2|0.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:53.019
(a / and 
      :op1 (d / delete-01 
            :ARG0 (w / we 
                  :ARG0-of (i / identify-01 
                        :ARG1 (g / gene 
                              :mod (m / mouse)) 
                        :ARG2 (c2 / chromosome) 
                        :condition (a2 / analyze-01 
                              :ARG0 9 
                              :ARG1 (r2 / role 
                                    :mod (p / physiological))))) 
            :ARG1 (r / recombination 
                  :location (c / cell 
                        :mod (e / e))) 
            :ARG2 (h / homologou)))

# ::snt Despite specific expression in early embryos , germ cells , and pluripotent cells , our data demonstrated that ESG1 is dispensable for mouse development , germ cell formation , and ES cell self-renewal .
# ::tok Despite specific expression in early embryos , germ cells , and pluripotent cells , our data demonstrated that ESG1 is dispensable for mouse development , germ cell formation , and ES cell self-renewal .
# ::alignments 32-33|0.1.1 31-32|0.1.1.0 30-31|0.1.1.0.0 29-30|0.1 27-28|0 26-27|0.0 25-26|0.0.0 23-24|0.1.0 22-23|0.1.0.0 20-21|0.1.0.2 16-17|0.1.0.2.0 15-16|0.1.0.2.0.0 14-15|0.1.0.2.0.0.0 12-13|0.1.0.1.3 11-12|0.1.0.1.3.0 10-11|0.1.0.1 8-9|0.1.0.1.2 7-8|0.1.0.1.2.0 5-6|0.1.0.1.1 4-5|0.1.0.1.1.0 2-3|0.1.0.1.0 1-2|0.1.0.1.0.0 0-1|0.1.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:54.396
(f / form-01 
      :ARG1 (c2 / cell 
            :mod (g / germ)) 
      :op2-of (a / and 
            :op1 (d / develop-02 
                  :ARG1 (m / mouse) 
                  :op4-of (a2 / and 
                        :ARG1-of (e4 / express-01 
                              :ARG1-of (s2 / specific-02) 
                              :op1-of (d5 / despite)) 
                        :op1 (e2 / embryo 
                              :mod (e3 / early)) 
                        :op2 (c4 / cell 
                              :mod (g2 / germ)) 
                        :op3 (c3 / cell 
                              :mod (p / pluripotent))) 
                  :purpose-of (d2 / dispensable 
                        :ARG1-of (d3 / demonstrate-01 
                              :ARG0 (d4 / data 
                                    :poss (w / we))))) 
            :op3 (s / self-renewal 
                  :mod (c / cell 
                        :mod (e / e)))))

# ::snt Identification and analyses of BAC clones containing the mouse ESG1 gene .
# ::tok Identification and analyses of BAC clones containing the mouse ESG1 gene .
# ::alignments 10-11|0.0.0.1.0 9-10|0.0.0.1.0.0 8-9|0.0.0.1.0.0.0 6-7|0.0.0.1 5-6|0.0.0 4-5|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 2-3|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:54.927
(a2 / and 
      :op1 (i / identification 
            :op1 (c2 / clone-01 
                  :ARG0 (o / organization 
                        :name (n / name 
                              :op1 "BAC")) 
                  :ARG0-of (c / contain-01 
                        :ARG2 (g / gene 
                              :mod (e / ESG1 
                                    :mod (m / mouse)))))) 
      :op2 (a / analysis))

# ::snt To identify bacterial artificial chromosome ( BAC ) clones containing mouse ESG1 gene , we performed PCR-based screening of mouse BAC library DNA pools ( Research Genetics ) using the pH34-u38 ( 5 ' - GAAGTCTGGTTCCTTGGCAGG-3 ' ) and pH34-L394 ( 5 ' - ACTCGATACACTGGCCTAGC-3 ' ) primers .
# ::tok To identify bacterial artificial chromosome ( BAC ) clones containing mouse ESG1 gene , we performed PCR-based screening of mouse BAC library DNA pools ( Research Genetics ) using the pH34-u38 ( 5 ' - GAAGTCTGGTTCCTTGGCAGG-3 ' ) and pH34-L394 ( 5 ' - ACTCGATACACTGGCCTAGC-3 ' ) primers .
# ::alignments 47-48|0.2.0.1.0.2 43-45|0.2.0.1.0.0.1+0.2.0.1.0.0.0+0.2.0.1.0.0+0.2.0.1.0 41-42|0.2.0.1.0.1 38-39|0.2.0.0.0.1.1.2 32-33|0.2.0.0.0.0 28-29|0.2.0.1 26-27|0.2.0.0.0.1.1.1 25-26|0.2.0.0.0.1.1 23-24|0.1 22-23|0.1.0 21-22|0.1.1 19-20|0.2.0.0.0.2 17-18|0 16-17|0.0.0.0+0.0.0+0.0 15-16|0.2 14-15|0.2.0 12-13|0.2.0.0.0.1.0 11-12|0.2.0.0.0.1.0.0 10-11|0.2.0.0.0.1.0.0.0 9-10|0.2.0.0.0.1 8-9|0.2.0.0.0 6-7|0.2.0.0.0.1.2.0.0+0.2.0.0.0.1.2.0+0.2.0.0.0.1.2 4-5|0.2.0.0.0.3 3-4|0.2.0.0.0.4 2-3|0.2.0.0.0.1.1.0 1-2|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:57.410
(s / screen-01 
      :ARG0 (t2 / thing 
            :name (n2 / name 
                  :op1 "PCR-based")) 
      :ARG1 (p2 / pool 
            :mod (d / DNA) 
            :mod (l / library)) 
      :ARG1-of (p3 / perform-02 
            :ARG0 (w / we 
                  :ARG0-of (i / identify-01 
                        :ARG1 (c2 / clone-01 
                              :ARG0 5 
                              :ARG0-of (c / contain-01 
                                    :ARG1 (g2 / gene 
                                          :mod (e / ESG1 
                                                :mod (m2 / mouse))) 
                                    :ARG1-of (r / research-01 
                                          :ARG0 (b / bacterial) 
                                          :mod-of (g / genetic) 
                                          :op1-of (a2 / and)) 
                                    :ARG2 (o / organization 
                                          :name (n3 / name 
                                                :op1 "BAC"))) 
                              :ARG1 (m / mouse) 
                              :mod (c3 / chromosome) 
                              :mod (a3 / artificial))) 
                  :ARG0-of (u / use-01 
                        :ARG1 (t / thing 
                              :name (n / name 
                                    :op1 - 
                                    :op2 (a / ACTCGATACACTGGCCTAGC-3)) 
                              :poss 5 
                              :poss-of (p / primer))))))

# ::snt Following restriction enzyme digestion , we performed Southern blot analyses of BAC clones as described [ 20 ] using the pH34-U258 ( 5 ' - CTCGAGTGTACAGTCAAGTGGTTGCTGGGA-3 ' ) , pH34-U65 ( 5 ' - GTGACCCTCGTGACCCGTAA-3 ' ) , pH34-intron1L ( 5 ' - CTGCGTGAGAGAAACACCAAACAGGC-3 ' ) , pH34-L545 ( 5 ' - TGTGAATGGGAAGGTTACCACTCT-3 ' ) and pH34-SCL1 ( 5 ' - GCCCTCTTCTGGTTTGTCTCGAAAT-3 ' ) probes .
# ::tok Following restriction enzyme digestion , we performed Southern blot analyses of BAC clones as described [ 20 ] using the pH34-U258 ( 5 ' - CTCGAGTGTACAGTCAAGTGGTTGCTGGGA-3 ' ) , pH34-U65 ( 5 ' - GTGACCCTCGTGACCCGTAA-3 ' ) , pH34-intron1L ( 5 ' - CTGCGTGAGAGAAACACCAAACAGGC-3 ' ) , pH34-L545 ( 5 ' - TGTGAATGGGAAGGTTACCACTCT-3 ' ) and pH34-SCL1 ( 5 ' - GCCCTCTTCTGGTTTGTCTCGAAAT-3 ' ) probes .
# ::alignments 64-65|0.1 60-62|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 58-59|0.1.0.1 55-56|0 49-50|0.0.1.1 40-41|0.0.0.0.0 31-32|0.0.1.0.0.0.0.1 22-23|0.0.1.0.0.1.0 18-19|0.0 16-17|0.0.1.0.0.1.1.0.0 14-15|0.0.1 12-13|0.0.0.0 11-12|0.0.0.1.0+0.0.0.1+0.0.0 9-10|0.0.1.0.0.0 8-9|0.0.1.0.0.0.0 7-8|0.0.1.0.0.0.0.0.0.0+0.0.1.0.0.0.0.0.0+0.0.1.0.0.0.0.0 6-7|0.0.1.0.0 5-6|0.0.1.0 3-4|0.0.1.0.0.1.1 2-3|0.0.1.0.0.1.1.1 1-2|0.0.1.0.0.1.1.0 0-1|0.0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:59.434
(a / and 
      :ARG1-of (u / use-01 
            :ARG0 (o / organization 
                  :ARG0-of (c / clone-01 
                        :ARG1 5) 
                  :name (n2 / name 
                        :op1 "BAC")) 
            :ARG2-of (d / describe-01 
                  :ARG1 (w / we 
                        :ARG0-of (p2 / perform-02 
                              :ARG1 (a2 / analysis 
                                    :ARG1-of (b / blot-01 
                                          :ARG0 (t2 / thing 
                                                :name (n3 / name 
                                                      :op1 "Southern")) 
                                          :ARG2 5)) 
                              :ARG1-of (f / follow-01 
                                    :ARG0 5 
                                    :ARG2 (d2 / digestion 
                                          :ARG1-of (r / restrict-01 
                                                :ARG0 20) 
                                          :mod (e / enzyme))))) 
                  :op1-of 5)) 
      :op1 (p / probe 
            :poss (t / thing 
                  :name (n / name 
                        :op1 - 
                        :op2 (g / GCCCTCTTCTGGTTTGTCTCGAAAT-3)) 
                  :poss 5)))

# ::snt Hybridization with these probes revealed bands containing either the ESG1 gene or pseudogenes .
# ::tok Hybridization with these probes revealed bands containing either the ESG1 gene or pseudogenes .
# ::alignments 12-13|0.1.0.0.2 11-12|0.1.0.0 10-11|0.1.0.0.1 7-8|0.1.0.0.0 6-7|0.1.0 5-6|0.1 4-5|0 3-4|0.2 2-3|0.2.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:56:59.765
(r / reveal-01 
      :ARG0 (h / hybridization) 
      :ARG1 (b / band 
            :ARG0-of (c / contain-01 
                  :ARG1 (o / or 
                        :mod (e / either) 
                        :op1 (g / gene) 
                        :op2 (p / pseudogen)))) 
      :manner (p2 / probe 
            :mod (t / this)))

# ::snt To sequence the region containing the mouse ESG1 gene and the 3 ' flanking region , we subcloned a ~ 15 kbp XhoI-SalI fragment into the pZERO-2 vector ( Invitrogen ) .
# ::tok To sequence the region containing the mouse ESG1 gene and the 3 ' flanking region , we subcloned a ~ 15 kbp XhoI-SalI fragment into the pZERO-2 vector ( Invitrogen ) .
# ::alignments 29-30|0.1.0.0+0.1.0+0.1 27-28|0.0.0.1.1 23-24|0.0.0.1.0 22-23|0.0.0.1.0.0.0.0+0.0.0.1.0.0.0+0.0.0.1.0.0 21-22|0.0.0.1.0.3 20-21|0.0.0.1.0.2.0 16-17|0.0.0.1 14-15|0.0.0.1.0.2.1 13-14|0.0.0.1.0.2 11-12|0.0.0.1.0.2.1.0 9-10|0 8-9|0.0.1 6-7|0.0.0.1.0.1 4-5|0.0 3-4|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:01.026
(a / and 
      :op1 (c / contain-01 
            :ARG0 (r2 / region 
                  :op1-of (s / sequence) 
                  :poss (w / we 
                        :ARG0-of (f / fragment-01 
                              :ARG1 (t / thing 
                                    :name (n2 / name 
                                          :op1 "XhoI-SalI")) 
                              :ARG2 (m / mouse) 
                              :ARG2-of (f2 / flank-01 
                                    :ARG0 15 
                                    :ARG1 (r / region 
                                          :part-of 3)) 
                              :mod (k / kbp)) 
                        :poss-of (v / vector))) 
            :ARG1 (g / gene)) 
      :op2 (o / organization 
            :name (n / name 
                  :op1 "Invitrogen")))

# ::snt HindIII - or EcoRI-digested fragments of this vector were then cloned into pBluescript KS ( - ) for sequencing .
# ::tok HindIII - or EcoRI-digested fragments of this vector were then cloned into pBluescript KS ( - ) for sequencing .
# ::alignments 18-19|0.2 12-14|0.1.0.1+0.1.0.0+0.1.0+0.1 10-11|0 9-10|0.3 7-8|0.0.0 6-7|0.0.0.0 4-5|0.0 3-4|0.0.1.0 2-3|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:01.153
(c / clone-01 
      :ARG1 (f / fragment-01 
            :ARG1 (v / vector 
                  :mod (t3 / this)) 
            :op2-of (o / or 
                  :op1 (e / ecori-digest))) 
      :ARG2 (t / thing 
            :name (n / name 
                  :op1 (p / pBluescript) 
                  :op2 (k / KS))) 
      :purpose (s / sequence) 
      :time (t2 / then))

# ::snt To sequence the ESG1 pseudogene and the 3 ' flanking region , an 8 kbp NotI/XhoI fragment was cloned into pBluescript KS ( - ) .
# ::tok To sequence the ESG1 pseudogene and the 3 ' flanking region , an 8 kbp NotI/XhoI fragment was cloned into pBluescript KS ( - ) .
# ::alignments 20-22|0.1.0.0.0.1.0.1+0.1.0.0.0.1.0.0+0.1.0.0.0.1.0+0.1.0.0.0.1 18-19|0.1.0.0.0 16-17|0.1.0.0.0.0 15-16|0.1.0.0.0.0.0.0.0+0.1.0.0.0.0.0.0+0.1.0.0.0.0.0 13-14|0.1.0.0.0.0.1 10-11|0.1 9-10|0 7-8|0.0 5-6|0.1.0 4-5|0.1.0.1 3-4|0.1.0.1.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:01.505
(f2 / flank-01 
      :ARG0 3 
      :ARG1 (r / region 
            :op3-of (a / and 
                  :op1 (s / sequence 
                        :ARG0-of (c / clone-01 
                              :ARG1 (f / fragment-01 
                                    :ARG1 (c2 / country 
                                          :name (n2 / name 
                                                :op1 "NotI/XhoI")) 
                                    :quant 8) 
                              :ARG2 (t / thing 
                                    :name (n / name 
                                          :op1 (p / pBluescript) 
                                          :op2 (k / KS))))) 
                  :op2 (p2 / pseudogene 
                        :mod (e / ESG1)))))

# ::snt BamHI - or PstI - fragments of this vector were also cloned into pBluescript KS ( - ) .
# ::tok BamHI - or PstI - fragments of this vector were also cloned into pBluescript KS ( - ) .
# ::alignments 13-15|0.1.0.1+0.1.0.0+0.1.0+0.1 11-12|0 10-11|0.2 8-9|0.0.0 7-8|0.0.0.0 5-6|0.0 2-3|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:01.620
(c / clone-01 
      :ARG1 (f / fragment-01 
            :ARG1 (v / vector 
                  :mod (t2 / this))) 
      :ARG2 (t / thing 
            :name (n / name 
                  :op1 (p / pBluescript) 
                  :op2 (k / KS)) 
            :op1-of (o / or)) 
      :mod (a / also))

# ::snt To identify the sequence containing the 5 ' flanking regions of the ESG1 gene and the related pseudogenes , we used a TOPO walker kit ( Invitrogen ) with the pH34-T2L ( 5 ' - ACTAGTCGCAGCAGGGATCCAGGAATATCT-3 ' ) and pH34-L394 primers .
# ::tok To identify the sequence containing the 5 ' flanking regions of the ESG1 gene and the related pseudogenes , we used a TOPO walker kit ( Invitrogen ) with the pH34-T2L ( 5 ' - ACTAGTCGCAGCAGGGATCCAGGAATATCT-3 ' ) and pH34-L394 primers .
# ::alignments 40-41|0.0.0.0.0.0.1.0 38-39|0.0.0.0.0.0.1 32-33|0.0.1.0.0 26-27|0.0.2.0.0+0.0.2.0+0.0.2 24-25|0.0.0.0.0.0.0 23-24|0.0.0.0.0.0.0.0 20-21|0.0.0.0.0.0 19-20|0.0.0.0.0 17-18|0.2 16-17|0.2.0 14-15|0 13-14|0.1 9-10|0.0.1 8-9|0.0.1.0 6-7|0.0.0.0.0.0.0.0.0 4-5|0.0 3-4|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:02.907
(a2 / and 
      :op1 (c / contain-01 
            :ARG0 (s / sequence 
                  :ARG1-of (i / identify-01 
                        :ARG0 (w2 / we 
                              :ARG0-of (u / use-01 
                                    :ARG1 (k / kit 
                                          :mod (w / walk-01 
                                                :ARG0 5)) 
                                    :ARG2 (a / and 
                                          :op1 (p / primer)))))) 
            :ARG1 (r2 / region 
                  :ARG1-of (f / flank-01 
                        :ARG0 5)) 
            :ARG2 (o / organization 
                  :name (n / name 
                        :op1 "Invitrogen"))) 
      :op2 (g / gene) 
      :op3 (p2 / pseudogen 
            :ARG1-of (r / relate-01)))

# ::snt The resulting sequence was cloned into pCR2 .1 ( Invitrogen ) .
# ::tok The resulting sequence was cloned into pCR2 .1 ( Invitrogen ) .
# ::alignments 9-10|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 4-5|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:02.941
(c / clone-01 
      :ARG1 (s / sequence 
            :ARG1-of (r / result-01 
                  :ARG0 (o / organization 
                        :name (n / name 
                              :op1 "Invitrogen")))))

# ::snt We obtained a ~ 6 kbp band from the NsiI-digensted library ; XbaI - , SpeI - , EcoRI - , and PstI-digested fragments of this band were cloned into pBluescript KS ( - ) for sequencing .
# ::tok We obtained a ~ 6 kbp band from the NsiI-digensted library ; XbaI - , SpeI - , EcoRI - , and PstI-digested fragments of this band were cloned into pBluescript KS ( - ) for sequencing .
# ::alignments 36-37|0.1.1.3 30-32|0.1.1.2.0.1+0.1.1.2.0.0+0.1.1.2.0+0.1.1.2 28-29|0.1.1 26-27|0.1.1.1.1 25-26|0.1.1.1.1.0 23-24|0.1.1.1 22-23|0.1.1.1.0.0.0+0.1.1.1.0.0+0.1.1.1.0 21-22|0.1 11-12|0 10-11|0.0 9-10|0.0.0 6-7|0.1.0.1 5-6|0.1.1.0 4-5|0.1.1.1.1.0.0 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:04.293
(a2 / and 
      :op1 (l / library 
            :mod (n3 / nsii-digenst)) 
      :op2 (a / and 
            :op1 (o / obtain-01 
                  :ARG0 (w / we) 
                  :ARG1 (b2 / band)) 
            :op2 (c / clone-01 
                  :ARG0 (k2 / kbp) 
                  :ARG1 (f / fragment-01 
                        :ARG1 (t3 / thing 
                              :name (n2 / name 
                                    :op1 "PstI-digested")) 
                        :ARG2 (b / band 
                              :mod (t2 / this 
                                    :mod-of 6))) 
                  :ARG2 (t / thing 
                        :name (n / name 
                              :op1 (p / pBluescript) 
                              :op2 (k / KS))) 
                  :purpose (s / sequence))))

# ::snt This fragment contained the 5 ' flanking region of the ESG1 gene .
# ::tok This fragment contained the 5 ' flanking region of the ESG1 gene .
# ::alignments 11-12|0.1.1 7-8|0.1 6-7|0.1.0 4-5|0.1.0.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:04.379
(c / contain-01 
      :ARG0 (f2 / fragment-01 
            :mod (t / this)) 
      :ARG1 (r / region 
            :ARG1-of (f / flank-01 
                  :ARG0 5) 
            :poss (g / gene)))

# ::snt A ~ 3 kbp fragment , obtained from the SacI-digested library , was cloned into pCR2 .1 for sequencing .
# ::tok A ~ 3 kbp fragment , obtained from the SacI-digested library , was cloned into pCR2 .1 for sequencing .
# ::alignments 18-19|0.1 13-14|0 10-11|0.0.0.0.0 9-10|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 6-7|0.0.0.0 4-5|0.0 3-4|0.0.0 2-3|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:04.516
(c / clone-01 
      :ARG1 (f / fragment-01 
            :ARG1 (k / kbp 
                  :ARG1-of (o / obtain-01 
                        :ARG2 (l / library 
                              :mod (t / thing 
                                    :name (n / name 
                                          :op1 "SacI-digested"))))) 
            :quant 3) 
      :purpose (s / sequence))

# ::snt This fragment was contained the 5 ' region flanking the pseudogene .
# ::tok This fragment was contained the 5 ' region flanking the pseudogene .
# ::alignments 8-9|0.0.0 7-8|0.0 5-6|0.0.1 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:04.662
(c / contain-01 
      :ARG1 (r / region 
            :ARG1-of (f / flank-01) 
            :poss 5) 
      :ARG2 (f2 / fragment-01 
            :mod (t / this)))

# ::snt Construction of ESG1 targeting vectors .
# ::tok Construction of ESG1 targeting vectors .
# ::alignments 4-5|0.1 3-4|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:04.709
(t / target-01 
      :ARG1 (c / construct-01) 
      :ARG2 (v / vector))

# ::snt We replaced all of the ESG1 exons with two targeting vectors containing either an IRES--geo cassette [ 21 ] or an IRES-HygR cassette by promoter trap selection .
# ::tok We replaced all of the ESG1 exons with two targeting vectors containing either an IRES--geo cassette [ 21 ] or an IRES-HygR cassette by promoter trap selection .
# ::alignments 26-27|0.1.1.0.0.0.1 25-26|0.1.1.0.0.0 24-25|0.1.1.0.0.0.0 22-23|0.1.1.0.0.3 19-20|0.1.1.0.0 17-18|0.1.1.0.0.0.0.0 15-16|0.1.1.0.0.0.1.0 14-15|0.1.1.0.0.2.0.0+0.1.1.0.0.2.0+0.1.1.0.0.2 12-13|0.1.1.0.0.1 11-12|0.1.1.0 10-11|0.1.1 9-10|0.1.1.1 8-9|0.1.1.2 6-7|0 2-3|0.0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:05.545
(e2 / exon 
      :quant (a / all) 
      :time-of (r / replace-01 
            :ARG0 (w / we) 
            :ARG1 (v / vector 
                  :ARG0-of (c3 / contain-01 
                        :ARG1 (o / or 
                              :ARG0-of (t / trap-01 
                                    :ARG1 (p / promote-01 
                                          :ARG1 21) 
                                    :ARG1-of (s / select-01 
                                          :ARG0 (c2 / cassette))) 
                              :mod (e / either) 
                              :op1 (t2 / thing 
                                    :name (n / name 
                                          :op1 "IRES--geo")) 
                              :op2 (c / cassette))) 
                  :ARG1-of (t3 / target-01) 
                  :quant 2)))

# ::snt We amplified the 5 ' arm ( 1.8 kbp ) using KOD plus ( TOYOBO ) with the pH34-targetpair5-U ( 5 ' - CCGCGGAAAGTCAAGAGATTGGGTGG-3 ' ) and pH34-targetpair5-L ( 5 ' - GCGGCCGCCTTTACGGGTCACGAGGGTCAC-3 ' ) primers .
# ::tok We amplified the 5 ' arm ( 1.8 kbp ) using KOD plus ( TOYOBO ) with the pH34-targetpair5-U ( 5 ' - CCGCGGAAAGTCAAGAGATTGGGTGG-3 ' ) and pH34-targetpair5-L ( 5 ' - GCGGCCGCCTTTACGGGTCACGAGGGTCAC-3 ' ) primers .
# ::alignments 35-36|0.2 29-30|0.0.0.0.2 26-27|0 20-21|0.0.0.0.1 14-15|0.1.0.0+0.1.0+0.1 12-13|0.0.2 11-12|0.0.1.0.0+0.0.1.0+0.0.1 10-11|0.0 7-8|0.0.0.0.2.0 5-6|0.0.0.0.0 3-4|0.0.0.0.0.0 1-2|0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:07.063
(a / and 
      :ARG2-of (u / use-01 
            :ARG0 (w / we 
                  :ARG0-of (a3 / amplify-01 
                        :ARG1 (a2 / arm 
                              :poss 5) 
                        :ARG2 5 
                        :op1-of (5 / 5 
                              :mod-of 1.8))) 
            :ARG1 (o2 / organization 
                  :name (n2 / name 
                        :op1 "KOD")) 
            :ARG3 (p2 / plus)) 
      :op1 (o / organization 
            :name (n / name 
                  :op1 "TOYOBO")) 
      :op2 (p / primer))

# ::snt The 3 ' arm ( 5.8 kbp ) was amplified using the pH34-targetpair3-U ( 5 ' - TGTGGCCAGTGTTTGGTTCTGGCGGG-3 ' ) and pH34-targetpair3-L ( 5 ' - CTCGAGGACTCGCCATTCTAGCCAAG-3 ' ) primers .
# ::tok The 3 ' arm ( 5.8 kbp ) was amplified using the pH34-targetpair3-U ( 5 ' - TGTGGCCAGTGTTTGGTTCTGGCGGG-3 ' ) and pH34-targetpair3-L ( 5 ' - CTCGAGGACTCGCCATTCTAGCCAAG-3 ' ) primers .
# ::alignments 29-30|0.0.0.1 25-27|0+0.0.1+0.0+0.0.0 23-24|0.0.0.0 20-21|0.0.0.0.0.1.0 14-15|0.0.0.0.0.0 10-11|0.0.0.0.0.1 9-10|0.0.0.0.0 6-7|0.0.0.1.0 3-4|0.0.0.0.0.1.1 1-2|0.0.0.0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:07.314
(c / CTCGAGGACTCGCCATTCTAGCCAAG-3 
      :op2-of (n / name 
            :name-of (t / thing 
                  :poss (5 / 5 
                        :op1 (a2 / amplify-01 
                              :ARG0 5 
                              :ARG1 (u / use-01 
                                    :ARG1 (a / and) 
                                    :ARG2 (a3 / arm 
                                          :part-of 3)))) 
                  :poss-of (p / primer 
                        :mod (k / kbp))) 
            :op1 -))

# ::snt The IRES -geo or IRES HygR cassettes were ligated in between the two PCR fragments .
# ::tok The IRES -geo or IRES HygR cassettes were ligated in between the two PCR fragments .
# ::alignments 14-15|0.0.0.0 12-13|0.0.0.0.0 8-9|0.0 6-7|0.1.0 4-6|0.1.1.1+0.1.1.0+0.1.1+0.1 3-4|0 1-2|0.0.0.1.0+0.0.0.1+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:07.555
(o / or 
      :ARG0-of (l / ligate-01 
            :ARG1 (o2 / organization 
                  :ARG1-of (f / fragment-01 
                        :quant 2) 
                  :name (n2 / name 
                        :op1 "IRES"))) 
      :op1 (t / thing 
            :mod-of (c / cassett) 
            :name (n / name 
                  :op1 (i / IRES) 
                  :op2 (h / HygR))))

# ::snt The diphtheria toxin A cassette was placed downstream of the 3 ' arm .
# ::tok The diphtheria toxin A cassette was placed downstream of the 3 ' arm .
# ::alignments 12-13|0.0.0 10-11|0.0.0.0 7-8|0.0 6-7|0 4-5|0.1 2-3|0.1.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:07.781
(p / place-01 
      :ARG1 (d / downstream 
            :poss (a / arm 
                  :quant 3)) 
      :ARG2 (c / cassette 
            :mod (t / toxin 
                  :mod (d2 / diphtheria))))

# ::snt After linearization with SacII , these targeting vectors were electroporated into 2.0  107 RF8 ES cells [ 22 ] using a Gene pulser ( BIORAD ) .
# ::tok After linearization with SacII , these targeting vectors were electroporated into 2.0  107 RF8 ES cells [ 22 ] using a Gene pulser ( BIORAD ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:07.783
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Transfected cells were selected with 250 g/mL G418 or 100 g/mL hygromycin B , respectively .
# ::tok Transfected cells were selected with 250 g/mL G418 or 100 g/mL hygromycin B , respectively .
# ::alignments 14-15|0.0 12-13|0.2.2.2+0.2.2.0.0+0.2.2.0+0.2.2 11-12|0.2.1.0 9-10|0.2.2.1 8-9|0.2 7-8|0.2.1 5-6|0.2.0 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:07.927
(s / select-01 
      :ARG0 (r / respective) 
      :ARG1 (c / cell 
            :mod (t / transfect)) 
      :ARG2 (o / or 
            :domain-of 250 
            :op1 (g / G418 
                  :part (h / hygromycin)) 
            :op2 (l / location 
                  :name (n / name 
                        :op1 "B") 
                  :quant 100 
                  :wiki -)))

# ::snt Genomic DNA from G418 - or hygromycin B-resistant colonies was screened for homologous recombination by Southern blotting .
# ::tok Genomic DNA from G418 - or hygromycin B-resistant colonies was screened for homologous recombination by Southern blotting .
# ::alignments 16-17|0.0 15-16|0.0.0.0.0+0.0.0.0+0.0.0 13-14|0.3 12-13|0.3.0 10-11|0 8-9|0.2.0 5-6|0.2 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:08.237
(s / screen-01 
      :ARG0 (b / blot-01 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 "Southern"))) 
      :ARG1 (d / DNA) 
      :ARG2 (o / or 
            :op1 (c / colony)) 
      :ARG3 (r / recombination 
            :mod (h / homologou)))

# ::snt Southern blot screening for homologous recombination .
# ::tok Southern blot screening for homologous recombination .
# ::alignments 5-6|0.0 4-5|0.0.0 2-3|0 1-2|0.2 0-1|0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:08.364
(s / screen-01 
      :ARG0 (r / recombination 
            :mod (h / homologou)) 
      :ARG1 (t / thing 
            :name (n / name 
                  :op1 "Southern")) 
      :ARG1-of (b / blot-01))

# ::snt ES cells genomic DNA was extracted with PUREGENE  Cell Lysis Solution ( Gentra systems ) .
# ::tok ES cells genomic DNA was extracted with PUREGENE  Cell Lysis Solution ( Gentra systems ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:08.366
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt For 5 ' Southern blot analysis , genomic DNA was first digested with PstI , then separated on an 0.8 % agarose gel and transferred to a nylon membrane as described [ 20 ] .
# ::tok For 5 ' Southern blot analysis , genomic DNA was first digested with PstI , then separated on an 0.8 % agarose gel and transferred to a nylon membrane as described [ 20 ] .
# ::alignments 32-33|0.1.1 30-31|0.2.2 28-29|0.2.1 27-28|0.2.0 24-25|0.2 23-24|0 22-23|0.1.0 21-22|0.1.0.0 20-21|0.1.0.0.0 19-20|0.1.0.0.0.0 16-17|0.1 15-16|0.1.2 11-12|0.0 8-9|0.0.0 5-6|0.0.1 4-5|0.0.1.1 3-4|0.0.1.1.0.0.0+0.0.1.1.0.0+0.0.1.1.0 1-2|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:09.200
(a / and 
      :op1 (d2 / digest-01 
            :ARG1 (d3 / DNA) 
            :purpose (a3 / analyze-01 
                  :ARG0 5 
                  :ARG1 (b / blot-01 
                        :ARG1 (t3 / thing 
                              :name (n2 / name 
                                    :op1 "Southern"))))) 
      :op2 (s / separate-01 
            :ARG0 (g / gel 
                  :mod (a2 / agarose 
                        :mod (p / percentage-entity 
                              :value 0.8))) 
            :ARG1 20 
            :time (t2 / then)) 
      :op3 (t / transfer-01 
            :ARG1 (n / nylon) 
            :ARG2 (m / membrane) 
            :condition (d / describe-01)))

# ::snt A 560 bp 5 ' probe was amplified using the ESG1S5 ( 5 ' - GATGGTGGTGGTGACTCAGAG -3 ' ) and ESG1AS5 as ( 5 ' - CCTCCATTGCCTCTATATCAG -3 ' ) primers .
# ::tok A 560 bp 5 ' probe was amplified using the ESG1S5 ( 5 ' - GATGGTGGTGGTGACTCAGAG -3 ' ) and ESG1AS5 as ( 5 ' - CCTCCATTGCCTCTATATCAG -3 ' ) primers .
# ::alignments 23-24|0.0 20-21|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 19-20|0.1.0 12-13|0.1.2.2 10-11|0.1.1.0.0+0.1.1.0+0.1.1 8-9|0.1 7-8|0 5-6|0.1.2 3-4|0.1.2.1 1-3|0.1.2.0.0.1+0.1.2.0.0.0+0.1.2.0.0+0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:10.017
(a2 / amplify-01 
      :ARG0 5 
      :ARG1 (u / use-01 
            :ARG0 (a / and 
                  :op1 (o / organization 
                        :name (n / name 
                              :op1 "ESG1AS5"))) 
            :ARG1 (t / thing 
                  :name (n2 / name 
                        :op1 "ESG1S5")) 
            :ARG2 (p / probe-01 
                  :ARG0 (t2 / thing 
                        :name (n3 / name 
                              :op1 560 
                              :op2 (b / bp))) 
                  :ARG1 5 
                  :ARG2 5)))

# ::snt The probe specifically labeled an 18 kbp band from the wild-type locus , a 15 kbp band from the -geo locus , and a 12 kbp band from the HygR locus .
# ::tok The probe specifically labeled an 18 kbp band from the wild-type locus , a 15 kbp band from the -geo locus , and a 12 kbp band from the HygR locus .
# ::alignments 30-31|0.2.0 26-27|0.2 24-25|0.0.0.0.0 22-23|0 20-21|0.0.0.0.1 16-17|0.1 14-15|0.1.0 11-12|0.0.0.1 7-8|0.0 6-7|0.0.0.2.0.0 5-6|0.0.0.2.0 3-4|0.0.0 2-3|0.0.0.2 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:10.742
(a / and 
      :op1 (b3 / band 
            :ARG1-of (l4 / label-01 
                  :ARG0 (p / probe-01 
                        :ARG0 12 
                        :ARG1 (l2 / locu)) 
                  :ARG2 (l3 / locu) 
                  :manner (s / specific-02 
                        :ARG1 (13 / 18 
                              :quant-of (k / kbp))))) 
      :op2 (b2 / band 
            :quant 15) 
      :op3 (b / band 
            :source (l / locu)))

# ::snt Genomic DNA was also digested with SpeI for 3 ' Southern blot analysis .
# ::tok Genomic DNA was also digested with SpeI for 3 ' Southern blot analysis .
# ::alignments 12-13|0.2 11-12|0.2.2 10-11|0.2.1.0.0+0.2.1.0+0.2.1 8-9|0.2.0 4-5|0 3-4|0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:10.779
(d / digest-01 
      :ARG1 (d2 / DNA) 
      :mod (a2 / also) 
      :purpose (a / analyze-01 
            :ARG0 3 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 "Southern")) 
            :ARG1-of (b / blot-01)))

# ::snt A 1,010 bp 3 ' probe was amplified with the pH34U-8000 ( 5 ' - CCAACCAGCCAGAGTTTCAGTTAT -3 ' ) and pH34L-9000 ( 5 ' - GATAAGCTGCTGCCAAAAGACAAG -3 ' ) primers .
# ::tok A 1,010 bp 3 ' probe was amplified with the pH34U-8000 ( 5 ' - CCAACCAGCCAGAGTTTCAGTTAT -3 ' ) and pH34L-9000 ( 5 ' - GATAAGCTGCTGCCAAAAGACAAG -3 ' ) primers .
# ::alignments 29-30|0.1 25-27|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 22-23|0.0.0 19-20|0 12-13|0.0.1.0 7-8|0.0 5-6|0.0.1 3-4|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:10.917
(a / and 
      :op1 (a2 / amplify-01 
            :ARG0 5 
            :ARG1 (p2 / probe-01 
                  :ARG0 5 
                  :ARG1 3)) 
      :op2 (p / primer 
            :poss (t / thing 
                  :name (n / name 
                        :op1 (g / GATAAGCTGCTGCCAAAAGACAAG) 
                        :op2 -3))))

# ::snt The probe hybridized to an 11.5 kbp band from the wild-type locus , a 12.5 kbp band from the -geo locus , and a 9.5 kbp band from the HygR locus .
# ::tok The probe hybridized to an 11.5 kbp band from the wild-type locus , a 12.5 kbp band from the -geo locus , and a 9.5 kbp band from the HygR locus .
# ::alignments 30-31|0.1.0 26-27|0.0.2 22-23|0.0 20-21|0.1.1 16-17|0.0.1 11-12|0.0.0 7-8|0.2 6-7|0.0.2.0.0 5-6|0.0.2.0 2-3|0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:11.053
(h / hybridize-01 
      :ARG0 (a / and 
            :op1 (l3 / locu) 
            :op2 (b2 / band) 
            :op3 (b / band 
                  :mod (1 / 11.5 
                        :value-of (k / kbp)))) 
      :ARG1 (p / probe-01 
            :ARG0 (l / locu) 
            :ARG1 (l2 / locu)) 
      :ARG2 (b3 / band))

# ::snt Generation of anti-ESG1 polyclonal antibodies .
# ::tok Generation of anti-ESG1 polyclonal antibodies .
# ::alignments 4-5|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:11.060
(g / generation 
      :mod (a / antibodi))

# ::snt The coding sequence of Esg1 was amplified by PCR with the pH34-gw-s ( 5 ' - AAAAAGCAGGCTGGATGATGGTGACCCTCGTGA-3 ' ) and pH34-gw-as ( 5 ' - AGAAAGCTGGGTCTGCATCCAGGTCGGAGACA-3 ' ) primers .
# ::tok The coding sequence of Esg1 was amplified by PCR with the pH34-gw-s ( 5 ' - AAAAAGCAGGCTGGATGATGGTGACCCTCGTGA-3 ' ) and pH34-gw-as ( 5 ' - AGAAAGCTGGGTCTGCATCCAGGTCGGAGACA-3 ' ) primers .
# ::alignments 28-29|0.3 22-23|0.0.0 20-21|0.2 19-20|0 13-14|0.0.1.0.0 11-12|0.1 6-7|0.0 4-5|0.0.1.1 2-3|0.0.1 1-2|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:11.227
(a / and 
      :op1 (a2 / amplify-01 
            :ARG0 5 
            :ARG1 (s / sequence 
                  :mod (c / code-01 
                        :ARG0 5) 
                  :mod (e / Esg1))) 
      :op2 (p3 / ph34-gw-) 
      :op3 (p2 / ph34-gw-a) 
      :op4 (p / primer))

# ::snt To construct pDONR-pH34 , the resulting PCR product was subcloned into pDONR201 ( Invitrogen ) .
# ::tok To construct pDONR-pH34 , the resulting PCR product was subcloned into pDONR201 ( Invitrogen ) .
# ::alignments 13-14|0.2.0.0+0.2.0+0.2 11-12|0.0.0.0 7-8|0.0 6-7|0.1 5-6|0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:11.328
(r / result-01 
      :ARG0 (p2 / product 
            :ARG1-of (c / construct-01 
                  :ARG0 (p / pDONR201))) 
      :ARG1 (p3 / PCR) 
      :ARG2 (o / organization 
            :name (n / name 
                  :op1 "Invitrogen")))

# ::snt pDONR-pH34 was interacted with pDEST17 ( Invitrogen ) by LR recombination .
# ::tok pDONR-pH34 was interacted with pDEST17 ( Invitrogen ) by LR recombination .
# ::alignments 10-11|0.0 9-10|0.0.0 6-7|0.2.0.0+0.2.0+0.2 4-5|0.1 2-3|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:11.372
(i / interact-01 
      :ARG0 (r / recombination 
            :mod (l / lr)) 
      :ARG1 (p / pDEST17) 
      :ARG2 (o / organization 
            :name (n / name 
                  :op1 "Invitrogen")))

# ::snt After introduction of the resulting expression vector pDEST17-pH34 into BL21-AI E. coli ( Invitrogen ) , recombinant protein production was induced according to the manufacture 's protocol .
# ::tok After introduction of the resulting expression vector pDEST17-pH34 into BL21-AI E. coli ( Invitrogen ) , recombinant protein production was induced according to the manufacture 's protocol .
# ::alignments 26-27|0.0 24-25|0.0.0 21-22|0 20-21|0.1 18-19|0.1.0 17-18|0.1.0.0 16-17|0.1.1.0.1.1.0 13-14|0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 10-12|0.1.1.0.1.0.1+0.1.1.0.1.0.0.1+0.1.1.0.1.0.0.0+0.1.1.0.1.0.0+0.1.1.0.1.0 6-7|0.1.1.0.2 5-6|0.1.1.0.1 4-5|0.1.1.0.1.1 1-2|0.1.1.0 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:11.794
(s / say-01 
      :ARG0 (p / protocol 
            :ARG0-of (m / manufacture-01)) 
      :ARG1 (i / induce-01 
            :ARG1 (p2 / produce-01 
                  :ARG1 (p3 / protein)) 
            :time (a / after 
                  :op1 (i2 / introduce-02 
                        :ARG0 (o / organization 
                              :name (n / name 
                                    :op1 "Invitrogen")) 
                        :ARG0-of (e / express-01 
                              :ARG1 (d / disease 
                                    :name (n2 / name 
                                          :op1 "E." 
                                          :op2 "coli") 
                                    :wiki "Escherichia_coli") 
                              :ARG1-of (r2 / result-01 
                                    :ARG0 (r / recombinant))) 
                        :ARG1 (v / vector)))))

# ::snt Histidine-tagged ESG1 was purified using Ni-nitrilotriacetic acid agarose ( Qiagen ) under denaturing conditions in the presence of 8 M urea .
# ::tok Histidine-tagged ESG1 was purified using Ni-nitrilotriacetic acid agarose ( Qiagen ) under denaturing conditions in the presence of 8 M urea .
# ::alignments 20-21|0.1.2.0 19-20|0.1.2.0.0.1+0.1.2.0.0.0.0+0.1.2.0.0.0+0.1.2.0.0 18-19|0.1.2 16-17|0.0 13-14|0.0.0 12-13|0.0.0.0 9-10|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 7-8|0.1.1 6-7|0.1.1.1 5-6|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 4-5|0.1 3-4|0 0-2|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:12.850
(p2 / purify-01 
      :ARG0 (p / presence 
            :location-of (c / condition 
                  :mod (d / denature 
                        :op1 (o / organization 
                              :name (n2 / name 
                                    :op1 "Qiagen"))))) 
      :ARG1 (u2 / use-01 
            :ARG0 (t2 / thing 
                  :name (n4 / name 
                        :op1 (h / Histidine-tagged) 
                        :op2 (e / ESG1))) 
            :ARG1 (a / agarose 
                  :mod (t / thing 
                        :name (n3 / name 
                              :op1 "Ni-nitrilotriacetic")) 
                  :mod (a2 / acid)) 
            :op1-of (8 / 8 
                  :quant-of (u / urea 
                        :mod (v / vehicle 
                              :name (n / name 
                                    :op1 "M1") 
                              :wiki "M1_Abrams")))))

# ::snt After dialysis against 6 M urea , the recombinant proteins were injected into New Zealand White rabbits to generate anti-ESG1 polyclonal antibodies .
# ::tok After dialysis against 6 M urea , the recombinant proteins were injected into New Zealand White rabbits to generate anti-ESG1 polyclonal antibodies .
# ::alignments 21-22|0.0.0.0 18-19|0.0.0 16-17|0.0.0.1 15-16|0.0.0.1.0.0 13-15|0.0.0.1.0.2+0.0.0.1.0.1.1+0.0.0.1.0.1.0+0.0.0.1.0.1+0.0.0.1.0 11-12|0.0 9-10|0 8-9|0.1 5-6|0.2.0 4-5|0.2.3+0.2.1.0+0.2.1+0.2 3-4|0.2.2 1-2|0.0.1.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:13.315
(p / protein 
      :ARG2-of (i / inject-01 
            :ARG1 (g / generate-01 
                  :ARG1 (a / antibodi) 
                  :ARG2-of (r / rabbit-01 
                        :ARG0 (c / country 
                              :mod-of (w / white) 
                              :name (n / name 
                                    :op1 "New" 
                                    :op2 "Zealand") 
                              :wiki "New_Zealand"))) 
            :time (a2 / after 
                  :op1 (d / dialysis))) 
      :mod (r2 / recombinant) 
      :mod (v / vehicle 
            :mod-of (u / urea) 
            :name (n2 / name 
                  :op1 "M1") 
            :quant 6 
            :wiki "M1_Abrams"))

# ::snt After preparation of ES cell extracts with M-Per ( Pierce ) , cellular proteins were separated on sodium dodecyl sulfate ( SDS ) -14 % polyacrylamide gels and transferred to nitrocellulose membranes ( Millipore ) .
# ::tok After preparation of ES cell extracts with M-Per ( Pierce ) , cellular proteins were separated on sodium dodecyl sulfate ( SDS ) -14 % polyacrylamide gels and transferred to nitrocellulose membranes ( Millipore ) .
# ::alignments 33-34|0.2.1.0.0.0+0.2.1.0.0+0.2.1.0 31-32|0.1.2 30-31|0.1.2.0 28-29|0.1 27-28|0 26-27|0.1.1 24-25|0.2.0.0 21-22|0.1.0.0.0+0.1.0.0+0.1.0 19-20|0.2.0.2 17-18|0.2.0.2.0 15-16|0.2.1 13-14|0.2.1.1 12-13|0.2.1.1.0 9-10|0.0.0.0+0.0.0+0.0 7-8|0.2.0.1.0.0.0.0+0.2.0.1.0.0.0+0.2.0.1.0.0 5-6|0.2.0.1.0+0.2.0.1 4-5|0.2.0.1.0.1 3-4|0.2.0.1.0.1.0 1-2|0.2.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:15.045
(a / and 
      :op1 (p3 / person 
            :name (n4 / name 
                  :op1 "Pierce")) 
      :op2 (t / transfer-01 
            :ARG0 (o2 / organization 
                  :name (n3 / name 
                        :op1 "SDS")) 
            :ARG1 (g / gel) 
            :ARG2 (m / membran 
                  :mod (n2 / nitrocellulose))) 
      :time (a2 / after 
            :op1 (p5 / prepare-02 
                  :ARG0 (p / percentage-entity) 
                  :ARG1 (t2 / thing 
                        :ARG1-of (e / extract-01 
                              :ARG2 (p4 / person 
                                    :name (n5 / name 
                                          :op1 "M-Per")) 
                              :mod (c2 / cell 
                                    :mod (e2 / e)))) 
                  :ARG2 (s / sulfate 
                        :mod (s2 / sodium))) 
            :time-of (s3 / separate-01 
                  :ARG0 (o / organization 
                        :name (n / name 
                              :op1 "Millipore")) 
                  :ARG1 (p2 / protein 
                        :mod (c / cell)))))

# ::snt Membranes were incubated with anti-ESG1 ( 1/500 dilution ) , anti-Oct3 / 4 ( 1/500 ; Santa Cruz Biotechnology ) , anti-CDK4 ( 1/200 ; Santa Cruz Biotechnology ) , and anti-GFP ( 1/1000 ; MBL ) primary antibodies .
# ::tok Membranes were incubated with anti-ESG1 ( 1/500 dilution ) , anti-Oct3 / 4 ( 1/500 ; Santa Cruz Biotechnology ) , anti-CDK4 ( 1/200 ; Santa Cruz Biotechnology ) , and anti-GFP ( 1/1000 ; MBL ) primary antibodies .
# ::alignments 38-39|0.1.0 37-38|0.1.0.1 30-31|0.1 25-28|0.1.0.1.0.1.0.2+0.1.0.1.0.1.0.1+0.1.0.1.0.1.0.0+0.1.0.1.0.1.0+0.1.0.1.0.1 16-19|0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 15-16|0 12-13|0.1.0.1.0.0 11-12|0.1.0.1.0 7-8|0.1.0.0.0.0 2-3|0.1.0.0.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:15.785
(a3 / and 
      :op1 (o2 / organization 
            :name (n2 / name 
                  :op1 "Santa" 
                  :op2 "Cruz" 
                  :op3 "Biotechnology")) 
      :op2 (a2 / and 
            :op1 (a / antibodi 
                  :domain (m / membran 
                        :ARG1-of (i / incubate-01 
                              :ARG0 (d / dilution))) 
                  :mod (p / primary 
                        :mod-of (s / slash 
                              :op1 4 
                              :op2 (o / organization 
                                    :name (n / name 
                                          :op1 "Santa" 
                                          :op2 "Cruz" 
                                          :op3 "Biotechnology")))))))

# ::snt Horseradish peroxidase-conjugated anti-rabbit and anti-mouse immunoglobulins ( 1/5000 ; Cell Signaling ) were used to detect antibody binding .
# ::tok Horseradish peroxidase-conjugated anti-rabbit and anti-mouse immunoglobulins ( 1/5000 ; Cell Signaling ) were used to detect antibody binding .
# ::alignments 17-18|0.0.1 16-17|0.0.1.0 15-16|0.0.1.0.0.0 13-14|0.0.1.0.0 10-11|0.0 9-10|0.0.0 8-9|0 5-6|0.0.1.0.0.0.0 3-4|0.0.1.0.0.0.1 1-2|0.0.1.0.0.0.0.0 0-1|0.0.1.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:16.129
(a2 / and 
      :op1 (s / signal-01 
            :ARG1 (c / cell) 
            :ARG2-of (b / binding-07 
                  :ARG0 (a / antibody 
                        :ARG1-of (u / use-01 
                              :ARG2 (d / detect-01 
                                    :ARG0 (i / immunoglobulin 
                                          :mod (p / peroxidase-conjugat) 
                                          :mod (h / horseradish)) 
                                    :ARG1 (a3 / and)))))))

# ::snt We visualized bound antibody with an ECL Western Blotting Detection System ( Amersham ) .
# ::tok We visualized bound antibody with an ECL Western Blotting Detection System ( Amersham ) .
# ::alignments 12-13|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 6-11|0.2.0.4+0.2.0.3+0.2.0.2+0.2.0.1+0.2.0.0+0.2.0+0.2 3-4|0.1 2-3|0.1.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:16.241
(v / visualize-01 
      :ARG0 (w / we) 
      :ARG1 (a / antibody 
            :ARG1-of (b / bind-01 
                  :op1-of (o / organization 
                        :name (n / name 
                              :op1 "Amersham")))) 
      :ARG2 (o2 / organization 
            :name (n2 / name 
                  :op1 "ECL" 
                  :op2 "Western" 
                  :op3 "Blotting" 
                  :op4 "Detection" 
                  :op5 "System")))

# ::snt Derivation of ESG1-deficient ES cells from blastocysts .
# ::tok Derivation of ESG1-deficient ES cells from blastocysts .
# ::alignments 6-7|0.0.1 4-5|0.0 3-4|0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:16.259
(d / derivation 
      :mod (c / cell 
            :mod (e / e) 
            :source (b / blastocyst)))

# ::snt Esg1 + / - or ESG1 - / - mutant female mice were injected with Tamoxifen ( 10 g ) and Depo-provera ( 1 mg ) subcutaneously on the third day of pregnancy .
# ::tok Esg1 + / - or ESG1 - / - mutant female mice were injected with Tamoxifen ( 10 g ) and Depo-provera ( 1 mg ) subcutaneously on the third day of pregnancy .
# ::alignments 32-33|0.0.0.2.0 30-31|0.0.0.2 26-27|0.2 24-25|0.0.0.0 23-24|0.0.0.0.0 21-22|0.1.0.0+0.1.0+0.1 20-21|0 17-18|0.0.0.1.1.0.1 15-16|0.0.1.0+0.0.1+0.0 13-14|0.0.0 11-12|0.0.0.1 10-11|0.0.0.1.0 9-10|0.0.0.1.1 7-8|0.0.0.1.1.0.0 4-5|0.0.0.1.1.0 2-3|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:16.664
(a / and 
      :op1 (p3 / person 
            :ARG2-of (i / inject-01 
                  :ARG0 (m / mg 
                        :quant 1) 
                  :ARG1 (m2 / mouse 
                        :mod (f / female) 
                        :mod (m3 / mutant 
                              :op2-of (o / or 
                                    :op1 (s2 / slash) 
                                    :poss 10))) 
                  :time (d / day 
                        :time-of (p / pregnancy))) 
            :name (n2 / name 
                  :op1 "Tamoxifen")) 
      :op2 (p2 / person 
            :name (n / name 
                  :op1 "Depo-provera") 
            :op1-of (s3 / slash)) 
      :op3 (s / subcutaneously))

# ::snt Four days later , embryos in diapause were flushed out of the uterus and cultured on STO feeder cells in four-well plates in Dulbecco 's Modified Eagle Medium ( DMEM ) supplemented with 20 % Fetal Bovine Serum ( Hyclone ) , 0.1 mM Non-Essential Amino Acids ( Invitrogen ) , 2 mM L-glutamine ( Invitrogen ) , 50 U/ml Penicillin-Streptomysin ( Invitrogen ) , and 0.11 mM 2-mercaptoethanol ( Invitrogen ) .
# ::tok Four days later , embryos in diapause were flushed out of the uterus and cultured on STO feeder cells in four-well plates in Dulbecco 's Modified Eagle Medium ( DMEM ) supplemented with 20 % Fetal Bovine Serum ( Hyclone ) , 0.1 mM Non-Essential Amino Acids ( Invitrogen ) , 2 mM L-glutamine ( Invitrogen ) , 50 U/ml Penicillin-Streptomysin ( Invitrogen ) , and 0.11 mM 2-mercaptoethanol ( Invitrogen ) .
# ::alignments 65-66|0 59-61|0.4.0.1+0.4.0.0+0.4.0+0.4 58-59|0.4.1 53-54|0.3.0.0+0.3.0+0.3 51-52|0.3.2 48-49|0.2.0.0+0.2.0+0.2 44-47|0.1.1.2+0.1.1.1+0.1.1.0+0.1.1+0.1 43-44|0.1.0 42-43|0.3.1.1.0 36-38|0.0.2.1+0.0.2.0+0.0.2+0.0 35-36|0.0.1 34-35|0.0.1.0 33-34|0.3.1.0.0 31-32|0.0.0 29-30|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 25-28|0.0.0.0.0.2+0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 23-24|0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 21-22|0.3.1.1.3 18-19|0.3.1.1.2 17-18|0.3.1.1.2.0 16-17|0.3.1.1.2.0.1.0.0+0.3.1.1.2.0.1.0+0.3.1.1.2.0.1 14-15|0.3.1.1 13-14|0.3.1 12-13|0.3.1.0.1 8-9|0.3.1.0 6-7|0.3.1.1.2.0.0 4-5|0.3.1.1.1 2-3|0.3.1.0.2 1-2|0.3.1.0.2.0+0.3.1.0.2.0.0 0-1|0.3.1.0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:18.930
(a / and 
      :op1 (t / thing 
            :ARG2-of (s2 / supplement-01 
                  :ARG0 (o4 / organization 
                        :name (n7 / name 
                              :op1 "Modified" 
                              :op2 "Eagle" 
                              :op3 "Medium") 
                        :poss (c / country 
                              :name (n8 / name 
                                    :op1 "Dulbecco"))) 
                  :ARG1 (o3 / organization 
                        :name (n6 / name 
                              :op1 "DMEM"))) 
            :mod (f / fetal 
                  :mod (p3 / percentage-entity)) 
            :name (n5 / name 
                  :op1 (b / Bovine) 
                  :op2 (s / Serum))) 
      :op2 (o2 / organization 
            :mod (m / mm) 
            :name (n4 / name 
                  :op1 "Non-Essential" 
                  :op2 "Amino" 
                  :op3 "Acids")) 
      :op3 (o / organization 
            :name (n3 / name 
                  :op1 "Invitrogen")) 
      :op4 (p2 / person 
            :name (n2 / name 
                  :op1 "L-glutamine") 
            :op3-of (a2 / and 
                  :op1 (f3 / flush-01 
                        :ARG0 20 
                        :ARG1 (u / uteru) 
                        :time (l / late 
                              :time-of (d2 / day 
                                    :unit-of (t2 / temporal-quantity 
                                          :quant 4)))) 
                  :op2 (c3 / culture-01 
                        :ARG0 0.1 
                        :ARG1 (e / embryo) 
                        :ARG2 (c2 / cell 
                              :mod (f2 / feed-01 
                                    :ARG0 (d / diapause) 
                                    :ARG1 (o5 / organization 
                                          :name (n9 / name 
                                                :op1 "STO")))) 
                        :time (p4 / plate))) 
            :quant 2) 
      :op5 (p / person 
            :name (n / name 
                  :op1 "U/ml" 
                  :op2 "Penicillin-Streptomysin") 
            :quant 50))

# ::snt After six days , the central mass of each explant was harvested , rinsed in PBS , and placed in a drop of trypsin for a few minutes .
# ::tok After six days , the central mass of each explant was harvested , rinsed in PBS , and placed in a drop of trypsin for a few minutes .
# ::alignments 27-28|0.1.2.1.0+0.1.2.1 26-27|0.1.2 23-24|0.1.1.0 21-22|0.1.1 18-19|0.1 17-18|0 15-16|0.0.1 13-14|0.0 11-12|0.2.0 9-10|0.1.0 8-9|0.1.0.0 6-7|0.0.0 5-6|0.0.0.0 2-3|0.1.2.0.1+0.1.2.0 1-2|0.1.2.0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:19.217
(a / and 
      :op1 (r / rinse-01 
            :ARG1 (m2 / mass 
                  :mod (c / central)) 
            :location (p2 / pb)) 
      :op2 (p / place-01 
            :ARG1 (e / explant 
                  :mod (e2 / each)) 
            :ARG2 (d / drop-01 
                  :ARG1 (t2 / trypsin)) 
            :duration (f / few 
                  :op1 (t3 / temporal-quantity 
                        :quant 6 
                        :unit (d2 / day)) 
                  :op2 (t / temporal-quantity 
                        :unit (m / minute)))) 
      :time (a2 / after 
            :time-of (h / harvest-01)))

# ::snt The cell mass was collected with a finely drawn-out Pasteur pipette preloaded with medium , ensuring minimal carryover of the trypsin .
# ::tok The cell mass was collected with a finely drawn-out Pasteur pipette preloaded with medium , ensuring minimal carryover of the trypsin .
# ::alignments 20-21|0.1.0.0.1 17-18|0.1.0.0 16-17|0.1.0.0.0 15-16|0.1.0 13-14|0.0 11-12|0.2 10-11|0.2.0 9-10|0.2.1 8-9|0.1.0.0.0.0 7-8|0.1.0.0.0.0.0 4-5|0 2-3|0.1 1-2|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:19.563
(c2 / collect-01 
      :ARG0 (m2 / medium) 
      :ARG1 (m3 / mass 
            :ARG0-of (e / ensure-01 
                  :ARG1 (c / carryov 
                        :ARG1-of (m / minimal-02 
                              :ARG0 (d / drawn-out 
                                    :mod (f / finely))) 
                        :poss (t / trypsin))) 
            :mod (c3 / cell)) 
      :ARG2 (p / preload 
            :mod (p2 / pipette) 
            :mod (p3 / pasteur)))

# ::snt The cells were gently transfered into a fresh well with 20 % FBS-containing medium .
# ::tok The cells were gently transfered into a fresh well with 20 % FBS-containing medium .
# ::alignments 13-14|0.1 12-13|0.1.1 11-12|0.1.2 10-11|0.1.0.0 7-8|0.1.0 4-5|0 3-4|0.2 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:19.643
(t / transfer-01 
      :ARG1 (c / cell) 
      :ARG2 (m / medium 
            :ARG1-of (f2 / fresh-04 
                  :ARG0 20) 
            :mod (f / fbs-contain) 
            :mod (p / percentage-entity)) 
      :manner (g / gently))

# ::snt The resulting primary ES cell colonies were individually passaged into wells of four-well plates containing STO feeder cell layers .
# ::tok The resulting primary ES cell colonies were individually passaged into wells of four-well plates containing STO feeder cell layers .
# ::alignments 18-19|0.0.0.0.0 17-18|0.0.0.0 16-17|0.0.0 15-16|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 14-15|0.0.0.0.0.0 13-14|0.0.0.0.0.0.0 10-11|0.0.0.0.0.0.0.0 7-8|0.0.0.0.0.0.1 5-6|0.0 4-5|0.0.1 3-4|0.0.1.0 2-3|0.0.1.0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:20.007
(r / result-01 
      :ARG1 (c3 / colony 
            :ARG2-of (f / feed-01 
                  :ARG0 (c / cell 
                        :mod-of (l / layer 
                              :ARG1-of (c2 / contain-01 
                                    :ARG0 (p / plate 
                                          :mod-of (w / well)) 
                                    :ARG2 (i / individual)))) 
                  :ARG1 (o / organization 
                        :name (n / name 
                              :op1 "STO"))) 
            :mod (c4 / cell 
                  :mod (e / e 
                        :mod (p2 / primary)))))

# ::snt Thereafter , cells were expanded by trypsinization of the entire culture .
# ::tok Thereafter , cells were expanded by trypsinization of the entire culture .
# ::alignments 10-11|0.0 9-10|0.0.0 4-5|0 2-3|0.1 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:20.031
(e2 / expand-01 
      :ARG0 (c / culture 
            :mod (e / entire)) 
      :ARG1 (c2 / cell) 
      :location (t / thereaft))

# ::snt Total RNA from wild-type ES cells and ESG1 - / - ES cells was labeled with Cy3 and Cy5 , respectively .
# ::tok Total RNA from wild-type ES cells and ESG1 - / - ES cells was labeled with Cy3 and Cy5 , respectively .
# ::alignments 20-21|0.2.1.0.2 18-19|0.2.1.2 17-18|0.2.1 16-17|0.2.0.0+0.2.0+0.2 14-15|0.2.1.0 12-13|0.2.1.0.1 9-10|0.2.1.0.0 7-8|0.1 6-7|0 5-6|0.0 4-5|0.0.0 1-2|0.2.1.1 0-1|0.2.1.1.0.0+0.2.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:20.300
(a2 / and 
      :op1 (c3 / cell 
            :mod (e2 / e)) 
      :op2 (e / ESG1) 
      :op3 (p / person 
            :name (n / name 
                  :op1 "Cy3") 
            :op2-of (a / and 
                  :ARG2-of (l / label-01 
                        :ARG0 (s / slash) 
                        :ARG1 (c2 / cell) 
                        :mod (r / respective)) 
                  :op1 (r2 / rna 
                        :mod (n2 / name 
                              :op1 "Total")) 
                  :op3 (c / Cy5))))

# ::snt The samples were hybridized to a Mouse Development Microarray ( Algilent ) according to the manufacturer 's protocol .
# ::tok The samples were hybridized to a Mouse Development Microarray ( Algilent ) according to the manufacturer 's protocol .
# ::alignments 17-18|0.0 15-16|0.0.0 12-13|0 10-11|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 6-9|0.1.1.0.2+0.1.1.0.1+0.1.1.0.0+0.1.1.0+0.1.1 3-4|0.1 1-2|0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:20.362
(s / say-01 
      :ARG0 (p / protocol 
            :poss (m / manufacture-01 
                  :ARG1 (o / organization 
                        :name (n / name 
                              :op1 "Algilent")))) 
      :ARG1 (h / hybridize-01 
            :ARG1 (t / thing 
                  :ARG1-of (s2 / sample-01)) 
            :ARG2 (o2 / organization 
                  :name (n2 / name 
                        :op1 "Mouse" 
                        :op2 "Development" 
                        :op3 "Microarray"))))

# ::snt Arrays were scanned with a G2565BA Microarray Scanner System ( Agilent ) .
# ::tok Arrays were scanned with a G2565BA Microarray Scanner System ( Agilent ) .
# ::alignments 10-11|0.0.0.0.0+0.0.0.0+0.0.0 5-9|0.1.0.3+0.1.0.2+0.1.0.1+0.1.0.0+0.1.0+0.1 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:20.464
(s / scan-01 
      :ARG1 (a / array-01 
            :ARG1 (o / organization 
                  :name (n / name 
                        :op1 "Agilent"))) 
      :ARG2 (o2 / organization 
            :name (n2 / name 
                  :op1 "G2565BA" 
                  :op2 "Microarray" 
                  :op3 "Scanner" 
                  :op4 "System")))

# ::snt Hybridization was repeated with two independent clones .
# ::tok Hybridization was repeated with two independent clones .
# ::alignments 6-7|0.1 5-6|0.1.0.0+0.1.0 4-5|0.1.1 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:20.520
(r / repeat-01 
      :ARG1 (h / hybridization) 
      :time (c / clone-01 
            :ARG0-of (d / depend-01 
                  :polarity -) 
            :quant 2))

# ::snt Data were analyzed with GeneSprings software ( Silico Genetics ) .
# ::tok Data were analyzed with GeneSprings software ( Silico Genetics ) .
# ::alignments 7-9|0.0.0.1+0.0.0.0+0.0.0+0.0 5-6|0.2 4-5|0.2.0.0.0+0.2.0.0+0.2.0 2-3|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:20.572
(a / analyze-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "Silico" 
                  :op2 "Genetics")) 
      :ARG1 (d / data) 
      :ARG2 (s / software 
            :mod (t / thing 
                  :name (n2 / name 
                        :op1 "GeneSprings"))))

# ::snt HA carried out the phenotypic studies of ESG1 knockout mice .
# ::tok HA carried out the phenotypic studies of ESG1 knockout mice .
# ::alignments 9-10|0.1.0 8-9|0.1.0.0 5-6|0.1 4-5|0.1.1 1-2|0 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:20.628
(c / carry-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "HA")) 
      :ARG1 (s / study-01 
            :ARG1 (m / mouse 
                  :mod (k / knockout)) 
            :mod (p / phenotypic)))

# ::snt KI determined the chromosomal localizations of the ESG1 gene and pseudogenes and constructed the targeting vector .
# ::tok KI determined the chromosomal localizations of the ESG1 gene and pseudogenes and constructed the targeting vector .
# ::alignments 15-16|0.0.0.0 14-15|0.0.0.0.0 12-13|0.0.0 11-12|0.0.0.1 10-11|0.0.0.2.0 9-10|0.0.0.2 8-9|0.0.0.1.0 4-5|0.1 3-4|0.1.0 1-2|0 0-1|0.0.1.0+0.0.1+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:20.729
(d / determine-01 
      :ARG0 (o / organization 
            :ARG0-of (c / construct-01 
                  :ARG1 (v / vector 
                        :ARG1-of (t / target-01)) 
                  :op2-of (a / and 
                        :op1 (g / gene)) 
                  :op2-of (a2 / and 
                        :op1 (p / pseudogen))) 
            :name (n / name 
                  :op1 "KI")) 
      :ARG1 (l / localization 
            :mod (c2 / chromosomal)))

# ::snt TI carried out mouse embryo manipulation .
# ::tok TI carried out mouse embryo manipulation .
# ::alignments 5-6|0.1 4-5|0.1.1 3-4|0.1.0 1-2|0 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:20.750
(c / carry-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "TI")) 
      :ARG1 (m / manipulate-01 
            :ARG1 (m2 / mouse) 
            :mod (e / embryo)))

# ::snt MM and MN carried out ES cell culture .
# ::tok MM and MN carried out ES cell culture .
# ::alignments 7-8|0.1 6-7|0.1.0 5-6|0.1.1 3-4|0 2-3|0.0.0.0.0+0.0.0.0+0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:20.778
(c3 / carry-01 
      :ARG0 (a / and 
            :op1 (c4 / country 
                  :name (n / name 
                        :op1 "MN"))) 
      :ARG1 (c / culture 
            :mod (c2 / cell) 
            :mod (e / e)))

# ::snt SY conceived of the study , and participated in its design and coordination and helped to draft the manuscript .
# ::tok SY conceived of the study , and participated in its design and coordination and helped to draft the manuscript .
# ::alignments 18-19|0.2.0.0.0 16-17|0.2.0.0 14-15|0.2.0 13-14|0.2 12-13|0.2.0.1.0 11-12|0.2.0.1 10-11|0.1.0 7-8|0.1 6-7|0 4-5|0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:20.844
(a3 / and 
      :ARG0-of (c2 / conceive-01 
            :ARG1 (s / study-01)) 
      :op1 (p / participate-01 
            :ARG1 (d2 / design-01)) 
      :op2 (a / and 
            :op1 (h / help-01 
                  :ARG1 (d / draft-01 
                        :ARG1 (m / manuscript)) 
                  :op2-of (a2 / and 
                        :op1 (c / coordinate-01)))))

# ::snt All authors read and approved the final manuscript .
# ::tok All authors read and approved the final manuscript .
# ::alignments 7-8|0.1.0.0 6-7|0.1.0.0.0 4-5|0.1.0 3-4|0.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:20.912
(r / read-01 
      :ARG1 (a3 / author-01 
            :mod (a4 / all)) 
      :op1-of (a2 / and 
            :ARG0-of (a / approve-01 
                  :ARG1 (m / manuscript 
                        :mod (f / final)))))

# ::snt We thank Chihiro Takigawa , Junko Iida , Masako Shirasaka , Yumi Ohuchi , and Megumi Narita for their technical and administrative assistance .
# ::tok We thank Chihiro Takigawa , Junko Iida , Masako Shirasaka , Yumi Ohuchi , and Megumi Narita for their technical and administrative assistance .
# ::alignments 22-23|0.2 21-22|0.2.0 20-21|0 19-20|0.1 15-17|0.0.1.1.3.0.1+0.0.1.1.3.0.0+0.0.1.1.3.0+0.0.1.1.3 14-15|0.0.1.1 11-13|0.0.1.1.2.0.1+0.0.1.1.2.0.0+0.0.1.1.2.0+0.0.1.1.2 8-10|0.0.1.1.1.0.1+0.0.1.1.1.0.0+0.0.1.1.1.0+0.0.1.1.1 5-7|0.0.1.1.0.0.1+0.0.1.1.0.0.0+0.0.1.1.0.0+0.0.1.1.0 2-4|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:21.619
(a3 / and 
      :op1 (t2 / thank-01 
            :ARG0 (w / we) 
            :ARG1 (p5 / person 
                  :name (n5 / name 
                        :op1 "Chihiro" 
                        :op2 "Takigawa") 
                  :op1-of (a4 / and 
                        :op2 (p4 / person 
                              :name (n4 / name 
                                    :op1 "Junko" 
                                    :op2 "Iida")) 
                        :op3 (p3 / person 
                              :name (n3 / name 
                                    :op1 "Masako" 
                                    :op2 "Shirasaka")) 
                        :op4 (p2 / person 
                              :name (n2 / name 
                                    :op1 "Yumi" 
                                    :op2 "Ohuchi")) 
                        :op5 (p / person 
                              :name (n / name 
                                    :op1 "Megumi" 
                                    :op2 "Narita"))))) 
      :op2 (t / technical) 
      :op3 (a / assist-01 
            :ARG1-of (a2 / administrate-01)))

# ::snt We are grateful to Drs. Minoru Ko and Azim Surani for sharing helpful data prior to publication , Dr. Hitoshi Niwa for generously providing various vectors , and Dr. Robert Farese Jr. for his kind gift of the RF8 ES cells .
# ::tok We are grateful to Drs. Minoru Ko and Azim Surani for sharing helpful data prior to publication , Dr. Hitoshi Niwa for generously providing various vectors , and Dr. Robert Farese Jr. for his kind gift of the RF8 ES cells .
# ::alignments 40-41|0.2.0.1.0.0 38-40|0.2.0.1.0.0.0.0.1+0.2.0.1.0.0.0.0.0+0.2.0.1.0.0.0.0+0.2.0.1.0.0.0 35-36|0.2.0.1.0+0.2.0.1 34-35|0.2.0.1.1 31-32|0.3.0 28-31|0.3.1.2+0.3.1.1+0.3.1.0+0.3.1+0.3 27-28|0 25-26|0.2.0.0 24-25|0.2.0.0.0 23-24|0.2.0 22-23|0.2.0.2 19-21|0.2.2.1+0.2.2.0+0.2.2+0.2 18-19|0.2.1 16-17|0.1.0+0.1 14-15|0.0.2 13-14|0.0.1 12-13|0.0.1.0 11-12|0.0 8-10|0.0.0.1.0.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 7-8|0.0.0 5-7|0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 2-3|0.0.0.2 0-1|0.0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:27.851
(a / and 
      :ARG2-of (s / share-01 
            :ARG0 (a3 / and 
                  :op1 (t6 / thing 
                        :name (n6 / name 
                              :op1 (m / Minoru) 
                              :op2 (k2 / Ko))) 
                  :op2 (t5 / thing 
                        :name (n5 / name 
                              :op1 (a2 / Azim) 
                              :op2 (s2 / Surani))) 
                  :prep-to-of (g3 / grateful 
                        :domain (w / we))) 
            :ARG1 (d3 / data 
                  :ARG1-of (h2 / helpful-04)) 
            :ARG4 (p3 / prior)) 
      :op1 (p2 / publication 
            :wiki -) 
      :op2 (t4 / thing 
            :beneficiary (p / provide-01 
                  :ARG1 (v / vector 
                        :mod (v2 / various)) 
                  :ARG2 (t2 / thing 
                        :ARG1-of (g / gift-01 
                              :ARG0 (c / cell 
                                    :mod (t / thing 
                                          :name (n / name 
                                                :op1 (r / RF8) 
                                                :op2 (e / ES))))) 
                        :mod (k / kind)) 
                  :manner (g2 / generosity)) 
            :mod (d2 / dr.) 
            :name (n3 / name 
                  :op1 (h / Hitoshi) 
                  :op2 (n4 / Niwa))) 
      :op3 (t3 / thing 
            :mod-of (j / jr.) 
            :name (n2 / name 
                  :op1 (d / Dr.) 
                  :op2 (r2 / Robert) 
                  :op3 (f / Farese))))

# ::snt This work was supported in part by research grants from the Ministry of Education , Culture , Sports , Science , and Technology of Japan , the Uehara Memorial Foundation , the Naito Foundation , the Sumitomo Research Foundation , the Mitsubishi Foundation .
# ::tok This work was supported in part by research grants from the Ministry of Education , Culture , Sports , Science , and Technology of Japan , the Uehara Memorial Foundation , the Naito Foundation , the Sumitomo Research Foundation , the Mitsubishi Foundation .
# ::alignments 41-43|0.0.0.0.2.0.1+0.0.0.0.2.0.0+0.0.0.0.2.0+0.0.0.0.2 36-39|0.0.0.0.1.0.2+0.0.0.0.1.0.1+0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 32-34|0.0.0.0.0.1.0.0.1+0.0.0.0.0.1.0.0.0+0.0.0.0.0.1.0.0+0.0.0.0.0.1.0 27-30|0.0.0.0.0.0.0.0.2+0.0.0.0.0.0.0.0.1+0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0 24-25|0.0.0.1.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 22-24|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 21-22|0.0.0.0.0 19-20|0.0.0.0.0.2 17-18|0.0.0.0.0.1 15-16|0.0.0.0.0.0 13-14|0.0.0.0 11-12|0.0.0 8-9|0.0 7-8|0.0.1 3-4|0 1-2|0.1 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:28.676
(s3 / support-01 
      :ARG0 (g / grant-01 
            :ARG0 (m / ministry 
                  :mod (e / education 
                        :op1-of (a / and 
                              :op2 (c3 / culture-01 
                                    :ARG1 (o4 / organization 
                                          :name (n4 / name 
                                                :op1 "Uehara" 
                                                :op2 "Memorial" 
                                                :op3 "Foundation"))) 
                              :op3 (s2 / sport-01 
                                    :ARG1 (o3 / organization 
                                          :name (n3 / name 
                                                :op1 "Naito" 
                                                :op2 "Foundation"))) 
                              :op4 (s / science)) 
                        :poss (o2 / organization 
                              :name (n2 / name 
                                    :op1 "Sumitomo" 
                                    :op2 "Research" 
                                    :op3 "Foundation")) 
                        :poss (o / organization 
                              :name (n / name 
                                    :op1 "Mitsubishi" 
                                    :op2 "Foundation"))) 
                  :poss (c / country 
                        :name (n5 / name 
                              :op1 "Japan") 
                        :wiki "Japan")) 
            :ARG1 (r / research-01)) 
      :ARG1 (w / work-01 
            :ARG0 (c2 / country 
                  :name (n6 / name 
                        :op1 "Technology" 
                        :op2 "of")) 
            :mod (t / this)))

# ::snt S.Y. was supported by a Toray Science and Technology Grant ( to S.Y. ) .
# ::tok S.Y. was supported by a Toray Science and Technology Grant ( to S.Y. ) .
# ::alignments 8-10|0.2.0.0.1+0.2.0.0.0+0.2.0.0+0.2.0 7-8|0.2 5-7|0.0.0.1+0.0.0.0+0.0.0+0.0 2-3|0 0-1|0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:29.114
(s / support-01 
      :ARG0 (o2 / organization 
            :name (n2 / name 
                  :op1 "Toray" 
                  :op2 "Science")) 
      :ARG1 (o3 / organization 
            :name (n3 / name 
                  :op1 "S.Y.")) 
      :manner (a / and 
            :op1 (o / organization 
                  :name (n / name 
                        :op1 "Technology" 
                        :op2 "Grant"))))

# ::snt This work was also supported in part by a Grant-in-Aid for 21st Century COE ( Center of Excellence ) Research from the Ministry of Education , Culture , Sports , Science , and Technology .
# ::tok This work was also supported in part by a Grant-in-Aid for 21st Century COE ( Center of Excellence ) Research from the Ministry of Education , Culture , Sports , Science , and Technology .
# ::alignments 33-34|0.0.0.0.3 32-33|0.0.0.0 30-31|0.0.0.0.0.0 28-29|0.0.0 26-27|0.0.0.0.2 24-25|0.0.0.0.1 22-23|0.0.0.0.1.0 19-20|0.0.0.0.0 17-18|0 15-16|0.0 12-14|0.0.0.0.2.0.0.1+0.0.0.0.2.0.0.0+0.0.0.0.2.0.0+0.0.0.0.2.0 11-12|0.0.0.0.0.1.1.0 9-10|0.0.0.0.0.1.0 4-5|0.0.0.0.0.1 3-4|0.0.0.0.0.1.2 1-2|0.0.0.0.0.1.1 0-1|0.0.0.0.0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T03:57:29.494
(e2 / excellence 
      :mod-of (c2 / center 
            :ARG1-of (s2 / sport-01 
                  :op4-of (a / and 
                        :op1 (r / research-01 
                              :ARG1 (s / science) 
                              :time-of (s3 / support-01 
                                    :ARG0 (g / grant-in-aid) 
                                    :ARG1 (w / work-01 
                                          :ARG1 21st 
                                          :mod (t3 / this)) 
                                    :mod (a2 / also))) 
                        :op2 (e / education 
                              :mod-of (m / ministry)) 
                        :op3 (c / culture-01 
                              :ARG1 (t2 / thing 
                                    :name (n / name 
                                          :op1 (c3 / Century) 
                                          :op2 (c4 / COE)))) 
                        :op5 (t / technology)))))

